: The AMEDEO Literature Guide

Home The Word Brain

Fast Track

My Amedeo

FAQ

About

Flying Publisher

	Fast Track

The Word Brain 2015 – Free PDF | Print | Web
A short guide to fast language learning

Free Abstracts

Bladder Cancer, January 2012
Free Subscription

Abstracts
Retrieve all available abstracts of the following 1458 articles:
HTML format

Single Articles

SZLISZKA E , Czuba ZP, Kawczyk-Krupka A, Sieron-Stoltny K, et al
Chlorin-based photodynamic therapy enhances the effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in bladder cancer cells.
Med Sci Monit. 2011;18:BR47-53.
Abstract Related articles

PAYTON S
Bladder cancer: Improving the management of T1 bladder cancer.
Nat Rev Urol. 2011;9:8.
Abstract Related articles

Bladder cancer: A new preoperative staging score for lymph node status emerges.
Nat Rev Urol. 2011;9:5.
Abstract Related articles

Bladder cancer: Long-term screening is recommended after BCG.
Nat Rev Urol. 2011;9:5.
Abstract Related articles

RAZZAK M
Bladder cancer: Hematuria and point-of-care tests.
Nat Rev Urol. 2011;9:4.
Abstract Related articles

RAZZAK M
Bladder cancer: Narrow-band imaging-improving urothelial carcinoma detection.
Nat Rev Urol. 2011;9:3.
Abstract Related articles

HASHIMOTO Y , Imanishi K, Tokui N, Okamoto T, et al
Carboplatin-gemcitabine combination chemotherapy upregulates AKR1B10 expression in bladder cancer.
Int J Clin Oncol. 2011.
Abstract Related articles

TRITSCHLER S , Mosler C, Straub J, Buchner A, et al
Staging of muscle-invasive bladder cancer: can computerized tomography help us to decide on local treatment?
World J Urol. 2011.
Abstract Related articles

FENG C , Wu Z, Guo T, Jiang H, et al
BLCA-4 expression is related to MMP-9, VEGF, IL-1alpha and IL-8 in bladder cancer but not to PEDF, TNF-alpha or angiogenesis.
Pathol Biol (Paris). 2011.
Abstract Related articles

LOUGHLIN KR
Bladder cancer: A window of opportunity to understand carcinogenesis.
Urol Oncol. 2011.
Abstract Related articles

HU T , Sinnott-Armstrong NA, Kiralis JW, Andrew AS, et al
Characterizing genetic interactions in human disease association studies using statistical epistasis networks.
BMC Bioinformatics. 2011;12:364.
Abstract Related articles

WILHELM-BENARTZI CS , Christensen BC, Koestler DC, Andres Houseman E, et al
Association of secondhand smoke exposures with DNA methylation in bladder carcinomas.
Cancer Causes Control. 2011;22:1205-13.
Abstract Related articles

ZHAI Z , Wang Z, Fu S, Lu J, et al
Antitumor effects of bladder cancer-specific adenovirus carrying E1A-androgen receptor in bladder cancer.
Gene Ther. 2012 Jan 5. doi: 10.1038/gt.2011.
Abstract Related articles

KIM TS , Rhew HY, Hwang HY
Pilot study of the clinical significance of serum and urinary her-2/neu protein in bladder cancer patients.
Korean J Urol. 2011;52:815-8.
Abstract Related articles

TSENG CH
Pioglitazone and Bladder Cancer: A population-based study of Taiwanese.
Diabetes Care. 2011.
Abstract Related articles

KIM WY , Chang SJ, Chang KH, Yoo SC, et al
Reliability of magnetic resonance imaging for bladder or rectum invasion in cervical cancer.
J Reprod Med. 2011;56.
Abstract Related articles

PARK SJ , Pai KS, Shin JI
Development of thrombotic microangiopathy in a patient with granulomatosis with polyangiitis.
Am J Kidney Dis. 2011;58:1038.
Abstract Related articles

GUNIA S , Koch S, Hakenberg OW, May M, et al
Different HER2 protein expression profiles aid in the histologic differential diagnosis between urothelial carcinoma in situ (CIS) and non-CIS conditions (dysplasia and reactive atypia) of the urinary bladder mucosa.
Am J Clin Pathol. 2011;136:881-8.
Abstract Related articles

CIMINO-MATHEWS A , Ali SZ
The clinicopathologic correlates of cellular atypia in urinary cytology of ileal neobladders.
Acta Cytol. 2011;55:449-54.
Abstract Related articles

GUAGNANO V , Furet P, Spanka C, Bordas V, et al
Discovery of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamin o]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), a potent and selective inhibitor of the fibroblast growth factor receptor family of receptor tyrosine kinase.
J Med Chem. 2011;54:7066-83.
Abstract Related articles

Toxicology and carcinogenesis studies of pulegone (CAS No. 89-82-7) in F344/N rats and B6C3F1 mice (gavage studies).
Natl Toxicol Program Tech Rep Ser. 2011;:1-201.
Abstract Related articles

NICOLAS MM , Jagirdar JS, Arisco AM, Valente PT, et al
Micropapillary carcinoma of the urinary bladder: report of a case and review of its cytologic features.
Diagn Cytopathol. 2011;39:784-7.
Abstract Related articles

CATENACCI M , Flyckt RL, Falcone T
Robotics in reproductive surgery: strengths and limitations.
Placenta. 2011;32 Suppl 3:S232-7.
Abstract Related articles

MERSEBURGER AS , Shariat SF
Urothelial carcinoma.
World J Urol. 2011;29:405-7.
Abstract Related articles

ABDOLLAH F , Sun M, Schmitges J, Thuret R, et al
Surgical caseload is an important determinant of continent urinary diversion rate at radical cystectomy: a population-based study.
Ann Surg Oncol. 2011;18:2680-7.
Abstract Related articles

NAGELE U , Kugler M, Nicklas A, Merseburger AS, et al
Waterjet hydrodissection: first experiences and short-term outcomes of a novel approach to bladder tumor resection.
World J Urol. 2011;29:423-7.
Abstract Related articles

PARK J , Kim S, Jeong IG, Song C, et al
Does the greater number of lymph nodes removed during standard lymph node dissection predict better patient survival following radical cystectomy?
World J Urol. 2011;29:443-9.
Abstract Related articles

GAKIS G , Schilling D, Perner S, Schwentner C, et al
Sequential resection of malignant ureteral margins at radical cystectomy: a critical assessment of the value of frozen section analysis.
World J Urol. 2011;29:451-6.
Abstract Related articles

MENASHE I , Figueroa JD, Garcia-Closas M, Chatterjee N, et al
Large-scale pathway-based analysis of bladder cancer genome-wide association data from five studies of European background.
PLoS One. 2012;7:e29396.
Abstract Related articles

HAN B , Cui D, Jing Y, Hong Y, et al
Estrogen receptor beta (ERbeta) is a novel prognostic marker of recurrence survival in non-muscle-invasive bladder cancer potentially by inhibiting cadherin switch.
World J Urol. 2012.
Abstract Related articles

YANG GL , Zhang LH, Bo JJ, Huo XJ, et al
Increased expression of HMGB1 is associated with poor prognosis in human bladder cancer.
J Surg Oncol. 2012 Jan 11. doi: 10.1002/jso.23040.
Abstract Related articles

CHEN YT , Chen HW, Domanski D, Smith DS, et al
Multiplexed quantification of 63 proteins in human urine by multiple reaction monitoring-based mass spectrometry for discovery of potential bladder cancer biomarkers.
J Proteomics. 2012.
Abstract Related articles

KADER AK
Bladder cancer.
ScientificWorldJournal. 2011;11:2565-6.
Abstract Related articles

PATEL P , Bryan RT, Wallace DM
Emerging endoscopic and photodynamic techniques for bladder cancer detection and surveillance.
ScientificWorldJournal. 2011;11:2550-8.
Abstract Related articles

TANG W , Fu YP, Figueroa JD, Malats N, et al
Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer.
Hum Mol Genet. 2012.
Abstract Related articles

HU H , Wang YL, Wang GW, Wong YC, et al
A novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer.
Urol Oncol. 2012.
Abstract Related articles

SARIBACAK A , Ozkurkcugil C, Ozkan L
Arteriovenous hemangioma of the urinary bladder following intravesical treatment.
Urol J. 2011;8:251-3.
Abstract Related articles

PAL K , Roy S, Mondal SA, Chatterjee U, et al
Urinary level of CA19-9 as a tumor marker in urothelial carcinoma of the bladder.
Urol J. 2011;8:203-8.
Abstract Related articles

KARADENIZ T , Baran C, Topsakal M, Kavukcu E, et al
Importance of the number of retreived lymph nodes during cystectomy.
Urol J. 2011;8:197-202.
Abstract Related articles

EBERLIN LS , Ferreira CR, Dill AL, Ifa DR, et al
Nondestructive, histologically compatible tissue imaging by desorption electrospray ionization mass spectrometry.
Chembiochem. 2011;12:2129-32.
Abstract Related articles

BRAASCH MR , Griffith TS, Cooper CS, Austin JC, et al
Description of a novel murine model for ileocystoplasty and early histologic changes.
ScientificWorldJournal. 2011;11:1325-31.
Abstract Related articles

HUGUET J
[Management of the male urethra before and after cystectomy: from the prophylactic urethrectomy to the intraoperative frozen section biopsy of the urethral margin].
Actas Urol Esp. 2011;35:552-8.
Abstract Related articles

WISLER JA , Afshari C, Fielden M, Zimmermann C, et al
Raf inhibition causes extensive multiple tissue hyperplasia and urinary bladder neoplasia in the rat.
Toxicol Pathol. 2011;39:809-22.
Abstract Related articles

MCKNIGHT R , Cohen C, Siddiqui MT
Fascin stain as a potential marker of invasiveness in carcinomas of the urinary bladder: a retrospective study with biopsy and cytology correlation.
Diagn Cytopathol. 2011;39:635-40.
Abstract Related articles

JONES G , Cleves A, Wilt TJ, Mason M, et al
Intravesical gemcitabine for non-muscle invasive bladder cancer.
Cochrane Database Syst Rev. 2012;1:CD009294.
Abstract Related articles

GECIT I , Aslan M, Gunes M, Pirincci N, et al
Serum prolidase activity, oxidative stress, and nitric oxide levels in patients with bladder cancer.
J Cancer Res Clin Oncol. 2012.
Abstract Related articles

CHOI W , Shah JB, Tran M, Svatek R, et al
p63 Expression Defines a Lethal Subset of Muscle-Invasive Bladder Cancers.
PLoS One. 2012;7:e30206.
Abstract Related articles

YANG W , Cui S, Ma J, Lu Q, et al
Cigarette smoking extract causes hypermethylation and inactivation of WWOX gene in T-24 human bladder cancer cells.
Neoplasma. 2012;59:216-23.
Abstract Related articles

SHEN Y , Liu Y, Liu S, Zhang A, et al
The Association Between -330T/G Polymorphism of Interleukin 2 Gene and Bladder Cancer.
DNA Cell Biol. 2012.
Abstract Related articles

MALKHASIAN KA , Petrov SV, Ul'ianin MIu, Abdrakhmanov EF, et al
[Use of fluorescent in situ hybridization in the cytogenetic diagnosis of urinary bladder urothelial carcinoma].
Vopr Onkol. 2011;57:462-9.
Abstract Related articles

BERA MK , Pal K
Bladder leiomyoma: a case report.
J Indian Med Assoc. 2011;109:272-3.
Abstract Related articles

HO CC
Electromotive administration of mitomycin.
Lancet Oncol. 2011;12:1183.
Abstract Related articles

JAIN D , Dhawan S, Chopra P
Urothelial carcinoma with multiple patterns of divergent differentiation featuring small cell, clear cell, papillary glandular and squamous cell morphology.
Indian J Pathol Microbiol. 2011;54:651-2.
Abstract Related articles

WNEK SM , Kuhlman CL, Camarillo JM, Medeiros MK, et al
Interdependent genotoxic mechanisms of monomethylarsonous acid: role of ROS-induced DNA damage and poly(ADP-ribose) polymerase-1 inhibition in the malignant transformation of urothelial cells.
Toxicol Appl Pharmacol. 2011;257:1-13.
Abstract Related articles

BASS L , Hegeman TW
Multiple primary cancers including mesothelioma of the tunica vaginalis: case report and literature review with primary care focus.
J Am Osteopath Assoc. 2011;111:483-6.
Abstract Related articles

WINQUIST E , Rodrigues G
Open clinical uro-oncology trials in Canada.
Can J Urol. 2011;18:5849-55.
Abstract Related articles

ABRAHAM NE , Simon R, Shah O
Thermal injury causing delayed perforation of small bowel after transurethral resection of bladder tumor without evidence of bladder perforation.
Can J Urol. 2011;18:5836-8.
Abstract Related articles

YANG X , Chan JC
Comment: analyses using time-dependent pioglitazone usage in Cox models may lead to wrong conclusions about its association with cancer.
Diabetes Care. 2011;34:e136.
Abstract Related articles

CHEN N , Gong J, Zeng H, Wei Q, et al
[Value of fluorescence in situ hybridization of urine exfoliative cells in diagnosis of urinary bladder neoplasms].
Sichuan Da Xue Xue Bao Yi Xue Ban. 2011;42:109-13.
Abstract Related articles

YAVUZER D , Karadayi N, Salepci T, Baloglu H, et al
Role of human papillomavirus in the development of urothelial carcinoma.
Med Oncol. 2011;28:919-23.
Abstract Related articles

HEIDENREICH A , Porres D, Pfister D
[Treatment of bladder cancer : Value of radical prostate-sparing cystectomy.]
Urologe A. 2012.
Abstract Related articles

SANCHEZ-CARBAYO M
Hypermethylation in bladder cancer: biological pathways and translational applications.
Tumour Biol. 2012.
Abstract Related articles

HUANG WW , Yang JS, Lin MW, Chen PY, et al
Cucurbitacin E Induces G(2)/M Phase Arrest through STAT3/p53/p21 Signaling and Provokes Apoptosis via Fas/CD95 and Mitochondria-Dependent Pathways in Human Bladder Cancer T24 Cells.
Evid Based Complement Alternat Med. 2012;2012:952762.
Abstract Related articles

CHEN H , Lin YW, Mao YQ, Wu J, et al
MicroRNA-449a acts as a tumor suppressor in human bladder cancer through the regulation of pocket proteins.
Cancer Lett. 2012.
Abstract Related articles

FEI X , Qi M, Wu B, Song Y, et al
MicroRNA-195-5p suppresses glucose uptake and proliferation of human bladder cancer T24 cells by regulating GLUT3 expression.
FEBS Lett. 2012.
Abstract Related articles

MIURA N , Takemori N, Kikugawa T, Tanji N, et al
Adseverin: A novel cisplatin-resistant marker in the human bladder cancer cell line HT1376 identified by quantitative proteomic analysis.
Mol Oncol. 2012.
Abstract Related articles

FENG CC , Wang PH, Guan M, Jiang HW, et al
Urinary BLCA-4 is Highly Specific for Detection of Bladder Cancer in Chinese Han Population and Is Related to Tumour Invasiveness.
Folia Biol (Praha). 2011;57:242-7.
Abstract Related articles

CASROUGE A , Bisiaux A, Stephen L, Schmolz M, et al
Discrimination of agonist and antagonist forms of CXCL10 in biological samples.
Clin Exp Immunol. 2012;167:137-48.
Abstract Related articles

CASWELL M
Transitional cell carcinoma of the urinary bladder in a 14-year-old dog.
Can Vet J. 2011;52:673-5.
Abstract Related articles

ROY S , Parwani AV
Adenocarcinoma of the urinary bladder.
Arch Pathol Lab Med. 2011;135:1601-5.
Abstract Related articles

SUZUKI K , Shimada T, Ebine T, Momma T, et al
[Local recurrence of micropapillary bladder tumor after radical cystectomy : successful treatment with radiation therapy : a case report].
Hinyokika Kiyo. 2011;57:577-9.
Abstract Related articles

YAMADA Y , Ueda Y, Higuchi Y, Suzuki T, et al
[Metachronous urothelial cancer in bilateral upper urinary tracts and bladder associated with hereditary nonpolyposis colorectal cancer].
Hinyokika Kiyo. 2011;57:559-63.
Abstract Related articles

KIM CJ , Sano T, Tomita K, Takimoto K, et al
[Incidence and risk factors of early postoperative paralytic ileus after radical cystectomy and cutaneous ureterostomy with a unilateral and parallel stoma].
Hinyokika Kiyo. 2011;57:535-8.
Abstract Related articles

MATSUSHITA S , Yonekura K, Mera K, Kawai K, et al
Successful treatment of metastatic extramammary Paget's disease with S-1 and docetaxel combination chemotherapy.
J Dermatol. 2011;38:996-8.
Abstract Related articles

GIL DA COSTA RM , Oliveira PA, Vilanova M, Bastos MM, et al
Ptaquiloside-induced, B-cell lymphoproliferative and early-stage urothelial lesions in mice.
Toxicon. 2011;58.
Abstract Related articles

HUA MY , Yang HW, Liu HL, Tsai RY, et al
Superhigh-magnetization nanocarrier as a doxorubicin delivery platform for magnetic targeting therapy.
Biomaterials. 2011;32:8999-9010.
Abstract Related articles

LEKKA M , Gil D, Dabros W, Jaczewska J, et al
Characterization of N-cadherin unbinding properties in non-malignant (HCV29) and malignant (T24) bladder cells.
J Mol Recognit. 2011;24:833-42.
Abstract Related articles

THOMPSON S , Cioffi-Lavina M, Chapman-Fredricks J, Gomez-Fernandez C, et al
Distinction of high-grade neuroendocrine carcinoma/small cell carcinoma from conventional urothelial carcinoma of urinary bladder: an immunohistochemical approach.
Appl Immunohistochem Mol Morphol. 2011;19:395-9.
Abstract Related articles

KOUIDHI S , Rouissi K, Khedhiri S, Ouerhani S, et al
MTHFR Gene Polymorphisms and Bladder Cancer Susceptibility: a Meta-Analysis Including Race, Smoking Status and Tumour Stage.
Asian Pac J Cancer Prev. 2011;12:2227-32.
Abstract Related articles

[Some molecular-genetic markers, defining the pathogenesis of superficial and invasive bladder cancer].
Mol Biol (Mosk). 2011;45:1012-6.
Abstract Related articles

ANASTASIADIS A , de Reijke TM
Best practice in the treatment of nonmuscle invasive bladder cancer.
Ther Adv Urol. 2012;4:13-32.
Abstract Related articles

JABLONOWSKI Z , Reszka E, Gromadzinska J, Wasowicz W, et al
Hypermethylation of p16 and DAPK promoter gene regions in patients with non-invasive urinary bladder cancer.
Arch Med Sci. 2011;7:512-6.
Abstract Related articles

KOTB AF , Kovac E, Kassouf W, Chin J, et al
Radical cystectomy for clinically muscle invasive bladder cancer: does prior non-invasive disease affect clinical outcomes?
World J Urol. 2012.
Abstract Related articles

MESSING E , Gee JR, Saltzstein DR, Kim K, et al
A Phase 2 Cancer Chemoprevention Biomarker Trial of Isoflavone G-2535 (Genistein) in Presurgical Bladder Cancer Patients.
Cancer Prev Res (Phila). 2012.
Abstract Related articles

AJILI F , Kaabi B, Darouiche A, Tounsi H, et al
Prognostic value of bcl-2 and bax tumor cell expression in patients with non muscle-invasive bladder cancer receiving bacillus calmette-guerin immunotherapy.
Ultrastruct Pathol. 2012;36:31-9.
Abstract Related articles

GULSEN F , Dikici S, Mihmanli I, Ozbayrak M, et al
Detection of Bladder Cancer Recurrence with Real-time Three-dimensional Ultrasonography-based Virtual Cystoscopy.
J Int Med Res. 2011;39:2264-72.
Abstract Related articles

LIN Y , Wu J, Chen H, Mao Y, et al
Cyclin-dependent kinase 4 is a novel target in micoRNA-195-mediated cell cycle arrest in bladder cancer cells.
FEBS Lett. 2012.
Abstract Related articles

CHEN LC , Chen CC, Cheng YY, Chen SC, et al
Cyclooxygenase-2 expression is up-regulated by 2-aminobiphenyl in a ROS and MAPK-dependent signaling pathway in a bladder cancer cell line.
Chem Res Toxicol. 2012.
Abstract Related articles

EISSA S , Zohny SF, Shehata HH, Hegazy MG, et al
Urinary retinoic acid receptot-beta2 gene promoter methylation and hyaluronidase activity as noninvasive tests for diagnosis of bladder cancer.
Clin Biochem. 2012.
Abstract Related articles

HUANG WW , Yang JS, Bai SR, Wu PP, et al
Bufalin induces G(0)/G(1) phase arrest through inhibiting the levels of cyclin D, cyclin E, CDK2 and CDK4, and triggers apoptosis via mitochondrial signaling pathway in T24 human bladder cancer cells.
Mutat Res. 2012.
Abstract Related articles

ROSENKRANTZ AB , Mussi TC, Spieler B, Melamed J, et al
High-grade bladder cancer: Association of the apparent diffusion coefficient with metastatic disease: Preliminary results.
J Magn Reson Imaging. 2012 Jan 26. doi: 10.1002/jmri.23590.
Abstract Related articles

RINK M , Chun FK, Chromecki TF, Fajkovic H, et al
[Advanced bladder cancer in elderly patients : Prognostic outcomes and therapeutic strategies.]
Urologe A. 2012.
Abstract Related articles

PEPE P , Candiano G, Pennisi M, Aragona F, et al
Unusual indications for transrectal pelvic ultrasound.
Arch Ital Urol Androl. 2011;83:166-8.
Abstract Related articles

SHIMADA K , Fujii T, Anai S, Fujimoto K, et al
ROS generation via NOX4 and its utility in the cytological diagnosis of urothelial carcinoma of the urinary bladder.
BMC Urol. 2011;11:22.
Abstract Related articles

YUAN XK , Zhao XK, Xia YC, Zhu X, et al
Increased circulating immunosuppressive CD14(+)HLA-DR(-/low) cells correlate with clinical cancer stage and pathological grade in patients with bladder carcinoma.
J Int Med Res. 2011;39:1381-91.
Abstract Related articles

SUAREZ SANTISTEBAN MA , Garcia-Bernalt Funes MV, Mora Mora M, Novillo Santano RA, et al
Varicella zoster virus: complications in an ANCA-positive vasculitis.
Nefrologia. 2011;31:616-8.
Abstract Related articles

MEMBRINO A , Cogoi S, Pedersen EB, Xodo LE, et al
G4-DNA formation in the HRAS promoter and rational design of decoy oligonucleotides for cancer therapy.
PLoS One. 2011;6:e24421.
Abstract Related articles

WU G , Cao Y, Fan B, Zheng F, et al
High-mobility group protein N2 (HMGN2) inhibited the internalization of Klebsiella pneumoniae into cultured bladder epithelial cells.
Acta Biochim Biophys Sin (Shanghai). 2011;43:680-7.
Abstract Related articles

SUN P , Zhou D, Gan Z
Novel reduction-sensitive micelles for triggered intracellular drug release.
J Control Release. 2011;155:96-103.
Abstract Related articles

OGUZTUZUN S , Sezgin Y, Yazici S, Firat P, et al
Expression of glutathione-S-transferases isoenzymes and p53 in exfoliated human bladder cancer cells.
Urol Oncol. 2011;29:538-44.
Abstract Related articles

BEHNSAWY HM , Miyake H, Abdalla MA, Sayed MA, et al
Expression of cell cycle-associated proteins in non-muscle-invasive bladder cancer: correlation with intravesical recurrence following transurethral resection.
Urol Oncol. 2011;29:495-501.
Abstract Related articles

DRAYTON RM , Catto JW
Molecular mechanisms of cisplatin resistance in bladder cancer.
Expert Rev Anticancer Ther. 2012;12:271-81.
Abstract Related articles

SONPAVDE G , Sternberg CN
Neoadjuvant Chemotherapy for Invasive Bladder Cancer.
Curr Urol Rep. 2012.
Abstract Related articles

YOUSSEF RF , Raj GV
Lymphadenectomy in management of invasive bladder cancer.
Int J Surg Oncol. 2011;2011:758189.
Abstract Related articles

YAN C , Kim YW, Ha YS, Kim IY, et al
RUNX3 methylation as a predictor for disease progression in patients with non-muscle-invasive bladder cancer.
J Surg Oncol. 2012;105:425-30.
Abstract Related articles

VOLKMER JP , Sahoo D, Chin RK, Ho PL, et al
Three differentiation states risk-stratify bladder cancer into distinct subtypes.
Proc Natl Acad Sci U S A. 2012.
Abstract Related articles

LESSEUR C , Gilbert-Diamond D, Andrew AS, Ekstrom RM, et al
A case-control study of polymorphisms in xenobiotic and arsenic metabolism genes and arsenic-related bladder cancer in New Hampshire.
Toxicol Lett. 2012.
Abstract Related articles

SVATEK RS , Rosenberg JE, Galsky MD, Lee CT, et al
Summary of the 6th annual bladder cancer think tank: New directions in urologic research.
Urol Oncol. 2012.
Abstract Related articles

ZHU X , Zhong Z, Zhang X, Zhao X, et al
DNA Repair Gene XRCC3 T241m Polymorphism and Bladder Cancer Risk in a Chinese Population.
Genet Test Mol Biomarkers. 2012.
Abstract Related articles

KYODA Y , Kunishima Y, Fukuta F
[Experience with gemcitabine monotherapy in three patients with metastatic urothelial carcinoma].
Nihon Hinyokika Gakkai Zasshi. 2011;102:701-4.
Abstract Related articles

UETSUKI H , Hirama H, Matsuoka Y, Miyauchi Y, et al
[A case with hepatitis and interstitial pneumonitis caused by intravesical bacillus Calmette-Guerin (BCG) instillation].
Nihon Hinyokika Gakkai Zasshi. 2011;102:691-5.
Abstract Related articles

OTSUBO S , Tanaka S, Kamiryo Y, Okumur K, et al
[A case of primary pleural angiosarcoma metastasing to the bladder].
Nihon Hinyokika Gakkai Zasshi. 2011;102:686-90.
Abstract Related articles

TATSUNO M , Tamura S, Taniguchi F, Yasuoka H, et al
[A case of metastatic pulmonary cancer from urachal carcinoma that required differentiation from primary lung adenocarcinoma].
Nihon Kokyuki Gakkai Zasshi. 2011;49:848-54.
Abstract Related articles

MEDEIROS M , Zheng X, Novak P, Wnek SM, et al
Global gene expression changes in human urothelial cells exposed to low-level monomethylarsonous acid.
Toxicology. 2012;291.
Abstract Related articles

LESTRE SI , Gameiro CD, Joao A, Lopes MJ, et al
Granulomas of the penis: a rare complication of intravesical therapy with Bacillus Calmette-Guerin.
An Bras Dermatol. 2011;86:759-62.
Abstract Related articles

SHIN JH , Chao ST, Angelov L
Stereotactic radiosurgery for spinal metastases: update on treatment strategies.
J Neurosurg Sci. 2011;55:197-209.
Abstract Related articles

GAO CQ , Mithani R, Leya J, Dawravoo L, et al
Granulomatous hepatitis, choroiditis and aortoduodenal fistula complicating intravesical Bacillus Calmette-Guerin therapy: Case report.
BMC Infect Dis. 2011;11:260.
Abstract Related articles

KAMRADT J , Ohlmann CH, Stockle M
[Current developments in the diagnostics and therapy of bladder carcinoma].
Urologe A. 2011;50 Suppl 1:179-83.
Abstract Related articles

TAUBER S , Brunken C, Vierbuchen M
[Expression of the tumormarker p16INK4a in cytology specimens of the urinary bladder. A new means for early recognition and surveillance of urothelial cancer].
Urologe A. 2011;50:1130-3.
Abstract Related articles

VOM DORP F , Tschirdewahn S, Olbricht T, Szarvas T, et al
[Photodynamic diagnostics of bladder carcinoma].
Urologe A. 2011;50:1068-71.
Abstract Related articles

RUBBEN H , Vom Dorp F
[Urothelial carcinoma].
Urologe A. 2011;50 Suppl 1:176-8.
Abstract Related articles

BUSATO WF JR , Almeida GL, Ogata DC
Primary primitive neuroectodermal tumor of the bladder: histologic and clinical features of 9 cases.
Clin Genitourin Cancer. 2011;9:63-7.
Abstract Related articles

STRITTMATTER F , Buchner A, Karl A, Sommer ML, et al
Individual learning curve reduces the clinical value of urinary cytology.
Clin Genitourin Cancer. 2011;9:22-6.
Abstract Related articles

TANG MS , Wang HT, Hu Y, Chen WS, et al
Acrolein induced DNA damage, mutagenicity and effect on DNA repair.
Mol Nutr Food Res. 2011;55:1291-300.
Abstract Related articles

GOMEZ-MORENO AZ , Repiso A, Del Mar Lombera M, Guardiola A, et al
[Endoscopic and echoendoscopic findings in secondary linitis plastica of the rectum].
Gastroenterol Hepatol. 2011;34:535-8.
Abstract Related articles

NIEGISCH G , Rabenalt R, Albers P
[Robot-assisted radical cystectomy. Pilot study for the prospective evaluation of perioperative parameters compared to open radical cystectomy].
Urologe A. 2011;50:1076-82.
Abstract Related articles

KALBLE T , Hofmann I
[Tumors following urinary diversions. Results of a multicenter study].
Urologe A. 2011;50:1134-6.
Abstract Related articles

WANG X , Yan J
Fitting semiparametric regressions for panel count survival data with an R package spef.
Comput Methods Programs Biomed. 2011;104:278-85.
Abstract Related articles

YOSHIOKA H , Kinoshita M, Ogawa M, Tsuruta T, et al
[A Case of a Patient with Bladder Cancer Who Received Warfarin and Showed a Significantly Prolonged PT-INR after Gemcitabine and Cisplatin Combination Therapy].
Gan To Kagaku Ryoho. 2012;39:321-3.
Abstract Related articles

SHEN CH , Wu JD, Jou YC, Cheng MC, et al
The correlation between TWIST, E-cadherin, and beta-catenin in human bladder cancer.
J BUON. 2011;16:733-7.
Abstract Related articles

BURGER M , Goebell PJ
Bladder cancer: Validity of the 2004 system for grading Ta bladder cancer.
Nat Rev Urol. 2012 Feb 14. doi: 10.1038/nrurol.2012.
Abstract Related articles

BOCHNER BH , Laudone VP
Bladder cancer treatment: optimize, don't compromise.
Oncology (Williston Park). 2011;25:1412-3.
Abstract Related articles

SKINNER EC
Challenges in the modern treatment of muscle-invasive bladder cancer.
Oncology (Williston Park). 2011;25:1405-6.
Abstract Related articles

DICKSTEIN RJ , Kamat AM
Contemporary management of locally invasive bladder cancer.
Oncology (Williston Park). 2011;25:1396-405.
Abstract Related articles

BEHRENS T , Pesch B, Bruning T
Urinary bladder cancer risk factors in Egypt - Letter.
Cancer Epidemiol Biomarkers Prev. 2012.
Abstract Related articles

ZHENG YL , Dash C, Loffredo C
Urinary bladder cancer risk factors in Egypt: a multicenter case-control study - Response.
Cancer Epidemiol Biomarkers Prev. 2012.
Abstract Related articles

SVATEK R , Zehnder P
Role and Extent of Lymphadenectomy During Radical Cystectomy for Invasive Bladder Cancer.
Curr Urol Rep. 2012.
Abstract Related articles

PARK WK , Kim YS
Pattern of lymph node metastasis correlates with tumor location in bladder cancer.
Korean J Urol. 2012;53:14-7.
Abstract Related articles

SON HW , Kim DY, Lee OK, Park SE, et al
Severe hypotension following urethral catheterization during general anesthesia in a patient with bladder cancer -A case report-.
Korean J Anesthesiol. 2012;62:91-5.
Abstract Related articles

JENTZMIK F , Schrader AJ, de Petriconi R, Hefty R, et al
The ileal neobladder in female patients with bladder cancer: long-term clinical, functional, and oncological outcome.
World J Urol. 2012.
Abstract Related articles

DAI QS , He HC, Cai C, Chen JH, et al
[Multicenter case-control study of the relationship between smoking and bladder cancer in China].
Zhonghua Yi Xue Za Zhi. 2011;91:2407-10.
Abstract Related articles

INOUE T , Sugi M, Masuda T, Nishida T, et al
[A case of primary urinary bladder and ureter cancer with a choriocarcinoma].
Hinyokika Kiyo. 2011;57:633-7.
Abstract Related articles

TEPPA A , Rosini R, Tonini G, Tosana M, et al
[Uretero-ileal anastomosis in orthotopic neobladder: antireflux versus direct techinique].
Urologia. 2011;78:190-5.
Abstract Related articles

FANARI M , Serra S, Corona A, De Lisa A, et al
[Fluorescence cystoscopy with hexaminolevulinate: our preliminary experience of 184 procedures].
Urologia. 2011;78:187-9.
Abstract Related articles

TAPIA C , Glatz K, Obermann EC, Grilli B, et al
Evaluation of chromosomal aberrations in patients with benign conditions and reactive changes in urinary cytology.
Cancer Cytopathol. 2011;119:404-10.
Abstract Related articles

GALVAN AB , Salido M, Espinet B, Placer J, et al
A multicolor fluorescence in situ hybridization assay: A monitoring tool in the surveillance of patients with a history of non-muscle-invasive urothelial cell carcinoma: A prospective study.
Cancer Cytopathol. 2011;119:395-403.
Abstract Related articles

KIM WJ , Kim YJ
Epigenetics of bladder cancer.
Methods Mol Biol. 2012;863:111-8.
Abstract Related articles

Comparison of virtual cystoscopy and ultrasonography for bladder cancer detection: a meta-analysis.
Ultrasound Q. 2012;28:41.
Abstract Related articles

GAZZANIGA P , Gradilone A, de Berardinis E, Busetto GM, et al
Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: a CellSearch analysis.
Ann Oncol. 2012.
Abstract Related articles

TAKEUCHI A , Taguchi M, Satoh Y, Ishida M, et al
Bilateral orbital inflammation following intravesical bacille Calmette-Guerin immunotherapy for bladder cancer.
Jpn J Ophthalmol. 2012.
Abstract Related articles

RESZKA E
Selenoproteins in bladder cancer.
Clin Chim Acta. 2012.
Abstract Related articles

MAZDAK H , Zia H
Vitamin e reduces superficial bladder cancer recurrence: a randomized controlled trial.
Int J Prev Med. 2012;3:110-5.
Abstract Related articles

CHUANG CH , Huang YW, Wu YT
System-level biochip for impedance sensing and programmable manipulation of bladder cancer cells.
Sensors (Basel). 2011;11:11021-35.
Abstract Related articles

SUZUKI K , Nohda H, Funahashi M, Chiba K, et al
[Assessments of progression in non-muscle-invasive bladder cancer].
Hinyokika Kiyo. 2012;58:1-5.
Abstract Related articles

ZHANG Y , Wang Z, Yu J, Shi JZ, et al
Cancer stem-like cells contribute to cisplatin resistance and progression in bladder cancer.
Cancer Lett. 2012.
Abstract Related articles

ZHANG T , Fan J, Wu K, Zeng J, et al
Roles of HIF-1alpha in a novel optical orthotopic spontaneous metastatic bladder cancer animal model.
Urol Oncol. 2012.
Abstract Related articles

MONTAGNER IM , Banzato A, Zuccolotto G, Renier D, et al
Paclitaxel-hyaluronan hydrosoluble bioconjugate: Mechanism of action in human bladder cancer cell lines.
Urol Oncol. 2012.
Abstract Related articles

TAKEUCHI M , Suzuki T, Sasaki S, Ito M, et al
Clinicopathologic Significance of High Signal Intensity on Diffusion-weighted MR Imaging in the Ureter, Urethra, Prostate and Bone of Patients with Bladder Cancer.
Acad Radiol. 2012.
Abstract Related articles

JOU YC , Shen CH, Cheng MC, Lin CT, et al
Bilateral ureteral complete obstruction with huge spontaneous urinoma formation in a patient with advanced bladder cancer.
J Chin Med Assoc. 2012;75:84-6.
Abstract Related articles

SHIPLEY WU
Thoughtful, practical and timely radiation therapy guidelines for patients with muscle-invasive bladder cancer.
J Med Imaging Radiat Oncol. 2012;56:4.
Abstract Related articles

GONG M , Dong W, An R
Glutathione S-transferase T1 Polymorphism Contributes to Bladder Cancer Risk: A Meta-Analysis Involving 50 Studies.
DNA Cell Biol. 2012.
Abstract Related articles

CHENG L , Xu JW, Teng XD, Zhao J, et al
[Recent advances in molecular pathology of bladder cancer].
Zhonghua Bing Li Xue Za Zhi. 2011;40:779-82.
Abstract Related articles

CROSWELL J , Fall B
Screening for bladder cancer.
Am Fam Physician. 2012;85:401-2.
Abstract Related articles

Screening for bladder cancer: recommendation statement.
Am Fam Physician. 2012;85:397-9.
Abstract Related articles

BANSAL P , Gupta A, Mongha R, Kundu AK, et al
Squamous cell carcinoma in exstrophic unreconstructed urinary bladder in an adult.
Saudi J Kidney Dis Transpl. 2012;23:122-4.
Abstract Related articles

CEKIC C , Sag D, Li Y, Theodorescu D, et al
Adenosine A2B receptor blockade slows growth of bladder and breast tumors.
J Immunol. 2012;188:198-205.
Abstract Related articles

NAKAMURA Y , Orikasa K, Fujishima F, Shibahara Y, et al
A case of villous adenoma of the urinary bladder with tubulovillous architecture: characterization by immunohistochemical analysis.
Pol J Pathol. 2011;62:179-82.
Abstract Related articles

WANG XH , Wang YJ, Lei CG
Evaluating the perfusion of occupying lesions of kidney and bladder with contrast-enhanced ultrasound.
Clin Imaging. 2011;35:447-51.
Abstract Related articles

HEINZELMANN F , Thorwarth D, Lamprecht U, Kaulich TW, et al
Comparison of different adjuvant radiotherapy approaches in childhood bladder/prostate rhabdomyosarcoma treated with conservative surgery.
Strahlenther Onkol. 2011;187:715-21.
Abstract Related articles

CALLE ML , Urrea V, Boulesteix AL, Malats N, et al
AUC-RF: a new strategy for genomic profiling with random forest.
Hum Hered. 2011;72:121-32.
Abstract Related articles

SHIN YS , Kim JY, Ko OS, Doo AR, et al
The direct anti-cancer effect of a single instillation of epirubicin after transurethral resection of bladder tumor for non-muscle-invasive bladder cancer.
Korean J Urol. 2012;53:78-81.
Abstract Related articles

DORNELAS CA , Fechine-Jamacaru FV, Albuquerque IL, Magalhaes HI, et al
Chemoprevention with green propolis green propolis extracted in L-lysine versus carcinogenesis promotion with L-lysine in N-Butyl-N-[4-hydroxybutyl] nitrosamine (BBN) induced rat bladder cancer.
Acta Cir Bras. 2012;27:185-92.
Abstract Related articles

BORKOWSKA E , Constantinou M, Jedrzejczyk A, Traczyk M, et al
Artificial neural network in predicting bladder cancer recurrence.
Hered Cancer Clin Pract. 2012;10 Suppl 1:A3.
Abstract Related articles

YANG HW , Hua MY, Liu HL, Tsai RY, et al
An epirubicin-conjugated nanocarrier with MRI function to overcome lethal multidrug-resistant bladder cancer.
Biomaterials. 2012.
Abstract Related articles

Bladder cancer: NMP22 cannot be used as a primary screening biomarker.
Nat Rev Urol. 2012 Feb 28. doi: 10.1038/nrurol.2012.
Abstract Related articles

KIM J , Kim WJ, Liu Z, Loda M, et al
The ubiquitin-specific protease USP2a enhances tumor progression by targeting cyclin A1 in bladder cancer.
Cell Cycle. 2012;11.
Abstract Related articles

TUNIO MA , Hashmi A, Rafi M, Qayyum A, et al
Bladder preservation by neoadjuvant chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer: experience at Sindh Institute of Urology & Transplantation (SIUT).
J Pak Med Assoc. 2011;61:6-10.
Abstract Related articles

QU G , Sheng Y, Chen B, Liu B, et al
[Effects of pseudolaric acid B on apoptosis of bladder cancer cell 5637].
Zhongguo Zhong Yao Za Zhi. 2011;36:3535-8.
Abstract Related articles

RAMIREZ-BACKHAUS M , Dominguez-Escrig J, Collado A, Rubio-Briones J, et al
Restaging Transurethral Resection of Bladder Tumor for High-risk Stage Ta and T1 Bladder Cancer.
Curr Urol Rep. 2012.
Abstract Related articles

PAN Q , Thariat J, Bogalhas F, Lagrange JL, et al
[Assessment of movements of the different anatomic portions of the bladder, implications for image-guided radiation therapy for bladder cancer.]
Cancer Radiother. 2012.
Abstract Related articles

SU CC , Su JH, Lin JJ, Chen CC, et al
An Investigation into the Cytotoxic Effects of 13-Acetoxysarcocrassolide from the Soft Coral Sarcophyton crassocaule on Bladder Cancer Cells.
Mar Drugs. 2011;9:2622-42.
Abstract Related articles

MARQUIS L , Tran M, Choi W, Lee IL, et al
p63 expression correlates with sensitivity to the Eg5 inhibitor ZD4877 in bladder cancer cells.
Cancer Biol Ther. 2012;13.
Abstract Related articles

TUNIO MA , Hashmi A, Qayyum A, Naimatullah N, et al
Outcome of trimodality protocol for invasive bladder cancer patients at Karachi, Pakistan.
J Pak Med Assoc. 2011;61:874-9.
Abstract Related articles

KOZUKA Y
[Diagnostic utility of immunohistochemistry for surgical pathology of the prostate].
Nihon Rinsho. 2011;69 Suppl 5:41-4.
Abstract Related articles

ANDERSEN FA
Annual Review of Cosmetic Ingredient Safety Assessments: 2007-2010.
Int J Toxicol. 2011;30.
Abstract Related articles

GALED-PLACED I , Valbuena-Ruvira L
Decoy cells and malignant cells coexisting in the urine from a transplant recipient with BK virus nephropathy and bladder adenocarcinoma.
Diagn Cytopathol. 2011;39:933-7.
Abstract Related articles

RAO RN , Sinha S, Babu S, Mehrotra R, et al
Fine-needle aspiration cytology of primitive neuroectodermal tumor of the urinary bladder: a case report.
Diagn Cytopathol. 2011;39:924-6.
Abstract Related articles

MCCARTHY TC
Comments on transurethral cystoscopy and on clinical practice.
J Am Vet Med Assoc. 2011;239:921-2.
Abstract Related articles

LANGENHOFF JM , Schoones JW
Re: Risk factors for bladder cancer: challenges of conducting a literature search using PubMed. September 2011.
Perspect Health Inf Manag. 2011;8:1g.
Abstract Related articles

ESCUDERO-LOURDES C , Wu T, Camarillo JM, Gandolfi AJ, et al
Interleukin-8 (IL-8) over-production and autocrine cell activation are key factors in monomethylarsonous acid [MMA(III)]-induced malignant transformation of urothelial cells.
Toxicol Appl Pharmacol. 2012;258:10-8.
Abstract Related articles

MUGABE C , Raven PA, Fazli L, Baker JH, et al
Tissue uptake of docetaxel loaded hydrophobically derivatized hyperbranched polyglycerols and their effects on the morphology of the bladder urothelium.
Biomaterials. 2012;33:692-703.
Abstract Related articles

DODURGA Y , Avci CB, Yilmaz S, Dogan ZO, et al
Evaluation of deleted in malignant brain tumors 1 (DMBT1) gene expression in bladder carcinoma cases: preliminary study.
Biomarkers. 2011;16:610-5.
Abstract Related articles

WANG Y , Luo H, Li Y, Chen T, et al
hsa-miR-96 up-regulates MAP4K1 and IRS1 and may function as a promising diagnostic marker in human bladder urothelial carcinomas.
Mol Med Report. 2012;5:260-5.
Abstract Related articles

MCMILLAN SK , Boria P, Moore GE, Widmer WR, et al
Antitumor effects of deracoxib treatment in 26 dogs with transitional cell carcinoma of the urinary bladder.
J Am Vet Med Assoc. 2011;239:1084-9.
Abstract Related articles

SALLAMI S , Ben Rhouma S, Hafsia G, Nouira Y, et al
[Intradiverticular tumors of the bladder: diagnostic and therapeutic problems: report of 32 cases].
Tunis Med. 2011;89.
Abstract Related articles

LEE JY , Kim SJ, Moon HS, Kim YT, et al
Initial experience of laparoendoscopic single-site nephroureterectomy with bladder cuff excision for upper urinary tract urothelial carcinoma performed by a single surgeon.
J Endourol. 2011;25:1763-8.
Abstract Related articles

ELLANTI P , Connolly SS, McDermott R, Crotty PL, et al
Malignant priapism: a case report.
Ir J Med Sci. 2011;180:921-2.
Abstract Related articles

FANNING DM , Sabah M, Conlon PJ, Mellotte GJ, et al
An unusual case of cancer of the urachal remnant following repair of bladder exstrophy.
Ir J Med Sci. 2011;180:913-5.
Abstract Related articles

CHANG JS , Lara PN Jr, Pan CX
Progress in personalizing chemotherapy for bladder cancer.
Adv Urol. 2012;2012:364919.
Abstract Related articles

METZGER T , Thalmann GN, Zehnder P
[Lymphadenectomy for bladder cancer : Current status and controversies].
Urologe A. 2012;51:310-8.
Abstract Related articles

HOSSEINI J , Golshan AR, Mazloomfard MM, Mehrsai AR, et al
Detection of Recurrent Bladder Cancer: NMP22 Test or Urine Cytology?
Urol J. 2012;9:367-72.
Abstract Related articles

FISHMAN AI , Johnson B, Alexander B, Won J, et al
Additively enhanced antiproliferative effect of interferon combined with proanthocyanidin on bladder cancer cells.
J Cancer. 2012;3:107-12.
Abstract Related articles

BELAKHLEF S , Church C, Jani C, Lakhanpal S, et al
Early Dynamic PET/CT and 18F-FDG Blood Flow Imaging in Bladder Cancer Detection: A Novel Approach.
Clin Nucl Med. 2012;37:366-8.
Abstract Related articles

LIU B , Mao Q, Lin Y, Zhou F, et al
The association of cruciferous vegetables intake and risk of bladder cancer: a meta-analysis.
World J Urol. 2012.
Abstract Related articles

YOSHIDA T , Takayama H, Uemura M, Nakai Y, et al
Solitary Skin Metastasis Adjacent to Ureterocutaneostomy 4 Years After Radical Cystectomy for Bladder Cancer.
Jpn J Clin Oncol. 2012.
Abstract Related articles

ZHENG QY , Yao C, Jin F, Zhang Y, et al
Ursolic acid-induced AMP-activated protein kinase (AMPK) activation contributes to growth inhibition and apoptosis in human bladder cancer T24 cells.
Biochem Biophys Res Commun. 2012.
Abstract Related articles

STOCCO B , Toledo K, Salvador M, Paulo M, et al
Dose-dependent effect of Resveratrol on bladder cancer cells: Chemoprevention and oxidative stress.
Maturitas. 2012.
Abstract Related articles

KOGA F , Numao N, Saito K, Masuda H, et al
Sensitivity to chemoradiation predicts development of metastasis in muscle-invasive bladder cancer patients.
Urol Oncol. 2012.
Abstract Related articles

WANG G , Chan ES, Kwan BC, Li PK, et al
Expression of microRNAs in the Urine of Patients With Bladder Cancer.
Clin Genitourin Cancer. 2012.
Abstract Related articles

STENZL A , Cowan NC, De Santis M, Kuczyk MA, et al
Treatment of Muscle-Invasive and Metastatic Bladder Cancer: Update of the EAU Guidelines.
Actas Urol Esp. 2012.
Abstract Related articles

SEE W
Commentary on "Association between smoking and risk of bladder cancer among men and women." Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes o
Urol Oncol. 2012;30:231-2.
Abstract Related articles

SEE W
Commentary on "Diabetes and risk of bladder cancer: Evidence from a case-control study in New England." MacKenzie T, Zens MS, Ferrara A, Schned A, Karagas MR, Department of Medicine, Dartmouth Medical School, Hanover, NH: Cancer 2011;117:1552-6.
Urol Oncol. 2012;30:230-1.
Abstract Related articles

SEE W
Commentary on "DNA methylation array analysis identifies profiles of blood-derived DNA methylation associated with bladder cancer." Marsit CJ, Koestler DC, Christensen BC, Karagas MR, Houseman EA, Kelsey KT, Pathology and Laboratory Medicine, Brown Un
Urol Oncol. 2012;30:230.
Abstract Related articles

GROSSMAN HB
Commentary on "Select screening in a specific high-risk population of patients suggests a stage migration toward detection of non-muscle-invasive bladder cancer." Zlotta AR, Roumeguere T, Kuk C, Alkhateeb S, Rorive S, Lemy A, van der Kwast TH, Fleshne
Urol Oncol. 2012;30:229.
Abstract Related articles

GROSSMAN HB
Commentary on "Paclitaxel gelatin nanoparticles for intravesical bladder cancer therapy." Lu Z, Yeh TK, Wang J, Chen L, Lyness G, Xin Y, Wientjes MG, Bergdall V, Couto G, Alvarez-Berger F, Kosarek CE, Au JL, Optimum Therapeutics, L.L.C., Columbus, OH:
Urol Oncol. 2012;30:228.
Abstract Related articles

GROSSMAN HB
Commentary on "International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: Long-term results of the BA06 30894 trial." Griffiths G, Hall R, Sylvester R, Raghavan D, Parm
Urol Oncol. 2012;30:226.
Abstract Related articles

KIRILUK KJ , Prasad SM, Patel AR, Steinberg GD, et al
Bladder cancer risk from occupational and environmental exposures.
Urol Oncol. 2012;30:199-211.
Abstract Related articles

WANG F , Wang Z, Tian H, Qi M, et al
Biodistribution and Safety Assessment of Bladder Cancer Specific Recombinant Oncolytic Adenovirus in Subcutaneous Xenografts Tumor Model in Nude Mice.
Curr Gene Ther. 2012.
Abstract Related articles

KIM JS , Chae Y, Ha YS, Kim IY, et al
Ras Association Domain Family 1A: A Promising Prognostic Marker in Recurrent Nonmuscle Invasive Bladder Cancer.
Clin Genitourin Cancer. 2012.
Abstract Related articles

FRASER B
Cancer cluster in Chile linked to arsenic contamination.
Lancet. 2012;379:603.
Abstract Related articles

ARAKAWA Y , Inoue D, Sakuyama T, Nagasaki E, et al
[Strontium-89 therapy and subarachnoid phenol block successfully eliminated intractable pain of metastasis in the patient with advanced urachal carcinoma].
Gan To Kagaku Ryoho. 2011;38 Suppl 1:59-60.
Abstract Related articles

LAMPE JW
Dairy products and cancer.
J Am Coll Nutr. 2011;30.
Abstract Related articles

AMORES-FUSTER I , Elliott JW, Freeman AI, Blackwood L, et al
Histiocytic sarcoma of the urinary bladder in a dog.
J Small Anim Pract. 2011;52:665.
Abstract Related articles

RACHH SH , Abhyankar S, Basu S
[(1)(3)(1)I]Metaiodobenzylguanidine therapy in neural crest tumors: varying outcome in different histopathologies.
Nucl Med Commun. 2011;32:1201-10.
Abstract Related articles

KE HL , Chang LL, Yang SF, Lin HH, et al
Osteopontin overexpression predicts poor prognosis of upper urinary tract urothelial carcinoma.
Urol Oncol. 2011;29:703-9.
Abstract Related articles

PASSEROTTI CC , Srougi M, Bomfim AC, Martins JR, et al
Testing for urinary hyaluronate improves detection and grading of transitional cell carcinoma.
Urol Oncol. 2011;29:710-5.
Abstract Related articles

BASSI PF , Bongiovanni L, Racioppi M, Volpe A, et al
Postoperative nomogram for invasive bladder cancer: does it really work? A multicenter cohort study.
Urol Oncol. 2011;29:698-702.
Abstract Related articles

WSZOLEK MF , Rieger-Christ KM, Kenney PA, Gould JJ, et al
A MicroRNA expression profile defining the invasive bladder tumor phenotype.
Urol Oncol. 2011;29:794-801.
Abstract Related articles

JUANPERE N , Agell L, Lorenzo M, de Muga S, et al
Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.
Hum Pathol. 2012.
Abstract Related articles

YOSHIDA S , Koga F, Kobayashi S, Ishii C, et al
Role of Diffusion-Weighted Magnetic Resonance Imaging in Predicting Sensitivity to Chemoradiotherapy in Muscle-Invasive Bladder Cancer.
Int J Radiat Oncol Biol Phys. 2012.
Abstract Related articles

VERMA S , Rajesh A, Prasad SR, Gaitonde K, et al
Urinary Bladder Cancer: Role of MR Imaging.
Radiographics. 2012;32:371-87.
Abstract Related articles

Bladder cancer: Circulating tumor cells could predict risk of recurrence.
Nat Rev Urol. 2012 Mar 13. doi: 10.1038/nrurol.2012.
Abstract Related articles

Bladder cancer: cis-Urocanic acid could prevent bladder cancer progression.
Nat Rev Urol. 2012 Mar 13. doi: 10.1038/nrurol.2012.
Abstract Related articles

BLACK PC
Molecular signaling and the role of targeted therapies in bladder cancer.
Minerva Urol Nefrol. 2012;64:7-17.
Abstract Related articles

KOZAK KR , Hamidi M, Manning M, Moody JS, et al
Bladder Preservation for Localized Muscle-Invasive Bladder Cancer: The Survival Impact of Local Utilization Rates of Definitive Radiotherapy.
Int J Radiat Oncol Biol Phys. 2012.
Abstract Related articles

MARTINEZ A , Ferron G, Mery E, Gladieff L, et al
Peritoneal pseudomyxoma arising from the urachus.
Surg Oncol. 2012;21:1-5.
Abstract Related articles

GOOSSENS ME , Buntinx F, Joniau S, Ackaert K, et al
Designing the selenium and bladder cancer trial (SELEBLAT), a phase lll randomized chemoprevention study with selenium on recurrence of bladder cancer in Belgium.
BMC Urol. 2012;12:8.
Abstract Related articles

ADAM RM
On the (C)USP(2a) of new targets for bladder cancer therapy?
Cell Cycle. 2012;11.
Abstract Related articles

PUERTA-GIL P , Garcia-Baquero R, Yuanyuan Jia A, Ocana S, et al
miR-143, miR-222, and miR-452 Are Useful as Tumor Stratification and Noninvasive Diagnostic Biomarkers for Bladder Cancer.
Am J Pathol. 2012.
Abstract Related articles

TSENG CH
Pioglitazone and bladder cancer in human studies: Is it diabetes itself, diabetes drugs, flawed analyses or different ethnicities?
J Formos Med Assoc. 2012;111:123-31.
Abstract Related articles

AHMAD I , Sansom OJ, Leung HY
Exploring molecular genetics of bladder cancer: lessons learned from mouse models.
Dis Model Mech. 2012.
Abstract Related articles

WU K , Zeng J, Zhou J, Fan J, et al
Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
Urol Oncol. 2012.
Abstract Related articles

TIGLI H , Seven D, Tunc M, Sanli O, et al
LKB1 mutations and their correlation with LKB1 and Rheb expression in bladder cancer.
Mol Carcinog. 2012 Mar 27. doi: 10.1002/mc.21902.
Abstract Related articles

FAN Y , Shi M, Xiong ZB, Han P, et al
[Critical analysis on risk factors of postoperative in-hospital complications in radical cystectomy of bladder cancer].
Sichuan Da Xue Xue Bao Yi Xue Ban. 2012;43:99-103.
Abstract Related articles

MIYAZAKI J , Nishiyama H
[Biomarker for bladder cancer].
Gan To Kagaku Ryoho. 2012;39:48-53.
Abstract Related articles

WU CL , Ping SY, Yu CP, Yu DS, et al
Tyrosine kinase receptor inhibitor-targeted combined chemotherapy for metastatic bladder cancer.
Kaohsiung J Med Sci. 2012;28:194-203.
Abstract Related articles

UESAKA Y , Takahi Y, Ito S, Kiuchi H, et al
[A case of tuberculous epididymitis after bacillus calmette-guerin intravesical instillation therapy for bladder cancer].
Hinyokika Kiyo. 2012;58:113-6.
Abstract Related articles

YANAGI M , Nishimura T, Kimura G, Kondo Y, et al
[A case of late recurrence of urothelial carcinoma in an ileal conduit after radical cystectomy and ileal conduit diversion for bladder cancer].
Hinyokika Kiyo. 2012;58:109-12.
Abstract Related articles

FENNER A
Bladder cancer: A noninvasive multi-analyte assay for triaging patients.
Nat Rev Urol. 2012 Mar 27. doi: 10.1038/nrurol.2012.
Abstract Related articles

FRISTRUP N , Ulhoi BP, Birkenkamp-Demtroder K, Mansilla F, et al
Cathepsin E, Maspin, Plk1, and Survivin Are Promising Prognostic Protein Markers for Progression in Non-Muscle Invasive Bladder Cancer.
Am J Pathol. 2012.
Abstract Related articles

HEGARTY PK
Editorial: MMP-2 and MMP-9 in lymph-node-positive bladder cancer.
J Clin Pathol. 2012.
Abstract Related articles

AKLI S , Zhang XQ, Bondaruk J, Tucker SL, et al
Low molecular weight cyclin E is associated with p27-resistant, high-grade, high-stage and invasive bladder cancer.
Cell Cycle. 2012;11.
Abstract Related articles

BADER MJ , Stepp H, Beyer W, Pongratz T, et al
Photodynamic Therapy of Bladder Cancer - A Phase I Study Using Hexaminolevulinate (HAL).
Urol Oncol. 2012.
Abstract Related articles

DECARO JJ , Kirsch AJ
Dextranomer-hyaluronic acid implants misdiagnosed as bladder tumor on transvaginal ultrasonography.
Obstet Gynecol. 2012;119.
Abstract Related articles

KANAMORI H , Isogami K, Hatakeyama T, Saito H, et al
Chest wall abscess due to Mycobacterium bovis BCG after intravesical BCG therapy.
J Clin Microbiol. 2012;50:533-5.
Abstract Related articles

JOBU K , Sun C, Yoshioka S, Yokota J, et al
Metabolomics study on the biochemical profiles of odor elements in urine of human with bladder cancer.
Biol Pharm Bull. 2012;35:639-42.
Abstract Related articles

MA L , Chu H, Wang M, Shi D, et al
hOGG1 Ser326Cys polymorphism is associated with risk of bladder cancer in a Chinese population: a case-control study.
Cancer Sci. 2012 Mar 29. doi: 10.1111/j.1349-7006.2012.02290.
Abstract Related articles

GOOSSENS-LAAN CA , Kil PJ, Ruud Bosch JL, De Vries J, et al
Pre-diagnosis quality of life (QoL) in patients with hematuria: comparison of bladder cancer with other causes.
Qual Life Res. 2012.
Abstract Related articles

NEUMANN A , Weill A, Ricordeau P, Fagot JP, et al
Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study.
Diabetologia. 2012.
Abstract Related articles

LI J , Zhang J, Liu Y, Ye G, et al
Increased expression of DNA repair gene XPF enhances resistance to hydroxycamptothecin in bladder cancer.
Med Sci Monit. 2012;18:BR156-162.
Abstract Related articles

KRANE LS , Kader AK, Levine EA
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for patients with peritoneal carcinomatosis secondary to urachal adenocarcinoma.
J Surg Oncol. 2012;105:258-60.
Abstract Related articles

HE Z , Kosinska W, Zhao ZL, Wu XR, et al
Tissue-specific mutagenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine as the basis for urothelial carcinogenesis.
Mutat Res. 2012;742.
Abstract Related articles

CHEN PC , Chen WC, Chao SC, Lin BW, et al
Six primary cancers in one Lynch syndrome patient with chronic arsenic exposure.
J Surg Oncol. 2012;105:329-30.
Abstract Related articles

KILANI-JAZIRI S , Frachet V, Bhouri W, Ghedira K, et al
Flavones inhibit the proliferation of human tumor cancer cell lines by inducing apoptosis.
Drug Chem Toxicol. 2012;35:1-10.
Abstract Related articles

WANG L , Fan JH, Guan ZF, Liu Y, et al
[Study on bladder cancer tissues with Raman spectroscopy].
Guang Pu Xue Yu Guang Pu Fen Xi. 2012;32:123-6.
Abstract Related articles

KATO M , Wei M, Yamano S, Kakehashi A, et al
DDX39 Acts as a Suppressor of Invasion for Bladder Cancer.
Cancer Sci. 2012 Apr 12. doi: 10.1111/j.1349-7006.2012.02298.
Abstract Related articles

MU HQ , Yang S, Wang YJ, Chen YH, et al
[Role of NF-kappaB in the anti-tumor effect of thymoquinone on bladder cancer].
Zhonghua Yi Xue Za Zhi. 2012;92:392-6.
Abstract Related articles

ZHANG Z , Hao H, Zhang CJ, Yang XY, et al
[Evaluation of novel gene UCA1 as a tumor biomarker for the detection of bladder cancer].
Zhonghua Yi Xue Za Zhi. 2012;92:384-7.
Abstract Related articles

CUI D , Han BM, Jing YF, Xia SJ, et al
[Analysis of N-E cadherin switch as an independent predictive parameter of bladder cancer survival outcomes].
Zhonghua Yi Xue Za Zhi. 2012;92:380-3.
Abstract Related articles

TIAN Y
[Attach importance to the chemotherapy of muscle invasive bladder cancer].
Zhonghua Yi Xue Za Zhi. 2012;92:363-5.
Abstract Related articles

ZHU YP , Yao XD, Zhang HL, Shen YJ, et al
Penile metastasis from primary bladder cancer: a study of 8 cases and review of the literature.
Onkologie. 2012;35:196-9.
Abstract Related articles

KRON T , Pham D, Roxby P, Rolfo A, et al
Credentialing of radiotherapy centres for a clinical trial of adaptive radiotherapy for bladder cancer (TROG 10.01).
Radiother Oncol. 2012.
Abstract Related articles

SUN F , Zheng XY, Ye J, Wu TT, et al
Potential Anticancer Activity of Myricetin in Human T24 Bladder Cancer Cells Both In Vitro and In Vivo.
Nutr Cancer. 2012.
Abstract Related articles

ARDELT P , Grunemay N, Strehl A, Jilg C, et al
LASP-1, a Novel Urinary Marker for Detection of Bladder Cancer.
Urol Oncol. 2012.
Abstract Related articles

AHMED H , Elsamra S, Sigman M
Case of malignant priapism and review of the literature.
Med Health R I. 2012;95:14-5.
Abstract Related articles

PANER GP , Barkan GA, Mehta V, Sirintrapun SJ, et al
Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis.
Am J Surg Pathol. 2012;36:432-42.
Abstract Related articles

YANG C , Li X, Wang Y, Zhao L, et al
Long non-coding RNA UCA1 regulated cell cycle distribution via CREB through PI3-K dependent pathway in bladder carcinoma cells.
Gene. 2012;496:8-16.
Abstract Related articles

CHANG WC , Chang YH, Pan CC
Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
Am J Surg Pathol. 2012;36:454-61.
Abstract Related articles

HOSHINO K , Kikuchi E, Tanaka N, Akita H, et al
Preoperative hydronephrosis: independent predictor for changes in renal function following nephroureterectomy.
Jpn J Clin Oncol. 2012;42:202-7.
Abstract Related articles

SOBTI RC , Kaur S, Sharma VL, Singh SK, et al
Susceptibility of XPD and RAD51 genetic variants to carcinoma of urinary bladder in North Indian population.
DNA Cell Biol. 2012;31:199-210.
Abstract Related articles

MARK JR , Gelpi-Hammerschmidt F, Trabulsi EJ, Gomella LG, et al
Blue light cystoscopy for detection and treatment of non-muscle invasive bladder cancer.
Can J Urol. 2012;19:6227-31.
Abstract Related articles

SHIPLEY WU , Zietman AL
Old drugs, new purpose--bladder cancer turning a corner.
N Engl J Med. 2012;366:1540-1.
Abstract Related articles

JAMES ND , Hussain SA, Hall E, Jenkins P, et al
Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer.
N Engl J Med. 2012;366:1477-88.
Abstract Related articles

LIU Y , Huang LQ, Wang J, Tong HM, et al
[Fabrication of silver ordered nanoarrays SERS-active substrates and their applications in bladder cancer cells detection].
Guang Pu Xue Yu Guang Pu Fen Xi. 2012;32:386-90.
Abstract Related articles

PAYTON S
Bladder cancer: New insight into the mechanisms of lung metastasis.
Nat Rev Urol. 2012 Apr 17. doi: 10.1038/nrurol.2012.
Abstract Related articles

GUIRADO M , Gil H, Saenz-Lopez P, Reinboth J, et al
Association between C13ORF31, NOD2, RIPK2 and TLR10 polymorphisms and urothelial bladder cancer.
Hum Immunol. 2012.
Abstract Related articles

ZHAN H , Wang JS, Wang HF, Zuo YG, et al
Apoptin Induces Apoptosis in Human Bladder Cancer EJ and BIU-87 Cells.
Asian Pac J Cancer Prev. 2012;13:135-8.
Abstract Related articles

JACOBSON MC , Devere White R, Demos SG
In vivo testing of a prototype system providing simultaneous white light and near infrared autofluorescence image acquisition for detection of bladder cancer.
J Biomed Opt. 2012;17:036011.
Abstract Related articles

KUMAGAI T , Ishino T, Nakagawa Y
Acidic sphingomyelinase induced by electrophiles promotes proinflammatory cytokine production in human bladder carcinoma ECV-304 cells.
Arch Biochem Biophys. 2012;519:8-16.
Abstract Related articles

LIN PY , Lin YL, Huang CC, Chen SS, et al
Inorganic arsenic in drinking water accelerates N-butyl-N-(4-hydroxybutyl)nitrosamine-induced bladder tissue damage in mice.
Toxicol Appl Pharmacol. 2012;259:27-37.
Abstract Related articles

GUNEY AI , Ergec DS, Tavukcu HH, Koc G, et al
Detection of Mitochondrial DNA Mutations in Nonmuscle Invasive Bladder Cancer.
Genet Test Mol Biomarkers. 2012.
Abstract Related articles

SELINSKI S , Lehmann ML, Blaszkewicz M, Ovsiannikov D, et al
Rs11892031[A] on chromosome 2q37 in an intronic region of the UGT1A locus is associated with urinary bladder cancer risk.
Arch Toxicol. 2012.
Abstract Related articles

MENG W , Huebner A, Shabsigh A, Chakravarti A, et al
Combined RASSF1A and RASSF2A Promoter Methylation Analysis as Diagnostic Biomarker for Bladder Cancer.
Mol Biol Int. 2012;2012:701814.
Abstract Related articles

HECK MM , Gschwend JE, Retz M
[Chemotherapy for bladder cancer: 2012 Update : From AUO ("Arbeitsgemeinschaft Urologische Onkologie") and IABC ("Interdisziplinare Arbeitsgruppe BlasenCarcinom").]
Urologe A. 2012.
Abstract Related articles

HAO M , Zheng J, Hou K, Wang J, et al
Role of chemokine receptor CXCR7 in bladder cancer progression.
Biochem Pharmacol. 2012.
Abstract Related articles

PAYTON S
Bladder cancer: LASP-1-a promising urine marker for detection of bladder cancer.
Nat Rev Urol. 2012 Apr 24. doi: 10.1038/nrurol.2012.
Abstract Related articles

GE WQ , Pu JX, Zheng SY
Clinical Application of the Adenosine Triphosphate-based Response Assay in Intravesical Chemotherapy for Superficial Bladder Cancer.
Asian Pac J Cancer Prev. 2012;13:689-92.
Abstract Related articles

ERBER B , Schrader M, Miller K, Schostak M, et al
Morbidity and Quality of Life in Bladder Cancer Patients following Cystectomy and Urinary Diversion: A Single-Institution Comparison of Ileal Conduit versus Orthotopic Neobladder.
ISRN Urol. 2012;2012:342796.
Abstract Related articles

D'AGOSTINO D , Racioppi M, Filianoti A, Di Gianfrancesco L, et al
[Therapy for non-muscle invasive bladder cancer: HP-NAP.]
Urologia. 2012 Apr 3:0. doi: 10.5301/RU.2012.9189.
Abstract Related articles

HUGUET J
Prostatic involvement by urothelial carcinoma in patients with bladder cancer and their implications in the clinical practice.
Actas Urol Esp. 2012.
Abstract Related articles

ANING J , Hunter-Campbell P, McInerney P
Intraoperative localisation of a urachal bladder tumour prior to partial cystectomy.
Ann R Coll Surg Engl. 2012;94:136-7.
Abstract Related articles

PAVIA PR , Havig ME, Donovan TA, Craft D, et al
Malignant peripheral nerve sheath tumour of the urinary bladder in a cat.
J Small Anim Pract. 2012;53:245-8.
Abstract Related articles

ISMAILI N
Treatment trends and outcomes of small-cell carcinoma of the bladder: in regard to Koay et al. (Int J Radiat Oncol Biol Phys 2011 Oct 20).
Int J Radiat Oncol Biol Phys. 2012;82:1319-20.
Abstract Related articles

GHAFOOR AU , Yousaf I, Pervez R, Khan RU, et al
Paraganglioma of urinary bladder: an unusual presentation. pitfalls in diagnosis and treatment.
J Pak Med Assoc. 2012;62:63-5.
Abstract Related articles

CERF DJ , Lindquist EC
Palliative ultrasound-guided endoscopic diode laser ablation of transitional cell carcinomas of the lower urinary tract in dogs.
J Am Vet Med Assoc. 2012;240:51-60.
Abstract Related articles

DING GQ , Yu YL, Shen ZJ, Zhou XL, et al
Antitumor effects of human interferon-alpha 2b secreted by recombinant bacillus Calmette-Guerin vaccine on bladder cancer cells.
J Zhejiang Univ Sci B. 2012;13:335-41.
Abstract Related articles

MARTA GN , Hanna SA, Gadia R, Correa SF, et al
The role of radiotherapy in urinary bladder cancer: current status.
Int Braz J Urol. 2012;38:144-54.
Abstract Related articles

MARTINEZ-PINEIRO JA
Comment to <<Acute Arthritis Secondary to Intravesical Bacillus Calmette-Guerin for Bladder Cancer>>
Actas Urol Esp. 2012.
Abstract Related articles

GORDETSKY J , Scosyrev E, Rashid H, Wu G, et al
Identifying additional lymph nodes in radical cystectomy lymphadenectomy specimens.
Mod Pathol. 2012;25:140-4.
Abstract Related articles

THANAN R , Murata M, Ma N, Hammam O, et al
Nuclear Localization of COX-2 in relation to the Expression of Stemness Markers in Urinary Bladder Cancer.
Mediators Inflamm. 2012;2012:165879.
Abstract Related articles

JUNKER K , Hartmann A, Stockle M
[Therapy selection in patients with advanced bladder cancer : Is molecular biology helpful?]
Urologe A. 2012.
Abstract Related articles

ABERN MR , Dude AM, Tsivian M, Coogan CL, et al
The characteristics of bladder cancer after radiotherapy for prostate cancer.
Urol Oncol. 2012.
Abstract Related articles

AJILI F , Kacem M, Tounsi H, Darouiche A, et al
Prognostic Impact of Angiogenesis in Nonmuscle Invasive Bladder Cancer as Defined by Microvessel Density after Immunohistochemical Staining for CD34.
Ultrastruct Pathol. 2012.
Abstract Related articles

LI W , Macdonald TM, Mackenzie IS
Pioglitazone and bladder cancer: A propensity score matched cohort study.
Br J Clin Pharmacol. 2012 May 11. doi: 10.1111/j.1365-2125.2012.04325.
Abstract Related articles

ZHU J , Pan X, Zhang Z, Gao J, et al
Downregulation of integrin-linked kinase inhibits epithelial-to-mesenchymal transition and metastasis in bladder cancer cells.
Cell Signal. 2012;24:1323-32.
Abstract Related articles

KESHTKAR A , Salehnia Z, Keshtkar A, Shokouhi B, et al
Bladder cancer detection using electrical impedance technique (tabriz mark 1).
Patholog Res Int. 2012;2012:470101.
Abstract Related articles

Bladder cancer: ASA score indicator of survival in radical cystectomy.
Nat Rev Urol. 2012 May 8. doi: 10.1038/nrurol.2012.
Abstract Related articles

ZHOU Y , Tian C, Jia C
A dose-response meta-analysis of coffee consumption and bladder cancer.
Prev Med. 2012.
Abstract Related articles

LEE SJ , Lim JH, Choi YH, Kim WJ, et al
Interleukin-28A triggers wound healing migration of bladder cancer cells via NF-kappaB-mediated MMP-9 expression inducing the MAPK pathway.
Cell Signal. 2012.
Abstract Related articles

FABRIS VT , Lodillinsky C, Pampena MB, Belgorosky D, et al
Cytogenetic characterization of the murine bladder cancer model MB49 and the derived invasive line MB49-I.
Cancer Genet. 2012;205:168-76.
Abstract Related articles

ALY MS , Khaled HM, Emara M, Hussein TD, et al
Cytogenetic profile of locally advanced and metastatic schistosoma-related bladder cancer and response to chemotherapy.
Cancer Genet. 2012;205:156-62.
Abstract Related articles

URQUIDI V , Chang M, Dai Y, Kim J, et al
IL-8 as a urinary biomarker for the detection of bladder cancer.
BMC Urol. 2012;12:12.
Abstract Related articles

OMRAN OM , Ata HS
CD44s and CD44v6 in Diagnosis and Prognosis of Human Bladder Cancer.
Ultrastruct Pathol. 2012;36:145-52.
Abstract Related articles

KIM CS , Kim SH, Lee HJ, Kim YW, et al
Clinical significance of bladder urothelial thickening and enhancement revealed on MDCT urography after transurethral resection of tumor.
J Comput Assist Tomogr. 2012;36:243-8.
Abstract Related articles

PEZARO C , Liew MS, Davis ID
Urothelial cancers: using biology to improve outcomes.
Expert Rev Anticancer Ther. 2012;12:87-98.
Abstract Related articles

KOUNTOURAS J , Zavos C, Gavalas E, Deretzi G, et al
A rebuttal to the potential anti-tumour benefit of Helicobacter pylori-induced neutrophil-activating protein.
Cancer Immunol Immunother. 2012;61:445-6.
Abstract Related articles

SARI A , Calli A, Cakalagaoglu F, Altinboga AA, et al
Association of mast cells with microvessel density in urothelial carcinomas of the urinary bladder.
Ann Diagn Pathol. 2012;16:1-6.
Abstract Related articles

HUGUET J
[Diagnosis and treatment of urethral recurrence after radical cystectomy in the male].
Actas Urol Esp. 2012;36:42-7.
Abstract Related articles

GUAIS A , Baronzio G, Sanders E, Campion F, et al
Adding a combination of hydroxycitrate and lipoic acid (METABLOC) to chemotherapy improves effectiveness against tumor development: experimental results and case report.
Invest New Drugs. 2012;30:200-11.
Abstract Related articles

GOFRIT ON , Shapiro A, Pode D, Katz R, et al
Subepithelial growth patterns in urothelial carcinoma-frequency and prognostic significance.
Urol Oncol. 2012;30:49-54.
Abstract Related articles

WU MJ , Chang CH, Chiu YT, Wen MC, et al
Rictor-dependent AKT activation and inhibition of urothelial carcinoma by rapamycin.
Urol Oncol. 2012;30:69-77.
Abstract Related articles

MIYAKE H , Furukawa J, Muramaki M, Takenaka A, et al
Orthotopic bladder substitution following radical cystectomy in women: comparative study between sigmoid and ileal neobladders.
Urol Oncol. 2012;30:38-43.
Abstract Related articles

GUZZO TJ , McNeil BK, Bivalacqua TJ, Elliott DJ, et al
The presence of circulating tumor cells does not predict extravesical disease in bladder cancer patients prior to radical cystectomy.
Urol Oncol. 2012;30:44-8.
Abstract Related articles

ARENTSEN HC , Hendricksen K, Hulsbergen-van de Kaa CA, Reddy G, et al
The orthotopic Fischer/AY-27 rat bladder urothelial cell carcinoma model to test the efficacy of different apaziquone formulations.
Urol Oncol. 2012;30:64-8.
Abstract Related articles

LI Y , Izumi K, Miyamoto H
The Role of the Androgen Receptor in the Development and Progression of Bladder Cancer.
Jpn J Clin Oncol. 2012.
Abstract Related articles

KIM KH , You D, Jeong IG, Hong JH, et al
Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma.
Urol Oncol. 2012.
Abstract Related articles

ZHAO PP , Liu CX, Xu K, Zheng SB, et al
[Expression of OCT4 protein in bladder cancer and its clinicopathological implications].
Nan Fang Yi Ke Da Xue Xue Bao. 2012;32:643-6.
Abstract Related articles

RICHARDS KA , Kader AK, Otto R, Pettus JA, et al
Is robotic radical cystectomy justified in the elderly? A comparison of robotic versus open radical cystectomy for bladder cancer in elderly >/= 75 years old.
J Endourol. 2012.
Abstract Related articles

ROS MM , Gago-Dominguez M, Aben KK, Bueno-de-Mesquita HB, et al
Personal hair dye use and the risk of bladder cancer: a case-control study from The Netherlands.
Cancer Causes Control. 2012.
Abstract Related articles

LATURNUS JM , Jocham D, Sommerauer M
[Recurrent bladder cancer after BCG instillation therapy : Local therapy options?]
Urologe A. 2012.
Abstract Related articles

BOJANIC N , Nale D, Micic S, Lalic N, et al
Glycosaminoglycans in the urinary bladder mucosa, tumor tissue and mucosal tissue around tumor.
Vojnosanit Pregl. 2012;69:147-50.
Abstract Related articles

GUAN H , Tatsas AD, Ali SZ
Signet ring cell carcinoma in urine cytology: cytomorphologic findings and differential diagnosis.
Acta Cytol. 2012;56:177-82.
Abstract Related articles

ALEXANDER N , Lane S, Hitchcock R
What is the evidence for radical surgery in the management of localized embryonal bladder/prostate rhabdomyosarcoma?
Pediatr Blood Cancer. 2012;58:833-5.
Abstract Related articles

DIETRICH HG , Golka K
Bladder tumors and aromatic amines - historical milestones from Ludwig Rehn to Wilhelm Hueper.
Front Biosci (Elite Ed). 2012;4:279-88.
Abstract Related articles

SERRANO C , Morales R, Suarez C, Nunez I, et al
Emerging therapies for urothelial cancer.
Cancer Treat Rev. 2012;38:311-7.
Abstract Related articles

ABDOLLAH F , Sun M, Schmitges J, Thuret R, et al
Development and validation of a reference table for prediction of postoperative mortality rate in patients treated with radical cystectomy: a population-based study.
Ann Surg Oncol. 2012;19:309-17.
Abstract Related articles

WIART C
A Note On The Relevance Of Norsolorinic Acid As A Chemopreventive Agent For The Treatment Of Bladder Cancer.
Clin Exp Pharmacol Physiol. 2012 May 24. doi: 10.1111/j.1440-1681.2012.05727.
Abstract Related articles

MONDUL AM , Weinstein SJ, Horst RL, Purdue MP, et al
Serum vitamin D and risk of bladder cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
Cancer Epidemiol Biomarkers Prev. 2012.
Abstract Related articles

KRAMER MW , Wolters M, Abdelkawi IF, Merseburger AS, et al
[Transurethral en bloc resection of non-muscle invasive bladder cancer : What is the state of the art?]
Urologe A. 2012.
Abstract Related articles

BANEK S , Schwentner C, Tager D, Pesch B, et al
Prospective evaluation of fluorescence-in situ-hybridization to detect bladder cancer: Results from the UroScreen-Study.
Urol Oncol. 2012.
Abstract Related articles

YANG S , Ma J, Xiao J, Lv X, et al
Arctigenin Anti-Tumor Activity in Bladder Cancer T24 Cell Line Through Induction of Cell-Cycle Arrest and Apoptosis.
Anat Rec (Hoboken). 2012 May 23. doi: 10.1002/ar.22497.
Abstract Related articles

CHIU HY , Sun KH, Chen SY, Wang HH, et al
Autocrine CCL2 promotes cell migration and invasion via PKC activation and tyrosine phosphorylation of paxillin in bladder cancer cells.
Cytokine. 2012.
Abstract Related articles

OFFUTT-POWELL TN , Ojha RP, Tota JE, Gurney JG, et al
Human papillomavirus infection and bladder cancer: An alternate perspective from a modified meta-analysis.
J Infect Dis. 2012.
Abstract Related articles

LI N , Yang L, Guo L, Zhang Y, et al
Human papillomavirus infection and bladder cancer: An alternate perspective from a modified meta-analysis.
J Infect Dis. 2012.
Abstract Related articles

PAJOR G , Alpar D, Kajtar B, Melegh B, et al
Automated signal pattern evaluation of a bladder cancer specific multiprobe-fish assay applying a user-trainable workstation.
Microsc Res Tech. 2012;75:814-20.
Abstract Related articles

SUN Z , Wang H, Ye S, Xiao S, et al
Beta-eleostearic acid induce apoptosis in T24 human bladder cancer cells through reactive oxygen species (ROS)-mediated pathway.
Prostaglandins Other Lipid Mediat. 2012.
Abstract Related articles

DHAWAN D , Ramos-Vara JA, Hahn NM, Waddell J, et al
DNMT1: An emerging target in the treatment of invasive urinary bladder cancer.
Urol Oncol. 2012.
Abstract Related articles

MIYAMOTO H , Izumi K, Yao JL, Li Y, et al
GATA binding protein 3 is down-regulated in bladder cancer yet strong expression is an independent predictor of poor prognosis in invasive tumor.
Hum Pathol. 2012.
Abstract Related articles

BOZKURT Y , Sancaktutar AA, Soylemez H, Atar M, et al
A solution for delay and survival in bladder cancer: the use of reminder text messages.
J Telemed Telecare. 2012.
Abstract Related articles

NETTO GJ , Cheng L
Emerging critical role of molecular testing in diagnostic genitourinary pathology.
Arch Pathol Lab Med. 2012;136:372-90.
Abstract Related articles

BEREZOWSKA S , Tomoka T, Kamiza S, Milner DA Jr, et al
Surgical pathology in sub-Saharan Africa--volunteering in Malawi.
Virchows Arch. 2012;460:363-70.
Abstract Related articles

PERRINO CM , Pohar KS, Zynger DL
Urinary bladder chondroma.
Virchows Arch. 2012;460:437-8.
Abstract Related articles

CODY JD , Nabi G, Dublin N, McClinton S, et al
Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy.
Cochrane Database Syst Rev. 2012;2:CD003306.
Abstract Related articles

TERADA T
Spindle cell carcinoma progressed from transitional cell carcinoma of the urinary bladder.
Int J Clin Exp Pathol. 2012;5:83-8.
Abstract Related articles

NONOMURA Y , Tanioka M, Mitomi Y, Fujisawa A, et al
Secondary extramammary Paget's disease with underlying recurrent bladder carcinoma.
Eur J Dermatol. 2012;22:129-30.
Abstract Related articles

NICOLAU RAMIS J , Masmiquel Comas L
[The new antidiabetic agents in the firing line.... safety reasons or witch hunt?].
Endocrinol Nutr. 2012;59:1-8.
Abstract Related articles

HUSSEIN M , Aldridge S, Guerrero Urbano T, Nisbet A, et al
The effect of 6 and 15 MV on intensity-modulated radiation therapy prostate cancer treatment: plan evaluation, tumour control probability and normal tissue complication probability analysis, and the theoretical risk of secondary induced malignancies.
Br J Radiol. 2011.
Abstract Related articles

KHALAF I , Shokeir A, Shalaby M
Urologic complications of genitourinary schistosomiasis.
World J Urol. 2012;30:31-8.
Abstract Related articles

BAROCAS DA , Globe DR, Colayco DC, Onyenwenyi A, et al
Surveillance and treatment of non-muscle-invasive bladder cancer in the USA.
Adv Urol. 2012;2012:421709.
Abstract Related articles

ADEWOLE AD , Roman SA, Kraev AI, Kim AW, et al
A fluorodeoxyglucose avid mediastinal parathyroid adenoma masquerading as metastatic bladder cancer.
Interact Cardiovasc Thorac Surg. 2012.
Abstract Related articles

CALABRO F , Sternberg CN
Metastatic bladder cancer: anything new?
Curr Opin Support Palliat Care. 2012.
Abstract Related articles

CHAI X , van Herk M, Betgen A, Hulshof M, et al
Automatic bladder segmentation on CBCT for multiple plan ART of bladder cancer using a patient-specific bladder model.
Phys Med Biol. 2012;57:3945-3962.
Abstract Related articles

WEISS C , Rodel C
Urological cancer: Chemoradiation superior in muscle-invasive bladder cancer.
Nat Rev Clin Oncol. 2012 May 29. doi: 10.1038/nrclinonc.2012.
Abstract Related articles

ROSENKRANTZ AB , Mussi TC, Melamed J, Taneja SS, et al
Bladder cancer: utility of MRI in detection of occult muscle-invasive disease.
Acta Radiol. 2012.
Abstract Related articles

OBARA W , Ohsawa R, Kanehira M, Takata R, et al
Cancer Peptide Vaccine Therapy Developed from Oncoantigens Identified through Genome-wide Expression Profile Analysis for Bladder Cancer.
Jpn J Clin Oncol. 2012.
Abstract Related articles

Accuracy of contrast-enhanced ultrasound in the detection of bladder cancer.
Ultrasound Q. 2012;28:126.
Abstract Related articles

MOULI S , Casalino DD, Nikolaidis P
Imaging features of common and uncommon bladder neoplasms.
Radiol Clin North Am. 2012;50:301-16.
Abstract Related articles

PATHANIA S , Dhama K, Saikumar G, Shahi S, et al
Detection and quantification of bovine papilloma virus type 2 (BPV-2) by real-time PCR in urine and urinary bladder lesions in enzootic bovine haematuria (EBH)-affected cows.
Transbound Emerg Dis. 2012;59:79-84.
Abstract Related articles

RANASINGHE WK , De Silva D, De Silva MV, Ranasinghe TI, et al
Incidence of bladder cancer in sri lanka: analysis of the cancer registry data and review of the incidence of bladder cancer in the South asian population.
Korean J Urol. 2012;53:304-9.
Abstract Related articles

WEISS C , Sauer R
[Organ-sparing chemoradiotherapy: a viable alternative to initial cystectomy for patients with muscle-invasive bladder cancer.]
Strahlenther Onkol. 2012.
Abstract Related articles

BAUMANN BC , Guzzo TJ, He J, Vaughn DJ, et al
Bladder Cancer Patterns of Pelvic Failure: Implications for Adjuvant Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2012.
Abstract Related articles

LAKMICHI MA , Zehraoui R, Dahami Z, Moudouni SM, et al
Bladder cancer in the second trimester of pregnancy: tough decisions. A case report with review of the literature.
Ther Adv Urol. 2012;4:139-42.
Abstract Related articles

AZOULAY L , Yin H, Filion KB, Assayag J, et al
The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study.
BMJ. 2012;344:e3645.
Abstract Related articles

HILLAIRE-BUYS D , Faillie JL
Pioglitazone and the risk of bladder cancer.
BMJ. 2012;344:e3500.
Abstract Related articles

GOLKA K , Abreu-Villaca Y, Anbari Attar R, Angeli-Greaves M, et al
Bladder cancer documentation of causes: multilingual questionnaire, 'bladder cancer doc'.
Front Biosci (Elite Ed). 2012;4:2809-22.
Abstract Related articles

HASHIMURA M , Momose H, Takenaga M, Hoshiyama H, et al
[Tubercular prostatic abscess following intravesical Bacillus Calmette-Guerin therapy].
Hinyokika Kiyo. 2012;58:169-72.
Abstract Related articles

KANEMIYA T , Arai H, Murosaki N, Honda M, et al
[Primary small cell carcinoma of the bladder in which the bladder preservation was achieved by chemotherapy and transurethral resection].
Hinyokika Kiyo. 2012;58:165-8.
Abstract Related articles

SEIKE K , Kameyama K, Kato T, Tsuchiya T, et al
[Solitary fibrous tumor of the urinary bladder: a case report].
Hinyokika Kiyo. 2012;58:105-8.
Abstract Related articles

TANAKA A , Ohori M, Hashimoto T, Hamada R, et al
[A case of plasmacytoid urothelial carcinoma of the bladder: rapid progression after transurethral resection].
Hinyokika Kiyo. 2012;58:101-3.
Abstract Related articles

TANIGUCHI H , Amari Y, Oka H, Kawakita S, et al
[Renal salt wasting syndrome induced by Cisplatin: a case report].
Hinyokika Kiyo. 2012;58:97-100.
Abstract Related articles

LU J , Xu Z, Jiang F, Wang Y, et al
Primary clear cell adenocarcinoma of the bladder with recurrence: a case report and literature review.
World J Surg Oncol. 2012;10:33.
Abstract Related articles

POLETAJEW S , Waledziak M, Fus L, Pomada P, et al
Urothelial bladder carcinoma in young patients is characterized by a relatively good prognosis.
Ups J Med Sci. 2012;117:47-51.
Abstract Related articles

ZOZUMI M , Nakai M, Matsuda I, Hao H, et al
Primary carcinoid tumor of the urinary bladder with prominent subnuclear eosinophilic granules.
Pathol Res Pract. 2012;208:109-12.
Abstract Related articles

REIS ST , Leite KR, Piovesan LF, Pontes-Junior J, et al
Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of Bladder Cancer.
BMC Urol. 2012;12:18.
Abstract Related articles

ZHOU B , Zhang P, Wang Y, Shi S, et al
Interleukin-17 gene polymorphisms are associated with bladder cancer in a Chinese Han population.
Mol Carcinog. 2012 Jun 12. doi: 10.1002/mc.21928.
Abstract Related articles

GORIN MA , Ayyathurai R, Soloway MS
Diagnosis and treatment of bladder cancer: how can we improve?
Postgrad Med. 2012;124:28-36.
Abstract Related articles

JIMENEZ-PACHECO A
[Relationship between bladder cancer and infection by human papillomavirus].
Rev Med Chil. 2012;140:406-7.
Abstract Related articles

CAO M , Zhao L, Chen H, Xue W, et al
NMR-based Metabolomic Analysis of Human Bladder Cancer.
Anal Sci. 2012;28:451-6.
Abstract Related articles

GOLKA K , Kopps S, Prager HM, Mende SV, et al
Bladder cancer in crack testers applying azo dye-based sprays to metal bodies.
J Toxicol Environ Health A. 2012;75.
Abstract Related articles

OVSIANNIKOV D , Selinski S, Lehmann ML, Blaszkewicz M, et al
Polymorphic enzymes, urinary bladder cancer risk, and structural change in the local industry.
J Toxicol Environ Health A. 2012;75.
Abstract Related articles

WADHWA N , Jatawa SK, Tiwari A
Non-invasive urine based tests for the detection of bladder cancer.
J Clin Pathol. 2012.
Abstract Related articles

Chemotherapy and radiotherapy improve bladder cancer outcomes.
Cancer Discov. 2012;2:OF10.
Abstract Related articles

BIOT C , Rentsch CA, Gsponer JR, Birkhauser FD, et al
Preexisting BCG-Specific T Cells Improve Intravesical Immunotherapy for Bladder Cancer.
Sci Transl Med. 2012;4:137ra72.
Abstract Related articles

JOCHAM D , Stockle M, Sommerauer M
[Aspects of bladder cancer].
Urologe A. 2012;51:783.
Abstract Related articles

JOU YC , Chiu YW, Chen YH, Hwang JM, et al
Expression of protein kinase Calpha and the MZF-1 and elk-1 transcription factors in human bladder transitional cell carcinoma cells.
Chin J Physiol. 2012;55:75-81.
Abstract Related articles

TOBISU K
The history and future of the Urologic Oncology Study Group (UOSG) of the Japan Clinical Oncology Group (JCOG).
Jpn J Clin Oncol. 2012;42:363-7.
Abstract Related articles

KAWAGUCHI S , Shigehara K, Sasagawa T, Kuribayashi M, et al
A case study of human papillomavirus-associated bladder carcinoma developing after urethral condyloma acuminatum.
Jpn J Clin Oncol. 2012;42:455-8.
Abstract Related articles

LIEW MS , Au-Yeung G, Davis ID
Pathological responses to gemcitabine/platinum-based neoadjuvant chemotherapy for muscle-invasive urothelial cancer.
Asia Pac J Clin Oncol. 2012;8:101-2.
Abstract Related articles

SIDDAPPA S , Mythri KM, Kowsalya R, Shivalingaiah M, et al
An unusual case of non-disseminated bladder aspergillosis in a setting of transitional cell carcinoma.
Indian J Med Microbiol. 2012;30:106-8.
Abstract Related articles

MARTINEZ-GIRON R , Gonzalez-Lopez JR
Uncommon fungal contamination in urine cytology.
Diagn Cytopathol. 2012;40:234-5.
Abstract Related articles

KAVA BR , Eldefrawy A, Ayyathurai R, Thompson SM, et al
Renal cell carcinoma with solitary metastasis to the bladder: mode of spread and prognosis.
Can J Urol. 2012;19:6121-3.
Abstract Related articles

QUMOSANI K , Chandok N
An unusual cause of cancer mimicry following liver transplantation.
Ann Hepatol. 2012;11:134-7.
Abstract Related articles

YOON JI , Kim SI, Tommasi S, Besaratinia A, et al
Organ specificity of the bladder carcinogen 4-aminobiphenyl in inducing DNA damage and mutation in mice.
Cancer Prev Res (Phila). 2012;5:299-308.
Abstract Related articles

ZAGHLOUL MS , Gouda I
Schistosomiasis and bladder cancer: similarities and differences from urothelial cancer.
Expert Rev Anticancer Ther. 2012;12:753-63.
Abstract Related articles

CALISTRI D , Casadio V, Bravaccini S, Zoli W, et al
Urinary biomarkers of non-muscle-invasive bladder cancer: current status and future potential.
Expert Rev Anticancer Ther. 2012;12:743-52.
Abstract Related articles

CHEUNG G , Dasgupta P, Guru KA, Billia M, et al
Minimally invasive cystectomy approaches in the treatment of bladder cancer.
Expert Rev Anticancer Ther. 2012;12:733-41.
Abstract Related articles

MINERVINI A , Siena G, Falciani C, Carini M, et al
Branched peptides as novel tumor-targeting agents for bladder cancer.
Expert Rev Anticancer Ther. 2012;12:699-701.
Abstract Related articles

PANIKAR V
Pioglitazone and bladder cancer: the pros and cons.
J Assoc Physicians India. 2012;60:72-3.
Abstract Related articles

MA Z , Hu Q, Chen Z, Tao S, et al
Systematic evaluation of bladder cancer risk-associated single-nucleotide polymorphisms in a Chinese population.
Mol Carcinog. 2012 Jun 18. doi: 10.1002/mc.21932.
Abstract Related articles

SANDHU GS , Aprikian A, Chin J, Fradet Y, et al
Outcomes of pT0N0 at radical cystectomy: The Canadian Bladder Cancer Network experience.
Can Urol Assoc J. 2012;6:E116-20.
Abstract Related articles

NAVASCUES A , Gil-Setas A, Tordoya IJ, Jimenez-Pajares MS, et al
[Retroperitoneal abscess in a patient under BCG treatment cause a bladder cancer].
Rev Esp Quimioter. 2012;25:167-8.
Abstract Related articles

HA YS , Lee HY, An GI, Kim J, et al
Synthesis and evaluation of a radioiodinated bladder cancer specific peptide.
Bioorg Med Chem. 2012.
Abstract Related articles

ZHU Z , Shen Z, Lu Y, Zhong S, et al
Increased risk of bladder cancer with pioglitazone therapy in patients with diabetes: A meta-analysis.
Diabetes Res Clin Pract. 2012.
Abstract Related articles

GRAVAS S , Efstathiou K, Zachos I, Melekos MD, et al
Is there a learning curve for photodynamic diagnosis of bladder cancer with hexaminolevulinate hydrochloride?
Can J Urol. 2012;19:6269-73.
Abstract Related articles

SANCHEZ-CARBAYO M
Urine epigenomics: a promising path for bladder cancer diagnostics.
Expert Rev Mol Diagn. 2012;12:429-32.
Abstract Related articles

KOSEVIC B , Aleksic P, Milovic N, Banfevit V, et al
Urodynamic characteristics of the modified orthotopic ileal neobladder.
Vojnosanit Pregl. 2012;69:253-6.
Abstract Related articles

PAVONE VL , Scarnato C, Marinilli P, Costellati L, et al
[Mortality in a cohort of railway rolling stock construction and repair workers in Bologna].
Med Lav. 2012;103:112-22.
Abstract Related articles

DOGHRI R , Sellami R, Driss M, Nfoussi H, et al
Sarcomatoid carcinoma of the urinary bladder.
Tunis Med. 2012;90:183-4.
Abstract Related articles

HINDSON BR , Turner SL, Millar JL, Foroudi F, et al
Australian & New Zealand Faculty of Radiation Oncology Genito-Urinary Group: 2011 consensus guidelines for curative radiotherapy for urothelial carcinoma of the bladder.
J Med Imaging Radiat Oncol. 2012;56:18-30.
Abstract Related articles

DARLONG V , Pandey R, Garg R, Kumar S, et al
Perioperative concerns of recurrent urinary bladder phaeochromocytoma with skeletal metastasis.
Singapore Med J. 2012;53:e40-1.
Abstract Related articles

VOM DORP F , Tschirdewahn S, Lummen G
[Intravesical therapy of non-muscle invasive bladder tumors].
Urologe A. 2012;51:257-64.
Abstract Related articles

KEEGAN KA , Resnick MJ, Clark PE
Multimodal therapies for muscle-invasive urothelial carcinoma of the bladder.
Curr Opin Oncol. 2012;24:278-83.
Abstract Related articles

LEHNERT M , Kraywinkel K, Pesch B, Holleczek B, et al
New malignancies following cancer of the urinary bladder: analysis of German cancer registry data.
Eur J Cancer Care (Engl). 2012;21:398-402.
Abstract Related articles

TSAO CK , Moshier E, Seng SM, Godbold J, et al
Impact of the CKD-EPI equation for estimating renal function on eligibility for cisplatin-based chemotherapy in patients with urothelial cancer.
Clin Genitourin Cancer. 2012;10:15-20.
Abstract Related articles

SRIVASTAVA S , Yan B, Chin SY, Muliana T, et al
Nuclear p53 expression is associated with allelic imbalance (TP53) in glandular dysplasia and typical cystitis glandularis: a LCM-based molecular analysis.
Clin Genitourin Cancer. 2012;10:57-9.
Abstract Related articles

COLE LA , Butler S
Hyperglycosylated hCG, hCGbeta and Hyperglycosylated hCGbeta: interchangeable cancer promoters.
Mol Cell Endocrinol. 2012;349:232-8.
Abstract Related articles

KOAY EJ , Teh BS, Paulino AC, Butler EB, et al
Treatment trends and outcomes of small-cell carcinoma of the bladder.
Int J Radiat Oncol Biol Phys. 2012;83:64-70.
Abstract Related articles

LEE JS , Bae MH, Choi SH, Lee SH, et al
Tumor establishment features of orthotopic murine bladder cancer models.
Korean J Urol. 2012;53:396-400.
Abstract Related articles

HUSSAIN SA , Palmer DH, Lloyd B, Collins SI, et al
A study of split-dose cisplatin-based neo-adjuvant chemotherapy in muscle-invasive bladder cancer.
Oncol Lett. 2012;3:855-859.
Abstract Related articles

KANG MR , Kang JS, Yang JW, Kim BG, et al
Gene expression profiling of KBH-A42, a novel histone deacetylase inhibitor, in human leukemia and bladder cancer cell lines.
Oncol Lett. 2012;3:113-118.
Abstract Related articles

VOELKER R
Diabetes drug is linked with bladder cancer risk.
JAMA. 2012;307:2577.
Abstract Related articles

SINGH V , Srivastava P, Srivastava N, Kapoor R, et al
Association of inflammatory chemokine gene CCL2I/D with bladder cancer risk in North Indian population.
Mol Biol Rep. 2012.
Abstract Related articles

PAYTON S
Bladder cancer: Pre-existing immunity to BCG can boost clinical response to intravesical therapy.
Nat Rev Urol. 2012 Jun 26. doi: 10.1038/nrurol.2012.
Abstract Related articles

CLYNE M
Bladder cancer: Pioglitazone increases risk of bladder cancer.
Nat Rev Urol. 2012 Jun 26. doi: 10.1038/nrurol.2012.
Abstract Related articles

PETROV SV , Malkhasyan KA, Ulyanin MY, Abdrakhmanov EF, et al
The Value of the Preoperative FISH Test in Unscreened Bladder Cancer Patients with TUR Indications.
Pathol Oncol Res. 2012.
Abstract Related articles

LAPINI A , Minervini A, Masala A, Schips L, et al
A comparison of hexaminolevulinate (Hexvix((R))) fluorescence cystoscopy and white-light cystoscopy for detection of bladder cancer: results of the HeRo observational study.
Surg Endosc. 2012.
Abstract Related articles

BILECOVA-RABAJDOVA M , Varga J, Urban P, Ostro A, et al
[New and clinically used oncomarkers of bladder cancer].
Klin Onkol. 2012;25:162-5.
Abstract Related articles

YING L , Chen Q, Wang Y, Zhou Z, et al
Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition.
Mol Biosyst. 2012.
Abstract Related articles

BLACH O , Rai B, Oates K, Franklin G, et al
An outbreak of schistosomiasis in travellers returning from endemic areas: the importance of rigorous tracing in peer groups exposed to risk of infection.
J Public Health (Oxf). 2012;34:32-6.
Abstract Related articles

OEZDEMIR RF , Gaisa NT, Lindemann-Docter K, Gostek S, et al
Proteomic tissue profiling for the improvement of grading of noninvasive papillary urothelial neoplasia.
Clin Biochem. 2012;45.
Abstract Related articles

DODURGA Y , Avci CB, Satiroglu-Tufan NL, Tataroglu C, et al
Detection of deleted in malignant brain tumors 1 and runt-related transcription factor 3 gene expressions in bladder carcinoma.
Mol Biol Rep. 2012;39:4691-5.
Abstract Related articles

WANG ZY , Zeng FQ, Zhu ZH, Jiang GS, et al
Evaluation of thymosin beta4 in the regulation of epithelial-mesenchymal transformation in urothelial carcinoma.
Urol Oncol. 2012;30:167-76.
Abstract Related articles

JUNE RR , Dougherty DW, Reese CT, Harpster LE, et al
Significant activity of single agent vinorelbine against small-cell cancer of the bladder as second line chemotherapy: a case series and review of the literature.
Urol Oncol. 2012;30:192-5.
Abstract Related articles

YANG Z , Cheng J, Pan L, Hu S, et al
Is whole-body fluorine-18 fluorodeoxyglucose PET/CT plus additional pelvic images (oral hydration-voiding-refilling) useful for detecting recurrent bladder cancer?
Ann Nucl Med. 2012.
Abstract Related articles

KERMODE-SCOTT B
Meta-analysis confirms raised risk of bladder cancer from pioglitazone.
BMJ. 2012;345:e4541.
Abstract Related articles

GOLDSMITH B , Tucker K, Conway RG, He J, et al
Discordance Between Preoperative and Postoperative Bladder Cancer Location: Implications for Partial-Bladder Radiation.
Int J Radiat Oncol Biol Phys. 2012.
Abstract Related articles

REINERT T
Methylation Markers for Urine-Based Detection of Bladder Cancer: The Next Generation of Urinary Markers for Diagnosis and Surveillance of Bladder Cancer.
Adv Urol. 2012;2012:503271.
Abstract Related articles

COLMERS IN , Bowker SL, Majumdar SR, Johnson JA, et al
Use of thiazolidinediones and the risk of bladder cancer among people with type 2 diabetes: a meta-analysis.
CMAJ. 2012.
Abstract Related articles

A 2-week Maintenance Regimen of Intravesical Instillation of Bacillus Calmette-Guerin is Safe, Adherent and Effective in Patients with Non-Muscle-Invasive Bladder Cancer: A Prospective, Multicenter Phase II Clinical Trial.
Jpn J Clin Oncol. 2012.
Abstract Related articles

EISSA S , Shehata H, Mansour A, Esmat M, et al
Detection of hyaluronidase RNA and activity in urine of schistosomal and non-schistosomal bladder cancer.
Med Oncol. 2012.
Abstract Related articles

MITTAL RD , Mandal RK
Genetic variation in nucleotide excision repair pathway genes influence prostate and bladder cancer susceptibility in North Indian population.
Indian J Hum Genet. 2012;18:47-55.
Abstract Related articles

RAZA SJ , Ather MH, Khan FA, Alam Z, et al
Grading complication following radical cystectomy and ileal conduit for bladder cancer using clavien grading system.
J Coll Physicians Surg Pak. 2012;22:448-51.
Abstract Related articles

BEEBE-DIMMER JL , Iyer PT, Nriagu JO, Keele G, et al
Genetic variation in Glutathione S-Transferase Omega-1, Arsenic Methyltransferase and Methylene-tetrahydrofolate Reductase, arsenic exposure and bladder cancer: a case-control study.
Environ Health. 2012;11:43.
Abstract Related articles

LIN TY , Zhang H, Luo J, Li Y, et al
Multifunctional targeting micelle nanocarriers with both imaging and therapeutic potential for bladder cancer.
Int J Nanomedicine. 2012;7:2793-804.
Abstract Related articles

HOGLUND M
The bladder cancer genome; chromosomal changes as prognostic makers, opportunities, and obstacles.
Urol Oncol. 2012;30:533-40.
Abstract Related articles

CHANG DW , Gu J, Wu X
Germline prognostic markers for urinary bladder cancer: Obstacles and opportunities.
Urol Oncol. 2012;30:524-32.
Abstract Related articles

VAN RHIJN BW
Combining molecular and pathologic data to prognosticate non-muscle-invasive bladder cancer.
Urol Oncol. 2012;30:518-23.
Abstract Related articles

KAO CH , Sun LM, Liang JA, Chang SN, et al
Relationship of zolpidem and cancer risk: a Taiwanese population-based cohort study.
Mayo Clin Proc. 2012;87:430-6.
Abstract Related articles

CELIA-TERRASSA T , Meca-Cortes O, Mateo F, de Paz AM, et al
Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells.
J Clin Invest. 2012;122:1849-68.
Abstract Related articles

RIVERA-NUNEZ Z , Meliker JR, Meeker JD, Slotnick MJ, et al
Urinary arsenic species, toenail arsenic, and arsenic intake estimates in a Michigan population with low levels of arsenic in drinking water.
J Expo Sci Environ Epidemiol. 2012;22:182-90.
Abstract Related articles

ROZANSKI W , Krzeslak A, Forma E, Brys M, et al
Prediction of bladder cancer based on urinary content of MGEA5 and OGT mRNA level.
Clin Lab. 2012;58.
Abstract Related articles

LETASIOVA S , Medvedova A, Sovcikova A, Dusinska M, et al
Bladder cancer, a review of the environmental risk factors.
Environ Health. 2012;11 Suppl 1:S11.
Abstract Related articles

KUMAR S , Singh D, Goel MM, Kushwaha JK, et al
FNAC site metastasis in gall bladder cancer - a rare presentation.
BMJ Case Rep. 2012;2012.
Abstract Related articles

ONOZAWA M , Miyanaga N, Hinotsu S, Miyazaki J, et al
Analysis of Intravesical Recurrence After Bladder-preserving Therapy for Muscle-invasive Bladder Cancer.
Jpn J Clin Oncol. 2012.
Abstract Related articles

CHEN G , He Y, Wu X, Zhang Y, et al
In vitro and in vivo studies of pirarubicin-loaded SWNT for the treatment of bladder cancer.
Braz J Med Biol Res. 2012 Jul 12. pii: S0100-879X2012007500111.
Abstract Related articles

MERTENS LS , Bruin NM, Vegt E, de Blok WM, et al
Catheter-assisted 18F-FDG-PET/CT imaging of primary bladder cancer: a prospective study.
Nucl Med Commun. 2012.
Abstract Related articles

SALEM H , El-Mazny A
Primary and secondary malignant involvement of gynaecological organs at radical cystectomy for bladder cancer: Review of literature and retrospective analysis of 360 cases.
J Obstet Gynaecol. 2012;32:590-3.
Abstract Related articles

REAUME J
You're the flight surgeon: renal stones and bladder cancer.
Aviat Space Environ Med. 2012;83:719-21.
Abstract Related articles

ASKELAND EJ , Newton MR, O'Donnell MA, Luo Y, et al
Bladder Cancer Immunotherapy: BCG and Beyond.
Adv Urol. 2012;2012:181987.
Abstract Related articles

MINNER S , De Silva C, Rink M, Dahlem R, et al
Reduced CD151 expression is related to advanced tumour stage in urothelial bladder cancer.
Pathology. 2012.
Abstract Related articles

WU SY , Lee YR, Huang CC, Li YZ, et al
Curcumin-induced heme oxygenase-1 expression plays a negative role for its anti-cancer effect in bladder cancers.
Food Chem Toxicol. 2012.
Abstract Related articles

AHMAD MR , Pervaiz MK, Pervaiz G
Non-occupational risk factors of urinary bladder cancer in Faisalabad and Lahore, Pakistan.
J Pak Med Assoc. 2012;62:236-9.
Abstract Related articles

PERAN TERUEL M , Gimenez Bachs JM, Martinez Ruiz J, Fernandez Anguita PJ, et al
Neuroendocrine carcinoma of the urinary bladder. 15-year retrospective analysis.
Arch Esp Urol. 2012;65:237-43.
Abstract Related articles

HUGUET J
Transitional cell carcinoma of the upper urinary tract after cystectomy.
Arch Esp Urol. 2012;65:227-36.
Abstract Related articles

SAID N , Sanchez-Carbayo M, Smith SC, Theodorescu D, et al
RhoGDI2 suppresses lung metastasis in mice by reducing tumor versican expression and macrophage infiltration.
J Clin Invest. 2012;122:1503-18.
Abstract Related articles

OREVI M , Klein M, Mishani E, Chisin R, et al
11C-Acetate PET/CT in Bladder Urothelial Carcinoma: Intraindividual Comparison With 11C-Choline.
Clin Nucl Med. 2012;37:e67-72.
Abstract Related articles

SHAN GY , Zhang Z, Chen QG, Yu XY, et al
Overexpression of RIN1 associates with tumor grade and progression in patients of bladder urothelial carcinoma.
Tumour Biol. 2012;33:847-55.
Abstract Related articles

CORTEGGIO A , Di Geronimo O, Roperto S, Roperto F, et al
Activated platelet-derived growth factor beta receptor and Ras-mitogen-activated protein kinase pathway in natural bovine urinary bladder carcinomas.
Vet J. 2012;191:393-5.
Abstract Related articles

VALENTINI CG , Bozzoli V, Larici AR, Larocca LM, et al
Systemic Granulomatous Reaction Secondary to Treatment of Bladder Cancer with Bacillus Calmette-Guerin.
Mediterr J Hematol Infect Dis. 2012;4:e2012040.
Abstract Related articles

ZHU Z , Shen Z, Xu C
Inflammatory pathways as promising targets to increase chemotherapy response in bladder cancer.
Mediators Inflamm. 2012;2012:528690.
Abstract Related articles

ZHAO Q , Shen WH, Chen ZW, Zhou ZS, et al
High expression level of BLCA-4 correlates with poor prognosis in human bladder cancer.
Int J Clin Exp Pathol. 2012;5:422-7.
Abstract Related articles

XIAO J , Chen JX, Zhu YP, Zhou LY, et al
Reduced expression of MTUS1 mRNA is correlated with poor prognosis in bladder cancer.
Oncol Lett. 2012;4:113-118.
Abstract Related articles

WANG G , Zheng L, Yu Z, Liao G, et al
Increased cyclin-dependent kinase 6 expression in bladder cancer.
Oncol Lett. 2012;4:43-46.
Abstract Related articles

KAWASHIMA A , Takayama H, Kawamura N, Doi N, et al
Co-expression of ERCC1 and Snail is a prognostic but not predictive factor of cisplatin-based neoadjuvant chemotherapy for bladder cancer.
Oncol Lett. 2012;4:15-21.
Abstract Related articles

MATSUBAYASHI H , Kimura H, Tobisu K, Onishi Y, et al
Autoimmune pancreatitis accompanied with recurrence of bladder cancer: difficulty in diagnosis and management of systemic lesions in a case with autoimmune pancreatitis.
JOP. 2012;13:446-50.
Abstract Related articles

HUANG C , Neoh KG, Xu LQ, Kang ET, et al
Polymeric Nanoparticles with Encapsulated Superparamagnetic Iron Oxide and Conjugated Cisplatin for Potential Bladder Cancer Therapy.
Biomacromolecules. 2012.
Abstract Related articles

PINTO-LEITE R , Arantes-Rodrigues R, Palmeira C, Gaivao I, et al
Everolimus enhances gemcitabine-induced cytotoxicity in bladder-cancer cell lines.
J Toxicol Environ Health A. 2012;75.
Abstract Related articles

KALRA S
The cage in search of a bird.
J Assoc Physicians India. 2012;60:74-5.
Abstract Related articles

MOHAN V , Bedi S, Unnikrishnan R, Sahay BK, et al
Pioglitazone--where do we stand in India?
J Assoc Physicians India. 2012;60:68-70.
Abstract Related articles

MASCIOVECCHIO S , Galatioto GP, Saldutto P, Del Rosso A, et al
An innovative combined antero-retrograde approach for the resolution of the complete iatrogenic obliteration of ureteral ostium: a case report.
Arch Ital Urol Androl. 2012;84:39-41.
Abstract Related articles

KANG WY , Chen WT, Huang YC, Su YC, et al
Overexpression of annexin 1 in the development and differentiation of urothelial carcinoma.
Kaohsiung J Med Sci. 2012;28:145-50.
Abstract Related articles

SHAHAB U , Moinuddin, Ahmad S, Dixit K, et al
Acquired immunogenicity of human DNA damaged by N-hydroxy-N-acetyl-4-aminobiphenyl.
IUBMB Life. 2012;64:340-5.
Abstract Related articles

WANG CY
Robust best linear estimation for regression analysis using surrogate and instrumental variables.
Biostatistics. 2012;13:326-40.
Abstract Related articles

SARI A , Calli A, Gorgel SN, Altinboga AA, et al
Immunohistochemical determination of ETS-1 oncoprotein expression in urothelial carcinomas of the urinary bladder.
Appl Immunohistochem Mol Morphol. 2012;20:153-8.
Abstract Related articles

MONDUL AM , Weinstein SJ, Albanes D
Serum vitamin D and risk of bladder cancer in PLCO-Response.
Cancer Epidemiol Biomarkers Prev. 2012.
Abstract Related articles

GRANT WB
Serum vitamin D and risk of bladder cancer in PLCO - Letter.
Cancer Epidemiol Biomarkers Prev. 2012.
Abstract Related articles

ATKINS CD , Wrzesinski SH
Radiotherapy plus Chemotherapy in Muscle-Invasive Bladder Cancer.
N Engl J Med. 2012;367:379-81.
Abstract Related articles

CATHCART P , Sylvester R, Catto J
Radiotherapy plus Chemotherapy in Muscle-Invasive Bladder Cancer.
N Engl J Med. 2012;367:379-81.
Abstract Related articles

CHUNG SD , Huang CY, Yu HJ
Radiotherapy plus Chemotherapy in Muscle-Invasive Bladder Cancer.
N Engl J Med. 2012;367:379-81.
Abstract Related articles

Radiotherapy plus Chemotherapy in Muscle-Invasive Bladder Cancer.
N Engl J Med. 2012;367:379-81.
Abstract Related articles

HAN H , Wolff EM, Liang G
Epigenetic Alterations in Bladder Cancer and Their Potential Clinical Implications.
Adv Urol. 2012;2012:546917.
Abstract Related articles

PANNEERSELVAM J , Park HK, Zhang J, Dudimah FD, et al
FAVL impairment of the Fanconi anemia pathway promotes the development of human bladder cancer.
Cell Cycle. 2012;11.
Abstract Related articles

KELLER J , Chiou HY, Lin HC
Increased risk of bladder cancer following diagnosis with bladder pain syndrome/interstitial cystitis.
Neurourol Urodyn. 2012 Jul 23. doi: 10.1002/nau.22283.
Abstract Related articles

ACIKALIN D , Oner U, Can C, Acikalin MF, et al
Predictive value of maspin and Ki-67 expression in transurethral resection specimens in patients with T1 bladder cancer.
Tumori. 2012;98:0.
Abstract Related articles

SZEPESHAZI K , Schally AV, Keller G, Block NL, et al
Receptor-targeted therapy of human experimental urinary bladder cancers with cytotoxic LH-RH analog AN-152 [AEZS- 108].
Oncotarget. 2012.
Abstract Related articles

FOROUDI F , Wilson L, Bressel M, Haworth A, et al
A dosimetric comparison of 3D Conformal vs Intensity Modulated vs Volumetric Arc Radiation Therapy for Muscle Invasive Bladder Cancer.
Radiat Oncol. 2012;7:111.
Abstract Related articles

RAHEEM OA , Kalunian K, Kellogg Parsons J
Acute Arthritis Secondary to Intravesical Bacillus Calmette-Guerin for Bladder Cancer.
Actas Urol Esp. 2012.
Abstract Related articles

KOSKELA LR , Poljakovic M, Ehren I, Peter Wiklund N, et al
Localization and expression of inducible Nitric oxide synthase in patients after bcg treatment for bladder cancer.
Nitric Oxide. 2012.
Abstract Related articles

FUNATSU H , Imamura A, Takano H, Ueda T, et al
Can pretreatment ADC values predict recurrence of bladder cancer after transurethral resection?
Eur J Radiol. 2012.
Abstract Related articles

MARENNE G , Real FX, Rothman N, Rodriguez-Santiago B, et al
Genome-wide CNV analysis replicates the association between GSTM1 deletion and bladder cancer: a support for using continuous measurement from SNP-array data.
BMC Genomics. 2012;13:326.
Abstract Related articles

LIEDBERG F , Holmang S, Hosseini A, Ljungberg B, et al
[Fast measures in macro hematuria are both necessary and possible].
Lakartidningen. 2012;109.
Abstract Related articles

ZHANG HZ , Wang CF, Sun JJ, Yu BH, et al
A combined clinicopathologic analysis of 658 urothelial carcinoma cases of urinary bladder.
Chin Med Sci J. 2012;27:24-8.
Abstract Related articles

ZULLIG LL , Jackson GL, Dorn RA, Provenzale DT, et al
Cancer incidence among patients of the U.S. Veterans Affairs Health Care System.
Mil Med. 2012;177:693-701.
Abstract Related articles

DENG J , Liu Y, Lee H, Herrmann A, et al
S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites.
Cancer Cell. 2012;21:642-54.
Abstract Related articles

HARIKRISHNAN JA , Chilka S, Jain S
Urinary tract transitional cell carcinoma and melanosis of the bladder: a case report and review of the literature.
Ann R Coll Surg Engl. 2012;94:e152-4.
Abstract Related articles

SOLOMIDES CC , Birbe RC, Nicolaou N, Bagley D, et al
Does mitosis-specific marker phosphohistone H3 help the grading of upper tract urothelial carcinomas in cell blocks?
Acta Cytol. 2012;56:285-8.
Abstract Related articles

QUIROGA-GARZA G , Nassar D, Khalbuss WE, Monaco SE, et al
Vegetable cell contaminants in urinary bladder diversion cytology specimens.
Acta Cytol. 2012;56:271-6.
Abstract Related articles

BENNETT MH , Feldmeier J, Smee R, Milross C, et al
Hyperbaric oxygenation for tumour sensitisation to radiotherapy.
Cochrane Database Syst Rev. 2012;4:CD005007.
Abstract Related articles

KNAPP DW
Ultrasound-guided endoscopic diode laser ablation in dogs with transitional cell carcinoma.
J Am Vet Med Assoc. 2012;240:802.
Abstract Related articles

CHASTAIN EC , Oliva IV, Osunkoya AO
Utility of p63 and high molecular weight cytokeratin in the distinction between urothelial carcinoma with prostatic stromal invasion and urothelial carcinoma with colonisation of prostatic ducts and acini.
Pathology. 2012;44:199-203.
Abstract Related articles

PIRA E , Pelucchi C, Romano C, Manzari M, et al
Mortality from cancer and other causes in an Italian cohort of male rubber tire workers.
J Occup Environ Med. 2012;54:345-9.
Abstract Related articles

RODRIGUEZ FABA O , Palou-Redorta J, Fernandez-Gomez JM, Algaba F, et al
Matrix Metalloproteinases and Bladder Cancer: What is New?
ISRN Urol. 2012;2012:581539.
Abstract Related articles

DORNELAS CA , Fechine-Jamacaru FV, Albuquerque IL, Magalhaes HI, et al
Angiogenesis inhibition by green propolis and the angiogenic effect of L-lysine on bladder cancer in rats.
Acta Cir Bras. 2012;27:529-36.
Abstract Related articles

KUO CC , Chiu HF, Lee IM, Kuo HW, et al
Statin use and the risk of bladder cancer: a population-based case-control study.
Expert Opin Drug Saf. 2012.
Abstract Related articles

AZZOUNI F
Current status of robot-assisted radical cystectomy for bladder cancer.
Nat Rev Urol. 2012 Jul 31. doi: 10.1038/nrurol.2012.
Abstract Related articles

DALL'ERA MA , Cheng L, Pan CX
Contemporary management of muscle-invasive bladder cancer.
Expert Rev Anticancer Ther. 2012;12:941-50.
Abstract Related articles

BHATT J , Cowan N, Protheroe A, Crew J, et al
Recent advances in urinary bladder cancer detection.
Expert Rev Anticancer Ther. 2012;12:929-39.
Abstract Related articles

WANG X , Wang H, Bu R, Fei X, et al
Methylation and aberrant expression of the Wnt antagonist secreted Frizzled-related protein 1 in bladder cancer.
Oncol Lett. 2012;4:334-338.
Abstract Related articles

HWANG EC , Hwang IS, Yu HS, Kim SO, et al
Utility of Inflammation-based Prognostic Scoring in Patients Given Systemic Chemotherapy First-line for Advanced Inoperable Bladder Cancer.
Jpn J Clin Oncol. 2012.
Abstract Related articles

SYRIOS J , Logothetis M, Grivas A, Lianos E, et al
Primary signet-ring adenocarcinoma of the urinary bladder with gastric metastasis or a second primary cancer?
J BUON. 2012;17:396.
Abstract Related articles

NAKAZAWA S , Yoneda S, Takezawa K, Tanigawa G, et al
[Plexiform neurofibroma of the bladder associated with neurofibromatosis type 1: a case report].
Hinyokika Kiyo. 2012;58:215-8.
Abstract Related articles

CAMPO G , Giannarini G, Pomara G, Manassero F, et al
Bladder papilloma in a 9-year-old girl: a case report.
Minerva Pediatr. 2012;64:361-3.
Abstract Related articles

EDGECOMBE A , Nguyen BN, Djordjevic B, Belanger EC, et al
Utility of cytokeratin 5/6, cytokeratin 20, and p16 in the diagnosis of reactive urothelial atypia and noninvasive component of urothelial neoplasia.
Appl Immunohistochem Mol Morphol. 2012;20:264-71.
Abstract Related articles

CHIANG YJ , Yang PS, Wang HH, Lin KJ, et al
Urothelial cancer after renal transplantation: an update.
Transplant Proc. 2012;44:744-5.
Abstract Related articles

MOLNAR T , Vajdovich P
Clinical factors determining the efficacy of urinary bladder tumour treatments in dogs: surgery, chemotherapy or both?
Acta Vet Hung. 2012;60:55-68.
Abstract Related articles

HEGELE A , Skrobek L, Schrader AJ
[Update uro-oncology: scientific meetings 2011].
Aktuelle Urol. 2012;43:13-27.
Abstract Related articles

ZELEFSKY MJ , Housman DM, Pei X, Alicikus Z, et al
Incidence of Secondary Cancer Development After High-Dose Intensity-Modulated Radiotherapy and Image-Guided Brachytherapy for the Treatment of Localized Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2011.
Abstract Related articles

EL-MOSALAMY H , Salman TM, Ashmawey AM, Osama N, et al
Role of chronic E. coli infection in the process of bladder cancer- an experimental study.
Infect Agent Cancer. 2012;7:19.
Abstract Related articles

YUGE K , Miyajima A, Tanaka N, Shirotake S, et al
Prognostic Value of Renin-Angiotensin System Blockade in Non-muscle-invasive Bladder Cancer.
Ann Surg Oncol. 2012.
Abstract Related articles

BENERINI GATTA L , Balzarini P, Cadei M, Castelli F, et al
Haematobium eggs detection in human bladder cancer and sporocysts in snail vectors: Seven cases report and a review of the Burkina Faso literature.
Pathol Biol (Paris). 2012.
Abstract Related articles

KWON DH , Song PH, Kim HT
Multivariate analysis of the prognostic significance of resection weight after transurethral resection of bladder tumor for non-muscle-invasive bladder cancer.
Korean J Urol. 2012;53:457-62.
Abstract Related articles

D'AGOSTINO D , Racioppi M, Filianoti A, Di Gianfrancesco L, et al
[Therapy for non-muscle invasive bladder cancer: HP-NAP.]
Urologia. 2012;0:0.
Abstract Related articles

OZCAN MF , Dizdar O, Dincer N, Balci S, et al
Low ERCC1 expression is associated with prolonged survival in patients with bladder cancer receiving platinum-based neoadjuvant chemotherapy.
Urol Oncol. 2012.
Abstract Related articles

ADAM L , Wszolek MF, Liu CG, Jing W, et al
Plasma microRNA profiles for bladder cancer detection.
Urol Oncol. 2012.
Abstract Related articles

FOROUDI F , Pham D, Bressel M, Wong J, et al
Bladder Cancer Radiotherapy Margins: A Comparison of Daily Alignment using Skin, Bone or Soft Tissue.
Clin Oncol (R Coll Radiol). 2012.
Abstract Related articles

VARGAS HA , Akin O, Schoder H, Olgac S, et al
Prospective evaluation of MRI, (11)C-acetate PET/CT and contrast-enhanced CT for staging of bladder cancer.
Eur J Radiol. 2012.
Abstract Related articles

VENUGOPAL R , Kurek SJ, Orucevic A
A case of peritoneal squamous metaplasia arising within obstructed small bowel: a rare pathological finding during a common surgical event.
Am Surg. 2012;78:E320-1.
Abstract Related articles

MCKENZIE PL , Hemal AK
Surgeon controlled robot-assisted laparoscopic radical cystectomy: current review of oncologic and functional outcomes.
Minerva Urol Nefrol. 2012;64:79-88.
Abstract Related articles

HUANG WT , Li LY, Pang J, Ruan XX, et al
Fluorescence in situ hybridization assay detects upper urinary tract transitional cell carcinoma in patients with asymptomatic hematuria and negative urine cytology.
Neoplasma. 2012;59:355-60.
Abstract Related articles

LI X , Li H
[The trends and progress in the comprehensive treatments of urological malignance].
Sichuan Da Xue Xue Bao Yi Xue Ban. 2012;43:74-8.
Abstract Related articles

CASTELLANO D , Carles J, Esteban E, Trigo JM, et al
Recommendations for the optimal management of early and advanced urothelial carcinoma.
Cancer Treat Rev. 2012;38:431-41.
Abstract Related articles

LU J , Luo JH, Pang J, Cao JZ, et al
Lentivirus-mediated RNA interference of clusterin enhances the chemosensitivity of EJ bladder cancer cells to epirubicin in vitro.
Mol Med Report. 2012 Aug 3. doi: 10.3892/mmr.2012.1017.
Abstract Related articles

NAMURA K , Takizawa A, Takeshima T, Tsuchiya F, et al
[A Case of Secondary Paget's Disease of the Glans Penis Originating from Bladder Cancer].
Hinyokika Kiyo. 2012;58:345-8.
Abstract Related articles

DICKSTEIN RJ , Nitti G, Dinney CP, Davies BR, et al
Autophagy limits the cytotoxic effects of the AKT inhibitor AZ7328 in human bladder cancer cells.
Cancer Biol Ther. 2012;13.
Abstract Related articles

MOSKOVITZ B , Halachmi S, Moskovitz M, Nativ O, et al
10-year single-center experience of combined intravesical chemohyperthermia for nonmuscle invasive bladder cancer.
Future Oncol. 2012;8:1041-9.
Abstract Related articles

TODENHOFER T , Hennenlotter J, Aufderklamm S, Kuhs U, et al
Individual risk assessment in bladder cancer patients based on a multi-marker panel.
J Cancer Res Clin Oncol. 2012.
Abstract Related articles

LAMARCA A , Barriuso J
Urine Telomerase for Diagnosis and Surveillance of Bladder Cancer.
Adv Urol. 2012;2012:693631.
Abstract Related articles

ZHANG P , Wang J, Wang D, Wang H, et al
Dendritic cell vaccine modified by Ag85A gene enhances anti-tumor immunity against bladder cancer.
Int Immunopharmacol. 2012.
Abstract Related articles

JEONG P , Min BD, Ha YS, Song PH, et al
RUNX3 methylation in normal surrounding urothelium of patients with non-muscle-invasive bladder cancer: Potential role in the prediction of tumor progression.
Eur J Surg Oncol. 2012.
Abstract Related articles

ZHANG Z , Xu XL, Ma L, Li JL, et al
[Intravesical anchoring of streptavidin-tagged interleukin-4 fusion protein for immunotherapy of mouse superficial bladder cancer].
Zhonghua Zhong Liu Za Zhi. 2012;34:331-5.
Abstract Related articles

MAMTANI R , Haynes K, Bilker WB, Vaughn DJ, et al
Association Between Longer Therapy With Thiazolidinediones and Risk of Bladder Cancer: A Cohort Study.
J Natl Cancer Inst. 2012.
Abstract Related articles

ENDO T , Emura M, Yamamoto T, Kikuchi K, et al
[Renal tuberculosis in an isthmus of a horseshoe kidney after bacillus Calmette-Guerin therapy for bladder cancer].
Nihon Hinyokika Gakkai Zasshi. 2012;103:562-5.
Abstract Related articles

CLANCY DL , Husain S, Hanna EB
ECG of the month. ECG in a man with metastatic malignancy. Sinus tachycardia at 110 beats/minute.
J La State Med Soc. 2012;164:97-8.
Abstract Related articles

LOPEZ-BELTRAN A
Rare lesions and tumors of the urinary bladder. Selected issues.
Tumori. 2012;98:274-7.
Abstract Related articles

BIONDANI P , Procopio G, Pietrantonio F, de Braud F, et al
New perspectives in advanced genitourinary malignancies.
Tumori. 2012;98:267-9.
Abstract Related articles

VAN DER MOLEN AJ , Hovius MC
Hematuria: a problem-based imaging algorithm illustrating the recent dutch guidelines on hematuria.
AJR Am J Roentgenol. 2012;198:1256-65.
Abstract Related articles

MOSCHONAS A , Ioannou M, Eliopoulos AG
CD40 stimulates a "feed-forward" NF-kappaB-driven molecular pathway that regulates IFN-beta expression in carcinoma cells.
J Immunol. 2012;188:5521-7.
Abstract Related articles

RAJAIAN S , Kumar RM, Kekre NS
Squamous cell carcinoma associated with large bladder calculus.
ANZ J Surg. 2012;82.
Abstract Related articles

PERCARPIO R , Siegel A, Seltzer M
Colon Cancer Metastatic to a Urachus Diagnosed by PET/CT.
Clin Nucl Med. 2012;37:528-9.
Abstract Related articles

LAMPRECHT C , Gierlinger N, Heister E, Unterauer B, et al
Mapping the intracellular distribution of carbon nanotubes after targeted delivery to carcinoma cells using confocal Raman imaging as a label-free technique.
J Phys Condens Matter. 2012;24:164206.
Abstract Related articles

NUHN P , May M, Fritsche HM, Buchner A, et al
External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
Eur J Surg Oncol. 2012;38:637-42.
Abstract Related articles

HAYASE E , Kurosawa M, Yonezumi M, Suzuki S, et al
[Early relapse in the central nervous system-after achieving complete response in primary vaginal lymphoma].
Rinsho Ketsueki. 2012;53:229-34.
Abstract Related articles

MUTA T , Nakaike T, Fujisaki T, Shiraishi T, et al
Diffuse large B-cell lymphoma arising primarily at the stoma after bladder reconstruction using ileal conduit.
Intern Med. 2012;51:643-6.
Abstract Related articles

REBOUISSOU S , Herault A, Letouze E, Neuzillet Y, et al
CDKN2A homozygous deletion is associated with muscle invasion in FGFR3-mutated urothelial bladder carcinoma.
J Pathol. 2012;227:315-24.
Abstract Related articles

AL-MAGHREBI M , Kehinde EO, Kapila K, Anim JT, et al
Urinary survivin mRNA expression and urinary nuclear matrix protein 22 BladderChek(R) and urine cytology in the detection of transitional cell carcinoma of the bladder.
Med Princ Pract. 2012;21:295-7.
Abstract Related articles

IGUCHI K , Sakurai F, Tomita K, Katayama K, et al
Efficient antitumor effects of carrier cells loaded with a fiber-substituted conditionally replicating adenovirus on CAR-negative tumor cells.
Cancer Gene Ther. 2012;19:118-25.
Abstract Related articles

D'SOUZA AM , Pohar KS, Arif T, Geyer S, et al
Retrospective analysis of survival in muscle-invasive bladder cancer: impact of pT classification, node status, lymphovascular invasion, and neoadjuvant chemotherapy.
Virchows Arch. 2012.
Abstract Related articles

GERULLIS H , Otto T, Ecke TH
Targeted agents in second-line bladder cancer therapy.
Anticancer Drugs. 2012.
Abstract Related articles

WU K , Fan J, Zhang L, Ning Z, et al
PI3K/Akt to GSK3beta/beta-catenin Signaling Cascade Coordinates Cell Colonization for Bladder Cancer Bone Metastasis through Regulating ZEB1 Transcription.
Cell Signal. 2012.
Abstract Related articles

GOETHUYS H , Van Poppel H
Update on the management of invasive bladder cancer 2012.
Cancer Manag Res. 2012;4:177-82.
Abstract Related articles

HE YF , Tian DY, Yi ZJ, Yin ZK, et al
Upregulation of cell adhesion through delta Np63 silencing in human 5637 bladder cancer cells.
Asian J Androl. 2012 Aug 20. doi: 10.1038/aja.2012.
Abstract Related articles

XU T , Xu ZC, Zou Q, Yu B, et al
P53 Arg72Pro Polymorphism and Bladder Cancer Risk - Meta- analysis Evidence for a Link in Asians but not Caucasians.
Asian Pac J Cancer Prev. 2012;13:2349-54.
Abstract Related articles

CHEN JX , Deng N, Chen X, Chen LW, et al
A Novel Molecular Grading Model: Combination of Ki67 and VEGF in Predicting Tumor Recurrence and Progression in Non-invasive Urothelial Bladder Cancer.
Asian Pac J Cancer Prev. 2012;13:2229-34.
Abstract Related articles

WANG HF , Wang JS
Research Progress in Potential Urinary Markers for the Early Detection, Diagnosis and Follow-up of Human Bladder Cancer.
Asian Pac J Cancer Prev. 2012;13:1723-6.
Abstract Related articles

DI MARTINO E , Tomlinson DC, Knowles MA
A Decade of FGF Receptor Research in Bladder Cancer: Past, Present, and Future Challenges.
Adv Urol. 2012;2012:429213.
Abstract Related articles

POTTS KG , Hitt MM, Moore RB
Oncolytic viruses in the treatment of bladder cancer.
Adv Urol. 2012;2012:404581.
Abstract Related articles

LUO DS , Mi QW, Meng XJ, Gao Y, et al
[Synergetic killing effects of external magnetic fields combined with porphyrin-dextran magnetic nanoparticles on the human bladder cancer cells].
Beijing Da Xue Xue Bao. 2012;44:524-7.
Abstract Related articles

ZHOU J , Li J, Wang Z, Yin C, et al
Metadherin is a novel prognostic marker for bladder cancer progression and overall patient survival.
Asia Pac J Clin Oncol. 2012;8:e42-8.
Abstract Related articles

Pioglitazone: European approval maintained despite the acknowledged risks.
Prescrire Int. 2012;21:181.
Abstract Related articles

LIAN HY , Hu M, Liu CH, Yamauchi Y, et al
Highly biocompatible, hollow coordination polymer nanoparticles as cisplatin carriers for efficient intracellular drug delivery.
Chem Commun (Camb). 2012;48:5151-3.
Abstract Related articles

ROUPRET M
Tumours of the bladder: what does the urologist expect from imaging?
Diagn Interv Imaging. 2012;93:291-6.
Abstract Related articles

ROY C
Tumour pathology of the bladder: the role of MRI.
Diagn Interv Imaging. 2012;93:297-309.
Abstract Related articles

COWAN CC , Hutchison C, Cole T, Barry SJ, et al
A Randomised Double-blind Placebo-controlled Trial to Determine the Effect of Cranberry Juice on Decreasing the Incidence of Urinary Symptoms and Urinary Tract Infections in Patients Undergoing Radiotherapy for Cancer of the Bladder or Cervix.
Clin Oncol (R Coll Radiol). 2011.
Abstract Related articles

PIERAERTS C , Martin V, Jichlinski P, Nardelli-Haefliger D, et al
Detection of functional antigen-specific T cells from urine of non-muscle invasive bladder cancer patients.
Oncoimmunology. 2012;1:694-698.
Abstract Related articles

MIYAKE M , Goodison S, Rizwani W, Ross S, et al
Urinary BTA: indicator of bladder cancer or of hematuria.
World J Urol. 2012.
Abstract Related articles

ZHI Y , Yu J, Liu Y, Wei Q, et al
Interaction between Polymorphisms of DNA Repair Genes Significantly Modulated Bladder Cancer Risk.
Int J Med Sci. 2012;9:498-505.
Abstract Related articles

PAYTON S
Bladder cancer: Intravesical RNA activation-a new treatment concept.
Nat Rev Urol. 2012 Aug 28. doi: 10.1038/nrurol.2012.
Abstract Related articles

MOHAMED NE , Diefenbach MA, Goltz HH, Lee CT, et al
Muscle invasive bladder cancer: from diagnosis to survivorship.
Adv Urol. 2012;2012:142135.
Abstract Related articles

QIN J , Xie B, Mao Q, Kong D, et al
Tea consumption and risk of bladder cancer: a meta-analysis.
World J Surg Oncol. 2012;10:172.
Abstract Related articles

NIU H , Jiang H, Cheng B, Li X, et al
Stromal proteome expression profile and muscle-invasive bladder cancer research.
Cancer Cell Int. 2012;12:39.
Abstract Related articles

SUN Y , Cheng MK, Griffiths TR, Mellon JK, et al
Inhibition of STAT Signalling in Bladder Cancer by Diindolylmethane - Relevance to Cell Adhesion, Migration and Proliferation.
Curr Cancer Drug Targets. 2012.
Abstract Related articles

LIMA L , Dinis-Ribeiro M, Longatto-Filho A, Santos L, et al
Predictive biomarkers of bacillus calmette-guerin immunotherapy response in bladder cancer: where are we now?
Adv Urol. 2012;2012:232609.
Abstract Related articles

HANJI AM , Rohan VS, Patel JJ, Tankshali RA, et al
Pheochromocytoma of the urinary bladder: a rare cause of severe hypertension.
Saudi J Kidney Dis Transpl. 2012;23:813-6.
Abstract Related articles

TIWARI P , Tripathi A, Bansal P, Vijay M, et al
Synchronous primary cancers of urinary bladder and kidney and prostate.
Saudi J Kidney Dis Transpl. 2012;23:786-9.
Abstract Related articles

OGAYA PINIES G , Herranz Amo F, Escribano Patino G, Lledo Garcia E, et al
Urachal adenocarcinoma. Case report and bibliographic review.
Arch Esp Urol. 2012;65:498-501.
Abstract Related articles

RAHMANI A , Alzohairy M, Khadri H, Mandal AK, et al
Expressional evaluation of vascular endothelial growth factor (VEGF) protein in urinary bladder carcinoma patients exposed to cigarette smoke.
Int J Clin Exp Pathol. 2012;5:195-202.
Abstract Related articles

KIM JJ
Recent advances in treatment of advanced urothelial carcinoma.
Curr Urol Rep. 2012;13:147-52.
Abstract Related articles

YUEN HF , McCrudden CM, Grills C, Zhang SD, et al
Combinatorial use of bone morphogenetic protein 6, noggin and SOST significantly predicts cancer progression.
Cancer Sci. 2012;103:1145-54.
Abstract Related articles

RINK M , Cha EK, Green D, Hansen J, et al
Biomolecular predictors of urothelial cancer behavior and treatment outcomes.
Curr Urol Rep. 2012;13:122-35.
Abstract Related articles

YU HM , Wang TC
Mechanism of cisplatin resistance in human urothelial carcinoma cells.
Food Chem Toxicol. 2012;50:1226-37.
Abstract Related articles

NIEGISCH G , Albers P, Rabenalt R
[Robot-assisted radical cystectomy: do we actually need a robot?].
Urologe A. 2012;51:319-24.
Abstract Related articles

SIGEL CS , Park KJ, Fine SW, Lin O, et al
Urothelial carcinoma involving vaginal specimens from patients with neobladder: a potential pitfall in diagnostic cytopathology.
Diagn Cytopathol. 2012;40:168-72.
Abstract Related articles

INOUE S , Shiina H, Igawa M
Paget's disease of the vulva with bladder invasion: a case report.
Arch Gynecol Obstet. 2012;285:1493-6.
Abstract Related articles

OHLMANN CH , Stockle M
[When should systemic chemotherapy be used for urinary bladder carcinoma?].
Urologe A. 2012;51:325-30.
Abstract Related articles

KUNIEDA F , Kitamura H, Niwakawa M, Kuroiwa K, et al
Watchful Waiting Versus Intravesical BCG Therapy for High-grade pT1 Bladder Cancer with pT0 Histology After Second Transurethral Resection: Japan Clinical Oncology Group Study JCOG1019.
Jpn J Clin Oncol. 2012.
Abstract Related articles

GULPINAR O , Halilioglu OH, Gokce MI, Gogus C, et al
The value of perioperative mitomycin C instillation in improving subsequent bacillus calmette-guerin instillation efficacy in intermediate and high-risk patients with non-muscle invasive bladder cancer: a prospective randomized study.
Int Braz J Urol. 2012;38:474-9.
Abstract Related articles

SHEPHARD EA , Stapley S, Neal RD, Rose P, et al
Clinical features of bladder cancer in primary care.
Br J Gen Pract. 2012;62:598-604.
Abstract Related articles

HE GN , Zhong WD, Bi XC, Hu ZQ, et al
[Case-control study on the correlation of bladder cancer incidence and occupational factors].
Zhonghua Yi Xue Za Zhi. 2012;92:1978-80.
Abstract Related articles

JEONG S , Park Y, Cho Y, Kim YR, et al
Diagnostic values of urine CYFRA21-1, NMP22, UBC, and FDP for the detection of bladder cancer.
Clin Chim Acta. 2012.
Abstract Related articles

NITTA Y , Konishi H, Makino T, Tanaka T, et al
Urinary levels of Hepatocarcinoma-intestine-pancreas/Pancreatitis-associated protein as a diagnostic biomarker in patients with bladder cancer.
BMC Urol. 2012;12:24.
Abstract Related articles

PARADA B , Reis F, Pinto A, Sereno J, et al
Chemopreventive Efficacy of Atorvastatin against Nitrosamine-Induced Rat Bladder Cancer: Antioxidant, Anti-Proliferative and Anti-Inflammatory Properties.
Int J Mol Sci. 2012;13:8482-99.
Abstract Related articles

QIN J , Wang Y, Bai Y, Yang K, et al
Epigallocatechin-3-gallate inhibits bladder cancer cell invasion via suppression of NF-kappaBmediated matrix metalloproteinase-9 expression.
Mol Med Report. 2012 Aug 30. doi: 10.3892/mmr.2012.1054.
Abstract Related articles

CORNU JN , Neuzillet Y, Herve JM, Yonneau L, et al
Patterns of local recurrence after radical cystectomy in a contemporary series of patients with muscle-invasive bladder cancer.
World J Urol. 2012.
Abstract Related articles

VASQUEZ JL , Gehl J, Hermann GG
Electroporation enhances mitomycin C cytotoxicity on T24 bladder cancer cell line: A potential improvement of intravesical chemotherapy in bladder cancer.
Bioelectrochemistry. 2012;88C:127-133.
Abstract Related articles

SARMIENTO JM , Wi MS, Piao Z, Stiner ES, et al
Solitary cerebral metastasis from transitional cell carcinoma after a 14-year remission of urinary bladder cancer treated with gemcitabine: Case report and literature review.
Surg Neurol Int. 2012;3:82.
Abstract Related articles

HOLLAND-BILL L , Froslev T, Friis S, Olsen M, et al
Completeness of bladder cancer staging in the Danish Cancer Registry, 2004-2009.
Clin Epidemiol. 2012;4:25-31.
Abstract Related articles

GONDO T , Yoshioka K, Nakagami Y, Okubo H, et al
Robotic versus open radical cystectomy: prospective comparison of perioperative and pathologic outcomes in Japan.
Jpn J Clin Oncol. 2012;42:625-31.
Abstract Related articles

JINESH G G , Chunduru S, Kamat AM
Smac mimetic enables the anticancer action of BCG-stimulated neutrophils through TNF-alpha but not through TRAIL and FasL.
J Leukoc Biol. 2012;92:233-44.
Abstract Related articles

ROH MR , Shin HJ, Lee SH, Chung KY, et al
Risk of second cancers after the diagnosis of non-melanoma skin cancer in Korean patients.
J Dermatol. 2012 Mar 2. doi: 10.1111/j.1346-8138.2011.01495.
Abstract Related articles

MATSUMOTO M , Suzuki M, Kano H, Aiso S, et al
Carcinogenicity of ortho-phenylenediamine dihydrochloride in rats and mice by two-year drinking water treatment.
Arch Toxicol. 2012;86:791-804.
Abstract Related articles

LEEK JT , Johnson WE, Parker HS, Jaffe AE, et al
The sva package for removing batch effects and other unwanted variation in high-throughput experiments.
Bioinformatics. 2012;28:882-3.
Abstract Related articles

LI Q , Tang J
Role of low-mechanical index CEUS in the differentiation between low and high grade bladder carcinoma: a pilot study.
Ultraschall Med. 2012;33:87-8.
Abstract Related articles

LERNER SP , Liu H, Wu MF, Thomas YK, et al
Fluorescence and white light cystoscopy for detection of carcinoma in situ of the urinary bladder.
Urol Oncol. 2012;30:285-9.
Abstract Related articles

SUNDI D , Svatek RS, Margulis V, Wood CG, et al
Upper tract urothelial carcinoma: impact of time to surgery.
Urol Oncol. 2012;30:266-72.
Abstract Related articles

LIBRENJAK D , Situm M, Vrdoljak E, Milostic K, et al
Results of long-term follow-up of patients with superficial bladder carcinoma treated with intravesically applied bacillus Calmette-Guerin vaccine according to the schedule of 6 weekly + 6 monthly instillations.
Urol Oncol. 2012;30:259-65.
Abstract Related articles

YOUSSEF RF , Schlomer BJ, Ho R, Sagalowsky AI, et al
Role of fluorescence in situ hybridization in bladder cancer surveillance of patients with negative cytology.
Urol Oncol. 2012;30:273-7.
Abstract Related articles

PLOEG M , Kiemeney LA, Smits GA, Vergunst H, et al
Discrepancy between clinical staging through bimanual palpation and pathological staging after cystectomy.
Urol Oncol. 2012;30:247-51.
Abstract Related articles

WHEAT JC , Weizer AZ, Wolf JS Jr, Lotan Y, et al
Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy.
Urol Oncol. 2012;30:252-8.
Abstract Related articles

PANAGIOTAKIS GI , Papadogianni D, Chatziioannou MN, Lasithiotaki I, et al
Association of human herpes, papilloma and polyoma virus families with bladder cancer.
Tumour Biol. 2012.
Abstract Related articles

VILLARES GJ , Zigler M, Blehm K, Bogdan C, et al
Retraction Note: Targeting EGFR in bladder cancer.
World J Urol. 2012.
Abstract Related articles

LI J , Wang H, Ma Z, Fan W, et al
TAT-Apoptin induces apoptosis in the human bladder cancer EJ cell line and regulates Bax, Bcl-2, caspase-3 and survivin expression.
Exp Ther Med. 2012;3:1033-1038.
Abstract Related articles

PENG M , Xie T, Yu J, Xu B, et al
Bladder cancer-associated protein is suppressed in human cervical tumors.
Exp Ther Med. 2012;3:336-340.
Abstract Related articles

YOO KH , Lim TJ, Chang SG
Monthly intravesical bacillus Calmette-Guerin maintenance therapy for non-muscle-invasive bladder cancer: 10-year experience in a single institute.
Exp Ther Med. 2012;3:221-225.
Abstract Related articles

ZHANG J , Wei S, Liu L, Nagana Gowda GA, et al
NMR-based metabolomics study of canine bladder cancer.
Biochim Biophys Acta. 2012.
Abstract Related articles

CUI X , Lu X, Hiura M, Omori H, et al
Association of genotypes of carcinogen-metabolizing enzymes and smoking status with bladder cancer in a Japanese population.
Environ Health Prev Med. 2012.
Abstract Related articles

EISSA S , Badr S, Elhamid SA, Helmy AS, et al
The value of combined use of survivin mRNA and matrix metalloproteinase 2 and 9 for bladder cancer detection in voided urine.
Dis Markers. 2012.
Abstract Related articles

YASSINE IA , Kobeissi L, Jabbour ME, Dhaini HR, et al
N-Acetyltransferase 1 (NAT1) Genotype: A Risk Factor for Urinary Bladder Cancer in a Lebanese Population.
J Oncol. 2012;2012:512976.
Abstract Related articles

NORDENTOFT I , Birkenkamp-Demtroder K, Agerbaek M, Theodorescu D, et al
miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer.
BMC Med Genomics. 2012;5:40.
Abstract Related articles

HUANG G , Redelman-Sidi G, Rosen N, Glickman MS, et al
Inhibition of mycobacterial infection by the tumor suppressor PTEN.
J Biol Chem. 2012;287:23196-202.
Abstract Related articles

CANTER DJ , Ogan K, Master VA
Initial North American experience with the use of the Olympus Button Electrode for vaporization of bladder tumors.
Can J Urol. 2012;19:6211-6.
Abstract Related articles

BARKIN J
Evolution or revolution: changes in the approach to urologic care.
Can J Urol. 2012;19:6155.
Abstract Related articles

TOLL AD , Epstein JI
Invasive low-grade papillary urothelial carcinoma: a clinicopathologic analysis of 41 cases.
Am J Surg Pathol. 2012;36:1081-6.
Abstract Related articles

REYES MC , Park KJ, Lin O, Ioffe O, et al
Urothelial Carcinoma Involving the Gynecologic Tract: A Morphologic and Immunohistochemical Study of 6 Cases.
Am J Surg Pathol. 2012.
Abstract Related articles

MIURA K , Ishida K, Fujibuchi W, Ito A, et al
Differentiating rectal carcinoma by an immunohistological analysis of carcinomas of pelvic organs based on the NCBI Literature Survey and the Human Protein Atlas database.
Surg Today. 2012;42:515-25.
Abstract Related articles

GARCIA GOMEZ M , Urbanos Garrido R, Castaneda Lopez R, Lopez Menduina P, et al
[Direct health care costs of lung and bladder cancer attributable to work. Spain, 2008].
Rev Esp Salud Publica. 2012;86:127-38.
Abstract Related articles

AL-AZAYZIH A , Gao F, Goc A, Somanath PR, et al
TGFbeta1 induces apoptosis in invasive prostate cancer and bladder cancer cells via Akt-independent, p38 MAPK and JNK/SAPK-mediated activation of caspases.
Biochem Biophys Res Commun. 2012 Sep 15. pii: S0006-291X(12)01775.
Abstract Related articles

VASDEV N , Dominguez-Escrig J, Paez E, Johnson MI, et al
The impact of early re-resection in patients with pT1 high-grade non-muscle invasive bladder cancer.
Ecancermedicalscience. 2012;6:269.
Abstract Related articles

POTTAKKAT B , Kapoor A, Prakash A, Singh RK, et al
Evaluation of a Prospective Surgical Strategy of Extended Resection to Achieve R0 Status in Gall Bladder Cancer.
J Gastrointest Cancer. 2012.
Abstract Related articles

CHEN Y , Li L, Zeng J, Wu K, et al
Twist Confers Chemoresistance to Anthracyclines in Bladder Cancer through Upregulating P-Glycoprotein.
Chemotherapy. 2012;58:264-272.
Abstract Related articles

LI F , Chen DN, He CW, Zhou Y, et al
Identification of urinary Gc-globulin as a novel biomarker for bladder cancer by two-dimensional fluorescent differential gel electrophoresis (2D-DIGE).
J Proteomics. 2012 Sep 9. pii: S1874-3919(12)00643.
Abstract Related articles

HE XL , Zhang P, Dong XZ, Yang MH, et al
JR6, a new compound isolated from Justicia procumbens, induces apoptosis in human bladder cancer EJ cells through caspase-dependent pathway.
J Ethnopharmacol. 2012 Sep 14. pii: S0378-8741(12)00605.
Abstract Related articles

FILLON M
Urology meeting highlights prostate, bladder cancers.
J Natl Cancer Inst. 2012;104:1348-9.
Abstract Related articles

KUCUKGERGIN C , Isman FK, Dasdemir S, Cakmakoglu B, et al
The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer.
Gene. 2012 Sep 13. pii: S0378-1119(12)01092-X. doi: 10.1016/j.gene.2012.
Abstract Related articles

LEI T , Zhao X, Jin S, Meng Q, et al
Discovery of Potential Bladder Cancer Biomarkers by Comparative Urine Proteomics and Analysis.
Clin Genitourin Cancer. 2012 Sep 13. pii: S1558-7673(12)00162.
Abstract Related articles

PAL SK , Ruel NH, Wilson TG, Yuh BE, et al
Retrospective Analysis of Clinical Outcomes With Neoadjuvant Cisplatin-Based Regimens for Muscle-Invasive Bladder Cancer.
Clin Genitourin Cancer. 2012 Sep 12. pii: S1558-7673(12)00171.
Abstract Related articles

MARGRETARDOTTIR OB , Geirsson G, Agnarsdottir M, Ulfarsson E, et al
[Case of the month: woman with hematuria and depressed mental status].
Laeknabladid. 2012;98.
Abstract Related articles

DAVAR S , Hanna D
Sister Mary Joseph's nodule.
J Cutan Med Surg. 2012;16:201-4.
Abstract Related articles

DASGUPTA P
Robotic assisted radical cystectomy and urinary diversion.
Int J Clin Pract. 2012;66:618-9.
Abstract Related articles

GAMAGEDARA S , Kaczmarek AT, Jiang Y, Cheng X, et al
Validation study of urinary metabolites as potential biomarkers for prostate cancer detection.
Bioanalysis. 2012;4:1175-83.
Abstract Related articles

MANOHAR K , Mittal BR, Bhattacharya A, Kashyap R, et al
A Rare Case of Malignant Urinary Bladder Paraganglioma With Distant Metastases Demonstrated by 18F-FDG PET/CT.
Clin Nucl Med. 2012;37:e148-9.
Abstract Related articles

BERTAGNA F , Motta F, Fisogni S, Lena MS, et al
Absence of Urine Production Due to Renal Failure Enables Clear Visualization of Primary Urinary Bladder Carcinoma on 18F-FDG PET/CT.
Clin Nucl Med. 2012;37:611-3.
Abstract Related articles

SHARMA S , Dey P, Saikia UN, Nijhawan R, et al
Micronucleus scoring in urine cytology specimen by DNA-specific stain.
Anal Quant Cytol Histol. 2012;34:56-60.
Abstract Related articles

CARAVATTA L , Padula GD, Macchia G, Ferrandina G, et al
Short-course accelerated radiotherapy in palliative treatment of advanced pelvic malignancies: a phase I study.
Int J Radiat Oncol Biol Phys. 2012;83:e627-31.
Abstract Related articles

ZHANG Z , Yu XY, Zhang GJ, Guo KF, et al
Low microsomal epoxide hydrolase expression is associated with bladder carcinogenesis and recurrence.
Asian Pac J Cancer Prev. 2012;13:521-5.
Abstract Related articles

KHAN MS , Challacombe B, Elhage O, Rimington P, et al
A dual-centre, cohort comparison of open, laparoscopic and robotic-assisted radical cystectomy.
Int J Clin Pract. 2012;66:656-62.
Abstract Related articles

METSER U , Goldstein MA, Chawla TP, Fleshner NE, et al
Detection of Urothelial Tumors: Comparison of Urothelial Phase with Excretory Phase CT Urography--A Prospective Study.
Radiology. 2012.
Abstract Related articles

WANG M , Gou X, Wang L
Protein kinase B promotes radiation-induced regulatory T cell survival in bladder carcinoma.
Scand J Immunol. 2012;76:70-4.
Abstract Related articles

HEEMSTRA KA , Bossink AW, Spermon R, Bouwman JJ, et al
Added value of use of a purified protein derivative-based enzyme-linked immunosorbent spot assay for patients with Mycobacterium bovis BCG infection after intravesical BCG instillations.
Clin Vaccine Immunol. 2012;19:974-7.
Abstract Related articles

LIEP J , Rabien A, Jung K
Feedback networks between microRNAs and epigenetic modifications in urological tumors.
Epigenetics. 2012;7:315-25.
Abstract Related articles

REIMER J , Bien S, Ameling S, Hammer E, et al
Antineoplastic agent busulfan regulates a network of genes related to coagulation and fibrinolysis.
Eur J Clin Pharmacol. 2012;68:923-35.
Abstract Related articles

NETTO GJ
Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?
Nat Rev Urol. 2011;9:41-51.
Abstract Related articles

MIYAMOTO H , Zheng Y, Izumi K
Nuclear hormone receptor signals as new therapeutic targets for urothelial carcinoma.
Curr Cancer Drug Targets. 2012;12:14-22.
Abstract Related articles

HUANG P , Chen J, Wang L, Na Y, et al
Implications of transcriptional factor, OCT-4, in human bladder malignancy and tumor recurrence.
Med Oncol. 2012;29:829-34.
Abstract Related articles

SENDUR MA , Aksoy S, Arik Z, Yaman S, et al
Small cell carcinoma of the urinary bladder with hypercalcemia.
Med Oncol. 2012;29:827-8.
Abstract Related articles

MIGITA K , Miyashita T, Mizuno A, Jiuchi Y, et al
IgG4-related epididymo-orchitis associated with bladder cancer: possible involvement of BAFF/BAFF-R interaction in IgG4-related urogenital disease.
Mod Rheumatol. 2012.
Abstract Related articles

BERRADA N , Amzazi S, Ameziane El Hassani R, Benbacer L, et al
EPIGENETIC ALTERATIONS OF ADENOMATOUS POLYPOSIS COLI (APC), RETINOIC ACID RECEPTOR BETA (RARbeta) AND SURVIVIN GENES IN TUMOR TISSUES AND VOIDED URINE OF BLADDER CANCER PATIENTS.
Cell Mol Biol (Noisy-le-grand). 2012;Suppl.
Abstract Related articles

ZHENG QY , Li PP, Jin FS, Yao C, et al
Ursolic acid induces ER stress response to activate ASK1-JNK signaling and induce apoptosis in human bladder cancer T24 cells.
Cell Signal. 2012 Sep 18. pii: S0898-6568(12)00254.
Abstract Related articles

ROTH E , Selinski S, Schikowsky C, Seidel T, et al
Bladder cancer survival in a former industrial area in saxony-anhalt, Germany.
J Toxicol Environ Health A. 2012;75.
Abstract Related articles

ASLAM M , Hassan Rivzi SA, Beg AE, Blaszkewicz M, et al
Analysis of ochratoxin a blood levels in bladder cancer cases and healthy persons from pakistan.
J Toxicol Environ Health A. 2012;75.
Abstract Related articles

BABICHENKO II , Samoilov MV, Kudriavtsev LV
[Urothelial tumor of the urinary bladder: immunohistochemical features].
Arkh Patol. 2012;74:7-10.
Abstract Related articles

BROWER V
Illuminating the diabetes-cancer link.
J Natl Cancer Inst. 2012;104:1048-50.
Abstract Related articles

FENG L , Ma LL, Zhang YH, Tian Y, et al
Impact of surgery and epirubicin intravesical chemotherapy on peripheral blood dendritic cell subsets in patients with superficial urothelial carcinoma of the bladder.
Chin Med J (Engl). 2012;125:1254-60.
Abstract Related articles

CHU H , Wang M, Jin H, Lv Q, et al
EGFR 3'UTR 774T>C polymorphism contributes to bladder cancer risk.
Mutagenesis. 2012.
Abstract Related articles

AJILI F , Manai M, Darouiche A, Chebil M, et al
Tumor Multiplicity Is an Independent Prognostic Factor of Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guerin Immunotherapy.
Ultrastruct Pathol. 2012;36:320-4.
Abstract Related articles

GEAVLETE B , Jecu M, Multescu R, Geavlete P, et al
Narrow-band imaging cystoscopy in non-muscle-invasive bladder cancer: a prospective comparison to the standard approach.
Ther Adv Urol. 2012;4:211-7.
Abstract Related articles

MEIJER GJ , van der Toorn PP, Bal M, Schuring D, et al
High precision bladder cancer irradiation by integrating a library planning procedure of 6 prospectively generated SIB IMRT plans with image guidance using lipiodol markers.
Radiother Oncol. 2012 Sep 27. pii: S0167-8140(12)00362.
Abstract Related articles

POUESSEL D , Mongiat-Artus P, Culine S
Neoadjuvant chemotherapy in muscle-invasive bladder cancer: Ready for prime time?
Crit Rev Oncol Hematol. 2012 Sep 26. pii: S1040-8428(12)00176.
Abstract Related articles

HYNDMAN ME , Kaye D, Field NC, Lawson KA, et al
The use of regenerative medicine in the management of invasive bladder cancer.
Adv Urol. 2012;2012:653652.
Abstract Related articles

ROUPRET M , Colin P
Urothelial carcinomas of the upper urinary tract are now recognised as a true and distinct entity from bladder cancer and belong fully to the broad spectrum of onco-urologic neoplasms.
World J Urol. 2012.
Abstract Related articles

GUNES M , Gecit I, Pirincci N, Kemik AS, et al
Plasma human neutrophil proteins-1, -2, and -3 levels in patients with bladder cancer.
J Cancer Res Clin Oncol. 2012.
Abstract Related articles

KOIE T , Ohyama C, Hashimoto Y, Hatakeyama S, et al
Efficacies and safety of neoadjuvant gemcitabine plus carboplatin followed by immediate cystectomy in patients with muscle-invasive bladder cancer, including those unfit for cisplatin: a prospective single-arm study.
Int J Clin Oncol. 2012.
Abstract Related articles

WANG YH , Yeh SD, Wu MM, Liu CT, et al
Comparing the joint effect of arsenic exposure, cigarette smoking and risk genotypes of vascular endothelial growth factor on upper urinary tract urothelial carcinoma and bladder cancer.
J Hazard Mater. 2012 Sep 7. pii: S0304-3894(12)00871.
Abstract Related articles

MEOLA M , Petrucci I, Giovannini L, Colombini E, et al
[Ultrasound and color Doppler imaging for kidney and urinary tract tumors].
G Ital Nefrol. 2012;29:452-66.
Abstract Related articles

WANG F , Shan Y
Sulforaphane retards the growth of UM-UC-3 xenographs, induces apoptosis, and reduces survivin in athymic mice.
Nutr Res. 2012;32:374-80.
Abstract Related articles

GILG MM , Wimmer B, Ott A, Langner C, et al
Urothelial carcinoma with abundant myxoid stroma: evidence for mucus production by cancer cells.
Virchows Arch. 2012;461:99-101.
Abstract Related articles

KOTASKA K , Dusek P, Prusa R, Vesely S, et al
Urine and serum cathepsin B concentrations in the transitional cell carcinoma of the bladder.
J Clin Lab Anal. 2012;26:61-5.
Abstract Related articles

RODRIGUEZ-RUIZ ME , San Miguel I, Gil-Bazo I, Perez-Gracia JL, et al
Pathological vertebral fracture after stereotactic body radiation therapy for lung metastases. Case report and literature review.
Radiat Oncol. 2012;7:50.
Abstract Related articles

LIU AY , Vencio RZ, Page LS, Ho ME, et al
Bladder expression of CD cell surface antigens and cell-type-specific transcriptomes.
Cell Tissue Res. 2012;348:589-600.
Abstract Related articles

TOMASKOVA H , Jirak Z, Splichalova A, Urban P, et al
Cancer incidence in Czech black coal miners in association with coalworkers' pneumoconiosis.
Int J Occup Med Environ Health. 2012;25:137-44.
Abstract Related articles

ZHANG B , Dong S, Cen X, Wang X, et al
Ampelopsin sodium exhibits antitumor effects against bladder carcinoma in orthotopic xenograft models.
Anticancer Drugs. 2012;23:590-6.
Abstract Related articles

LALONDRELLE S , Sohaib SA, Castellano IA, Mears D, et al
Investigating the relationship between virtual cystoscopy image quality and CT slice thickness.
Br J Radiol. 2012.
Abstract Related articles

LIU J , Zhang Z, Li ZH, Kong CZ, et al
Clinical significance of UNC5B expression in bladder cancer.
Tumour Biol. 2012.
Abstract Related articles

JI HX , Zhao Q, Pan JH, Shen WH, et al
Association of BLCA-4 Hypomethylation in Blood Leukocyte DNA and the Risk of Bladder Cancer in a Chinese Population.
Pathol Oncol Res. 2012.
Abstract Related articles

WU K , Wang X, Xie Z, Liu Z, et al
Glutathione S-transferase P1 gene polymorphism and bladder cancer susceptibility: an updated analysis.
Mol Biol Rep. 2012.
Abstract Related articles

DA SILVA GN , de Camargo EA, Salvadori DM
Toxicogenomic activity of gemcitabine in two TP53-mutated bladder cancer cell lines: special focus on cell cycle-related genes.
Mol Biol Rep. 2012.
Abstract Related articles

BEGNINI KR , Rizzi C, Campos VF, Borsuk S, et al
Auxotrophic recombinant Mycobacterium bovis BCG overexpressing Ag85B enhances cytotoxicity on superficial bladder cancer cells in vitro.
Appl Microbiol Biotechnol. 2012.
Abstract Related articles

BARMAN I , Dingari NC, Singh GP, Kumar R, et al
Selective sampling using confocal Raman spectroscopy provides enhanced specificity for urinary bladder cancer diagnosis.
Anal Bioanal Chem. 2012.
Abstract Related articles

SUZUKI K , Nohda H, Funahashi M, Chiba K, et al
[Assessment of Clinical Features in Solitary Minimum Size (<1 cm) Bladder Cancer].
Hinyokika Kiyo. 2012;58:401-4.
Abstract Related articles

AKAGASHI K , Nakajima H, Nitta T, Sato Y, et al
[Follow-UpMethod for Patients with Non-Muscle-Invasive Bladder Cancer who Remained Recurrence-Free for a Long Time].
Hinyokika Kiyo. 2012;58:395-9.
Abstract Related articles

ZHANG X , Lin J, Wu X, Lin Z, et al
Association between GSTM1 copy number, promoter variants and susceptibility to urinary bladder cancer.
Int J Mol Epidemiol Genet. 2012;3:228-36.
Abstract Related articles

FAHED E , Hansel DE, Raghavan D, Quinn DI, et al
Small cell bladder cancer: biology and management.
Semin Oncol. 2012;39:615-8.
Abstract Related articles

BELLMUNT J , Petrylak DP
New therapeutic challenges in advanced bladder cancer.
Semin Oncol. 2012;39:598-607.
Abstract Related articles

RAGHAVAN D , Burgess E, Gaston KE, Haake MR, et al
Neoadjuvant and adjuvant chemotherapy approaches for invasive bladder cancer.
Semin Oncol. 2012;39:588-97.
Abstract Related articles

SANDLER HM , Mirhadi AJ
Current role of radiation therapy for bladder cancer.
Semin Oncol. 2012;39:583-7.
Abstract Related articles

NARGUND VH , Tanabalan CK, Kabir MN
Management of non-muscle-invasive (superficial) bladder cancer.
Semin Oncol. 2012;39:559-72.
Abstract Related articles

PURYSKO AS , Leao Filho HM, Herts BR
Radiologic imaging of patients with bladder cancer.
Semin Oncol. 2012;39:543-58.
Abstract Related articles

AMIT D , Gofrit ON, Matouk I, Birman T, et al
Use of preclinical models to assess the therapeutic potential of new drug candidates for bladder cancer.
Semin Oncol. 2012;39:534-42.
Abstract Related articles

MITRA AP , Hansel DE, Cote RJ
Prognostic value of cell-cycle regulation biomarkers in bladder cancer.
Semin Oncol. 2012;39:524-33.
Abstract Related articles

RAGHAVAN D
Introduction: bladder cancer.
Semin Oncol. 2012;39:523.
Abstract Related articles

ABBAOUI B , Riedl KM, Ralston RA, Thomas-Ahner JM, et al
Inhibition of bladder cancer by broccoli isothiocyanates sulforaphane and erucin: Characterization, metabolism, and interconversion.
Mol Nutr Food Res. 2012 Oct 5. doi: 10.1002/mnfr.201200276.
Abstract Related articles

ZHENG Y , Izumi K, Li Y, Ishiguro H, et al
Contrary Regulation of Bladder Cancer Cell Proliferation and Invasion by Dexamethasone-Mediated Glucocorticoid Receptor Signals.
Mol Cancer Ther. 2012.
Abstract Related articles

MAYADAGLI A , Kocak M, Demir O, Karabulut Gul S, et al
Elective bladder preservation with multimodality treatment for bladder cancer.
J BUON. 2012;17:483-9.
Abstract Related articles

OOSTERLINCK W , Decaestecker K
Current strategies in the treatment of non-muscle-invasive bladder cancer.
Expert Rev Anticancer Ther. 2012;12:1097-106.
Abstract Related articles

HOSKIN P , Dubash S
Bladder conservation for muscle-invasive bladder cancer.
Expert Rev Anticancer Ther. 2012;12:1015-20.
Abstract Related articles

MIKI M , Soga N, Masui S, Hori Y, et al
[A case of bladder metastasis of renal cell carcinoma: a case report and literature review].
Hinyokika Kiyo. 2012;58:231-5.
Abstract Related articles

GRANT EJ , Ozasa K, Preston DL, Suyama A, et al
Effects of radiation and lifestyle factors on risks of urothelial carcinoma in the Life Span Study of atomic bomb survivors.
Radiat Res. 2012;178:86-98.
Abstract Related articles

GUNIA S , Kakies C, Erbersdobler A, Koch S, et al
Scoring the percentage of Ki67 positive nuclei is superior to mitotic count and the mitosis marker phosphohistone H3 (PHH3) in terms of differentiating flat lesions of the bladder mucosa.
J Clin Pathol. 2012;65:715-20.
Abstract Related articles

SELMAN SH
Editorial comment for Maurice et al.
J Endourol. 2012;26:617.
Abstract Related articles

KANG SG , Ko YH, Jang HA, Kim J, et al
Initial experience of robot-assisted radical cystectomy with total intracorporeal urinary diversion: comparison with extracorporeal method.
J Laparoendosc Adv Surg Tech A. 2012;22:456-62.
Abstract Related articles

MAURICE MJ , Vricella GJ, MacLennan G, Buehner P, et al
Endoscopic snare resection of bladder tumors: evaluation of an alternative technique for bladder tumor resection.
J Endourol. 2012;26:614-7.
Abstract Related articles

MIYAZAKI K , Morimoto Y, Nishiyama N, Maekawa Y, et al
A novel homogeneous irradiation fiber probe for whole bladder wall photodynamic therapy.
Lasers Surg Med. 2012;44:413-20.
Abstract Related articles

YANG Y , Wei ZT, Lu JS, Zu Q, et al
Transurethral partial cystectomy with 2 mum thulium continuous wave laser in the treatment of bladder pheochromocytoma.
J Endourol. 2012;26:686-90.
Abstract Related articles

DI LORIA A , Piantedosi D, Cortese L, Roperto S, et al
Clotting profile in cattle showing chronic enzootic haematuria (CEH) and bladder neoplasms.
Res Vet Sci. 2012;93:331-5.
Abstract Related articles

DENG N , Chen JX, Chen LW, Qiu SP, et al
Shorter recurrence-free survival time, higher risk of multiple recurrences: a retrospective study of non-muscle invasive bladder cancer after transurethral resection.
Chin Med J (Engl). 2012;125:3681-6.
Abstract Related articles

YANG J , Wang J, Zuo Y, Zhan H, et al
Molecularly modified VP3 (30-121) induces apoptosis in human bladder cancer (EJ) cells but not in normal (3T3) cells.
Cell Biol Int. 2012;36:1037-42.
Abstract Related articles

TANG W , Yang Z, Nie S, Zhu H, et al
Association of p53 Arg72Pro polymorphism with bladder cancer: A meta-analysis.
Gene. 2012 Oct 13. pii: S0378-1119(12)01194-8. doi: 10.1016/j.gene.2012.
Abstract Related articles

CHANG TC , Liu JJ, Hsiao ST, Pan Y, et al
Interobserver Agreement of Confocal Laser Endomicroscopy for Bladder Cancer.
J Endourol. 2012.
Abstract Related articles

FENNER A
Bladder cancer: Androgen-dependent CD24 regulates bladder cancer progression-a new role for antiandrogen therapy?
Nat Rev Urol. 2012 Oct 16. doi: 10.1038/nrurol.2012.
Abstract Related articles

FABA OR , Palou J, Breda A, Villavicencio H, et al
High-risk non-muscle-invasive bladder cancer: update for a better identification and treatment.
World J Urol. 2012.
Abstract Related articles

INOUE S , Shiina H, Mitsui Y, Yasumoto H, et al
Identification of lymphatic pathway involved in the spread of bladder cancer: Evidence obtained from fluorescence navigation with intraoperatively injected indocyanine green.
Can Urol Assoc J. 2012 Sep 10:1-7. doi: 10.5489/cuaj.12096.
Abstract Related articles

YAN L , Yan K, Kun W, Xu L, et al
Berberine inhibits the migration and invasion of T24 bladder cancer cells via reducing the expression of heparanase.
Tumour Biol. 2012.
Abstract Related articles

SHEN Y , Liu Y, Liu S, Zhang A, et al
Toll-like Receptor 4 Gene Polymorphisms and Susceptibility to Bladder Cancer.
Pathol Oncol Res. 2012.
Abstract Related articles

LI HL , Zhang S, Wang Y, Liang RR, et al
Baicalein induces apoptosis via a mitochondrial-dependent caspase activation pathway in T24 bladder cancer cells.
Mol Med Report. 2012 Oct 9. doi: 10.3892/mmr.2012.1123.
Abstract Related articles

KANG HW , Yoon HY, Ha YS, Kim WT, et al
FAM70B as a Novel Prognostic Marker for Cancer Progression and Cancer-Specific Death in Muscle-Invasive Bladder Cancer.
Korean J Urol. 2012;53:598-606.
Abstract Related articles

AGARWAL AK , Kalayarasan R, Javed A, Gupta N, et al
Role of Staging Laparoscopy in Primary Gall Bladder Cancer-An Analysis of 409 Patients: A Prospective Study to Evaluate the Role of Staging Laparoscopy in the Management of Gallbladder Cancer.
Ann Surg. 2012.
Abstract Related articles

MAZZUCCHELLI R , Scarpelli M, Lopez-Beltran A, Cheng L, et al
A contemporary update on pathology reporting for urinary bladder cancer.
Int J Immunopathol Pharmacol. 2012;25:565-71.
Abstract Related articles

LOUKIL I , Ammari L, Hachicha F
[Unilateral panuveitis following intravesical therapy with bacille of Calmette et Guerin].
Bull Soc Belge Ophtalmol. 2012;:23-8.
Abstract Related articles

SOJITRA P , Venkataraman G, Masoom S, Kapur U, et al
Dysplastic squamous cells are frequently present in urine cytology specimens of patients with high-grade urothelial carcinoma.
Acta Cytol. 2012;56:408-12.
Abstract Related articles

HUANG Y , Liu D, Jiang L, Liu S, et al
Assessment of cystitis glandularis by transvaginal sonography in women.
J Ultrasound Med. 2012;31:1025-31.
Abstract Related articles

HANLEY KW , Viet SM, Hein MJ, Carreon T, et al
Exposure to o-toluidine, aniline, and nitrobenzene in a rubber chemical manufacturing plant: a retrospective exposure assessment update.
J Occup Environ Hyg. 2012;9:478-90.
Abstract Related articles

TAKEDA T , Kikuchi E, Mikami S, Suzuki E, et al
Prognostic role of KiSS-1 and possibility of therapeutic modality of metastin, the final peptide of the KiSS-1 gene, in urothelial carcinoma.
Mol Cancer Ther. 2012;11:853-63.
Abstract Related articles

URQUIDI V , Goodison S, Cai Y, Sun Y, et al
A Candidate Molecular Biomarker Panel for the Detection of Bladder Cancer.
Cancer Epidemiol Biomarkers Prev. 2012.
Abstract Related articles

MEHTA AR , Mehta PR, Mehta RL
A cough conundrum in a patient with a previous history of BCG immunotherapy for bladder cancer.
BMJ Case Rep. 2012;2012.
Abstract Related articles

SARTINI D , Muzzonigro G, Milanese G, Pozzi V, et al
Upregulation of Tissue and Urinary Nicotinamide N-Methyltransferase in Bladder Cancer: Potential for the Development of a Urine-Based Diagnostic Test.
Cell Biochem Biophys. 2012.
Abstract Related articles

BOOTH CM , Mackillop WJ
Achieving the achievable in muscle-invasive bladder cancer.
Can Urol Assoc J. 2012;6:251-2.
Abstract Related articles

XI RC , Sheng YR, Chen WH, Sheng L, et al
Expression of survivin and livin predicts early recurrence in non-muscle invasive bladder cancer.
J Surg Oncol. 2012 Oct 22. doi: 10.1002/jso.23272.
Abstract Related articles

KECK B , Ott OJ, Haberle L, Kunath F, et al
Female sex is an independent risk factor for reduced overall survival in bladder cancer patients treated by transurethral resection and radio- or radiochemotherapy.
World J Urol. 2012.
Abstract Related articles

JENSEN SE , Beaumont JL, Jacobsen PB, Abernethy A, et al
Measuring Priority Symptoms in Advanced Bladder Cancer: Development and Initial Validation of a Brief Symptom Index.
J Support Oncol. 2012 Oct 20. pii: S1544-6794(12)00142.
Abstract Related articles

CAFFO O , Veccia A, Fellin G, Russo L, et al
Trimodality treatment in the conservative management of infiltrating bladder cancer: A critical review of the literature.
Crit Rev Oncol Hematol. 2012 Oct 19. pii: S1040-8428(12)00194.
Abstract Related articles

CHEN PC , Yu HJ, Chang YH, Pan CC, et al
Her2 amplification distinguishes a subset of non-muscle-invasive bladder cancers with a high risk of progression.
J Clin Pathol. 2012.
Abstract Related articles

CHEN CL , Lai YF, Tang P, Chien KY, et al
Comparative and Targeted Proteomic Analyses of Urinary Microparticles from Bladder Cancer and Hernia Patients.
J Proteome Res. 2012.
Abstract Related articles

PSOINOS CM , Simons JP, Baril DT, Robinson WP, et al
A Mycobacterium bovis Mycotic Abdominal Aortic Aneurysm Resulting from Bladder Cancer Treatment, Resection and Reconstruction with a Cryopreserved Aortic Graft.
Vasc Endovascular Surg. 2012.
Abstract Related articles

ZHONG DY , Chu HY, Wang ML, Ma L, et al
Meta-analysis demonstrates lack of association of the hOGG1 Ser326Cys polymorphism with bladder cancer risk.
Genet Mol Res. 2012;11:3490-6.
Abstract Related articles

IYER G , Hanrahan AJ, Milowsky MI, Al-Ahmadie H, et al
Genome sequencing identifies a basis for everolimus sensitivity.
Science. 2012;338:221.
Abstract Related articles

BROOS S , Sandin LC, Apel J, Totterman TH, et al
Synergistic augmentation of CD40-mediated activation of antigen-presenting cells by amphiphilic poly(gamma-glutamic acid) nanoparticles.
Biomaterials. 2012;33:6230-9.
Abstract Related articles

DUAN C , Yuan K, Liu F, Xiao P, et al
An adaptive window-setting scheme for segmentation of bladder tumor surface via MR cystography.
IEEE Trans Inf Technol Biomed. 2012;16:720-9.
Abstract Related articles

JAIN M , Robinson BD, Scherr DS, Sterling J, et al
Multiphoton microscopy in the evaluation of human bladder biopsies.
Arch Pathol Lab Med. 2012;136:517-26.
Abstract Related articles

HOWL J , Matou-Nasri S, West DC, Farquhar M, et al
Bioportide: an emergent concept of bioactive cell-penetrating peptides.
Cell Mol Life Sci. 2012;69:2951-66.
Abstract Related articles

LIM KS , Tan CH
Diffusion-weighted MRI of adult male pelvic cancers.
Clin Radiol. 2012;67:899-908.
Abstract Related articles

MAKER AV , Maker VK
Malignant masquerade of xanthogranulomatous cholecystitis on intraoperative ultrasound of the liver.
J Surg Oncol. 2012;106:525-6.
Abstract Related articles

MORITA K , Nakamura F, Nannya Y, Nomiya A, et al
Primary MALT lymphoma of the urinary bladder in the background of interstitial cystitis.
Ann Hematol. 2012;91:1505-6.
Abstract Related articles

ZHANG HH , Qi F, Zu XB, Cao YH, et al
A proteomic study of potential VEGF-C-associated proteins in bladder cancer T24 cells.
Med Sci Monit. 2012;18:BR441-449.
Abstract Related articles

AMARAL AF , Mendez-Pertuz M, Munoz A, Silverman DT, et al
Plasma 25-Hydroxyvitamin D3 and Bladder Cancer Risk According to Tumor Stage and FGFR3 Status: A Mechanism-Based Epidemiological Study.
J Natl Cancer Inst. 2012.
Abstract Related articles

NOGUCHI S , Yasui Y, Iwasaki J, Kumazaki M, et al
Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways.
Cancer Lett. 2012 Oct 24. pii: S0304-3835(12)00605.
Abstract Related articles

ANASTASIADIS A , Cordeiro E, Bus MT, Alivizatos G, et al
Follow-up procedures for non-muscle-invasive bladder cancer: an update.
Expert Rev Anticancer Ther. 2012;12:1229-41.
Abstract Related articles

MAZZUCCHELLI R , Cheng L, Lopez-Beltran A, Scarpelli M, et al
Clinicopathological significance of lymphovascular invasion in urothelial carcinoma.
Anal Quant Cytol Histol. 2012;34:173-9.
Abstract Related articles

MAZZUCCHELLI R , Cheng L, Lopez-Beltran A, Scarpelli M, et al
Classification and grading of noninvasive and invasive neoplasms of the urothelium.
Anal Quant Cytol Histol. 2012;34:111-9.
Abstract Related articles

FICHTENBAUM EJ , Marsh WL Jr, Zynger DL
CK5, CK5/6, and double-stains CK7/CK5 and p53/CK5 discriminate in situ vs invasive urothelial cancer in the prostate.
Am J Clin Pathol. 2012;138:190-7.
Abstract Related articles

KUNG J , Henry RR
Thiazolidinedione safety.
Expert Opin Drug Saf. 2012;11:565-79.
Abstract Related articles

POLUDNIOWSKI GG , Evans PM, Webb S
Cone beam computed tomography number errors and consequences for radiotherapy planning: an investigation of correction methods.
Int J Radiat Oncol Biol Phys. 2012;84:e109-14.
Abstract Related articles

ALAMEDA F , Juanpere N, Pijuan L, Lloveras B, et al
Value of p16(INK4a) in the diagnosis of low-grade urothelial carcinoma of the urinary bladder in urinary cytology.
Cancer Cytopathol. 2012;120:276-82.
Abstract Related articles

CHEN YJ , Suh S, Nelson RA, Liu A, et al
Setup variations in radiotherapy of anal cancer: advantages of target volume reduction using image-guided radiation treatment.
Int J Radiat Oncol Biol Phys. 2012;84:289-95.
Abstract Related articles

GRIFFITHS TR
Current perspectives in bladder cancer management.
Int J Clin Pract. 2012 Nov 9. doi: 10.1111/ijcp.12075.
Abstract Related articles

PEREZ AT
Pioglitazone and risk of bladder cancer: clarification of the design of the French study.
Diabetologia. 2012.
Abstract Related articles

WANG JK , Boorjian SA, Cheville JC, Kim SP, et al
Outcomes following radical cystectomy for micropapillary bladder cancer versus pure urothelial carcinoma: a matched cohort analysis.
World J Urol. 2012.
Abstract Related articles

FRIEDRICH-FREKSA M , Schulz E, Nitzke T, Wenzel O, et al
Cystectomy and urinary diversion in the treatment of bladder cancer without artificial respiration.
Int Braz J Urol. 2012;38:645-51.
Abstract Related articles

SONG SO , Kim KJ, Lee BW, Kang ES, et al
The risk of bladder cancer in korean diabetic subjects treated with pioglitazone.
Diabetes Metab J. 2012;36:371-8.
Abstract Related articles

WEI J , Cheang T, Tang B, Xia H, et al
The inhibition of human bladder cancer growth by calcium carbonate/CaIP6 nanocomposite particles delivering AIB1 siRNA.
Biomaterials. 2012 Nov 2. pii: S0142-9612(12)01091.
Abstract Related articles

MATSUBARA N , Mukai H, Naito Y, Nezu M, et al
Comparison between neoadjuvant and adjuvant gemcitabine plus cisplatin chemotherapy for muscle-invasive bladder cancer.
Asia Pac J Clin Oncol. 2012 Nov 6. doi: 10.1111/ajco.12017.
Abstract Related articles

LIU GH , Zhong Q, Ye YL, Wang HB, et al
Expression of beclin 1 in bladder cancer and its clinical significance.
Int J Biol Markers. 2012 Nov 5:0. doi: 10.5301/JBM.2012.9769.
Abstract Related articles

CHA EK , Tirsar LA, Schwentner C, Hennenlotter J, et al
Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancer.
World J Urol. 2012.
Abstract Related articles

TOCHIGI T , Sakurada Y, Aoki H, Kawamura S, et al
[The intravesical recurrence after 3-day consecutive intravesical instillation of pirarubicine hydrochloride (THP) following transurethral resection of bladder tumor (TURBT) for non-muscle-invasive bladder cancer].
Nihon Hinyokika Gakkai Zasshi. 2012;103:610-6.
Abstract Related articles

REGIS L , Lozano F, Planas J, Morote J, et al
Bladder cancer in an inguinoscrotal vesical hernia.
Case Rep Oncol Med. 2012;2012:142351.
Abstract Related articles

KATAYAMA K , Fukumoto R, Hayashi T, Matsuoka A, et al
[A case of myxofibrosarcoma of the bladder].
Hinyokika Kiyo. 2012;58:291-3.
Abstract Related articles

MATSUMURA E , Ashikari A, Tasaki S, Kato S, et al
[A case of micropapillary bladder carcinoma].
Hinyokika Kiyo. 2012;58:279-82.
Abstract Related articles

KANG MR , Yang G, Charisse K, Epstein-Barash H, et al
An orthotopic bladder tumor model and the evaluation of intravesical saRNA treatment.
J Vis Exp. 2012;.
Abstract Related articles

CHITAMBAR CR
Gallium-containing anticancer compounds.
Future Med Chem. 2012;4:1257-72.
Abstract Related articles

HALAC M , Aliyev A, Ylmaz S, Ozhan M, et al
Delayed Imaging of the Pelvis With Diluted and Filled Bladder: A Simple and Efficient Method in FDG PET/CT Imaging of Bladder Carcinoma.
Clin Nucl Med. 2012;37:778-80.
Abstract Related articles

BEUKERS W , Meijer T, Vissers CJ, Boormans JL, et al
Down-staging (<pT2) of urothelial cancer at cystectomy after the diagnosis of detrusor muscle invasion (pT2) at diagnostic transurethral resection (TUR): is prediction possible?
Virchows Arch. 2012;461:149-56.
Abstract Related articles

CASTILLO OA , Landerer E, Feria-Flores M, Vidal-Mora I, et al
Histological changes due to intravesical instillation of mitomycin C.
Arch Esp Urol. 2012;65:578-82.
Abstract Related articles

GARRIDO ABAD P , Gomez de Vicente JM, Herranz Fernandez LM, Jimenez Galvez M, et al
Giant adrenal carcinoma associated with renal vein and inferior vena cava thrombus. Case report and literature review.
Arch Esp Urol. 2012;65:570-4.
Abstract Related articles

JIMENEZ-PACHECO A , Lardelli Claret P, Lopez Luque A, Lahoz-Garcia C, et al
Randomized clinical trial on antimicrobial prophylaxis for flexible urethrocystoscopy.
Arch Esp Urol. 2012;65:542-9.
Abstract Related articles

WILKINSON C , Chowdhury F, Scarsbrook A, Smith J, et al
BCG-induced granulomatous prostatitis--an incidental finding on FDG PET-CT.
Clin Imaging. 2012;36:413-5.
Abstract Related articles

DOEHN C
[Endourological imaging with narrow band imaging].
Urologe A. 2012;51:784-90.
Abstract Related articles

SOMMERAUER M , Jocham D, Laturnus JM
[Non-muscle invasive transitional cell carcinoma of the bladder. New developments in diagnostics and therapy].
Urologe A. 2012;51:791-7.
Abstract Related articles

POCH MA , Stegemann A, Chandrasekhar R, Hayn M, et al
Does body mass index impact the performance of robot-assisted intracorporeal ileal conduit?
J Endourol. 2012;26:857-60.
Abstract Related articles

HUA L , Zhang Y
Spline-based semiparametric projected generalized estimating equation method for panel count data.
Biostatistics. 2012;13:440-54.
Abstract Related articles

ELMANSY H , Kotb A, Hammam O, Abdelraouf H, et al
Prognostic impact of apoptosis marker Fas (CD95) and its ligand (FasL) on bladder cancer in Egypt: study of the effect of schistosomiasis.
Ecancermedicalscience. 2012;6:278.
Abstract Related articles

O'DONNELL PH
Bladder cancer pharmacogenomics: recent insights and future perspectives.
Pharmacogenomics. 2012;13:1553-1556.
Abstract Related articles

IZUMI K , Li Y, Ishiguro H, Zheng Y, et al
Expression of UDP-glucuronosyltransferase 1A in bladder cancer: Association with prognosis and regulation by estrogen.
Mol Carcinog. 2012 Nov 9. doi: 10.1002/mc.21978.
Abstract Related articles

NEUMANN A , Weill A, Ricordeau P, Fagot JP, et al
Pioglitazone and risk of bladder cancer: clarification of the design of the French study. Reply to Perez AT [letter].
Diabetologia. 2012.
Abstract Related articles

LIU C , Yin Q, Li L, Zhuang YZ, et al
APE1 Asp148Glu gene polymorphism and bladder cancer risk: a meta-analysis.
Mol Biol Rep. 2012.
Abstract Related articles

SINGH V , Srivastava N, Kapoor R, Mittal RD, et al
Single-nucleotide Polymorphisms in Genes Encoding Toll-like Receptor -2, -3, -4, and -9 in a Case-Control Study with Bladder Cancer Susceptibility in a North Indian Population.
Arch Med Res. 2012 Nov 6. pii: S0188-4409(12)00290.
Abstract Related articles

CASADIO V , Calistri D, Tebaldi M, Bravaccini S, et al
Urine Cell-Free DNA integrity as a marker for early bladder cancer diagnosis: Preliminary data.
Urol Oncol. 2012 Nov 7. pii: S1078-1439(12)00255.
Abstract Related articles

KU JH , Kim HH, Kwak C
Nodal staging score: A tool for survival prediction of node-negative bladder cancer.
Urol Oncol. 2012 Nov 7. pii: S1078-1439(12)00238.
Abstract Related articles

PITTMAN M , Sakai L, Craig R, Joehl R, et al
Primary aortoenteric fistula following disseminated bacillus Calmette-Guerin infection: a case report.
Vascular. 2012;20:221-4.
Abstract Related articles

PRONK A , Stewart PA, Coble JB, Katki HA, et al
Comparison of two expert-based assessments of diesel exhaust exposure in a case-control study: programmable decision rules versus expert review of individual jobs.
Occup Environ Med. 2012;69:752-8.
Abstract Related articles

CHO HS , Hayami S, Toyokawa G, Maejima K, et al
RB1 methylation by SMYD2 enhances cell cycle progression through an increase of RB1 phosphorylation.
Neoplasia. 2012;14:476-86.
Abstract Related articles

SUN XF , Li L, Li XJ, Shen W, et al
Methylation pattern of oncogene HRAS gene promoter region and its clinical relevance to urocystic tumorigenesis.
Mol Biol Rep. 2012;39:8431-7.
Abstract Related articles

ZHANG CT , Lu R, Lin YL, Liu RL, et al
The significance of fragile histidine triad protein as a molecular prognostic marker of bladder urothelial carcinoma.
J Int Med Res. 2012;40:507-16.
Abstract Related articles

XIAO GQ , Chow J, Unger PD
Metastatic tumors to the urinary bladder: clinicopathologic study of 11 cases.
Int J Surg Pathol. 2012;20:342-8.
Abstract Related articles

LUO Y
Blocking IL-10 enhances bacillus Calmette-Guerin induced T helper Type 1 immune responses and anti-bladder cancer immunity.
Oncoimmunology. 2012;1:1183-1185.
Abstract Related articles

SAID N , Theodorescu D
RhoGDI2 suppresses bladder cancer metastasis via reduction of inflammation in the tumor microenvironment.
Oncoimmunology. 2012;1:1175-1177.
Abstract Related articles

JINESH G G , Kamat AM
Redirecting neutrophils against bladder cancer cells by BCG and Smac mimetic combination.
Oncoimmunology. 2012;1:1161-1162.
Abstract Related articles

LI S , Zeng XT, Ruan XL, Wang XH, et al
Simultaneous transurethral resection of bladder cancer and prostate may reduce recurrence rates: A systematic review and meta-analysis.
Exp Ther Med. 2012;4:685-692.
Abstract Related articles

TSENG CH , Tseng FH
Peroxisome proliferator-activated receptor agonists and bladder cancer: lessons from animal studies.
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2012;30:368-402.
Abstract Related articles

SOLOWAY MS
Bladder cancer: Lack of progress in bladder cancer-what are the obstacles?
Nat Rev Urol. 2012 Nov 20. doi: 10.1038/nrurol.2012.
Abstract Related articles

RAZZAK M
Bladder cancer: Toxic effects-a BCG balancing act.
Nat Rev Urol. 2012 Nov 20. doi: 10.1038/nrurol.2012.
Abstract Related articles

ZHANG ZH , Yang LS, Sun YH
The association between milk consumption and bladder cancer risk: appraisal of a recent meta-analysis.
Nutr Cancer. 2012;64:1288-9.
Abstract Related articles

ZAGHLOUL MS
Bladder cancer and schistosomiasis.
J Egypt Natl Canc Inst. 2012;24:151-9.
Abstract Related articles

SHAN Y , Zhang L, Bao Y, Li B, et al
Epithelial-mesenchymal transition, a novel target of sulforaphane via COX-2/MMP2, 9/Snail, ZEB1 and miR-200c/ZEB1 pathways in human bladder cancer cells.
J Nutr Biochem. 2012 Nov 13. pii: S0955-2863(12)00211.
Abstract Related articles

XU C , Jiang XZ, Zhang NZ, Ma L, et al
[Efficacy of European Organization for Research and Treatment of Cancer (EORTC) risk tables for the prediction of recurrence and progression of non-muscle invasive bladder cancer after intravesical pirarubicin instillation].
Zhonghua Zhong Liu Za Zhi. 2012;34:609-12.
Abstract Related articles

YAN ZJ , Cheng Y, Jiang JH, Hu JS, et al
[Gene therapy study on bladder cancer with recombinant adenoviral vector carrying LRIG1 gene driven by Survivin promoter].
Zhonghua Wai Ke Za Zhi. 2012;50:732-6.
Abstract Related articles

HONG SH , Choi YS, Cho HJ, Lee JY, et al
Induction of apoptosis of bladder cancer cells by zinc-citrate compound.
Korean J Urol. 2012;53:800-6.
Abstract Related articles

FEKI-TOUNSI M , Olmedo P, Gil F, Khlifi R, et al
Low-level arsenic exposure is associated with bladder cancer risk and cigarette smoking: a case-control study among men in Tunisia.
Environ Sci Pollut Res Int. 2012.
Abstract Related articles

LIU ZH , Bao ED
Quantitative assessment of the association between TP53 Arg72Pro polymorphism and bladder cancer risk.
Mol Biol Rep. 2012.
Abstract Related articles

CLYNE M
Bladder cancer: Replacing cystoscopies with FGFR3 urine assays.
Nat Rev Urol. 2012 Nov 27. doi: 10.1038/nrurol.2012.
Abstract Related articles

MENG Q , Lei T, Zhang M, Zhao J, et al
Identification of proteins differentially expressed in adriamycin-resistant (pumc-91/ADM) and parental (pumc-91) human bladder cancer cell lines by proteome analysis.
J Cancer Res Clin Oncol. 2012.
Abstract Related articles

KAWAI K , Miyazaki J, Joraku A, Nishiyama H, et al
Bacillus Calmette-Guerin immunotherapy for bladder cancer: Current understanding and perspectives on engineered BCG vaccine.
Cancer Sci. 2012 Nov 26. doi: 10.1111/cas.12075.
Abstract Related articles

CAI T , Nesi G, Mazzoli S, Meacci F, et al
Prediction of response to bacillus Calmette-Guerin treatment in non-muscle invasive bladder cancer patients through interleukin-6 and interleukin-10 ratio.
Exp Ther Med. 2012;4:459-464.
Abstract Related articles

NAYAK B , Dogra PN, Naswa N, Kumar R, et al
Diuretic (18)F-FDG PET/CT imaging for detection and locoregional staging of urinary bladder cancer: prospective evaluation of a novel technique.
Eur J Nucl Med Mol Imaging. 2012.
Abstract Related articles

WU D , Tao J, Ding J, Qu P, et al
Interleukin-11, an interleukin-6-like cytokine, is a promising predictor for bladder cancer prognosis.
Mol Med Report. 2012 Nov 23. doi: 10.3892/mmr.2012.1199.
Abstract Related articles

ZHANG Y , Denton BT, Nielsen ME
Comparison of Surveillance Strategies for Low-Risk Bladder Cancer Patients.
Med Decis Making. 2012.
Abstract Related articles

RESZKA E , Jablonowski Z, Wieczorek E, Gromadzinska J, et al
Expression of NRF2 and NRF2-modulated genes in peripheral blood leukocytes of bladder cancer males.
Neoplasma. 2012 Nov 25. doi: 10.4149/neo_2013.
Abstract Related articles

WILLIAMS SV , Hurst CD, Knowles MA
Oncogenic FGFR3 gene fusions in bladder cancer.
Hum Mol Genet. 2012.
Abstract Related articles

WANG S , Xue S, Dai Y, Yang J, et al
Reduced expression of microRNA-100 confers unfavorable prognosis in patients with bladder cancer.
Diagn Pathol. 2012;7:159.
Abstract Related articles

KANNO T , Gotoh A, Fujita Y, Nakano T, et al
A(3) Adenosine Receptor Mediates Apoptosis in 5637 Human Bladder Cancer Cells by G(q) Protein/PKC-Dependent AIF Upregulation.
Cell Physiol Biochem. 2012;30:1159-1168.
Abstract Related articles

WASHINO S , Hirai M, Matsuzaki A, Kobayashi Y, et al
Long-term survival after adrenalectomy for asynchronous metastasis of bladder cancer to the bilateral adrenal glands.
Case Rep Urol. 2012;2012:425230.
Abstract Related articles

COUPLAND C , Hippisley-Cox J
Predicting risk of bladder cancer in the UK.
Br J Gen Pract. 2012;62:570-1.
Abstract Related articles

KUYUMCIAN A , Pham D, Thomas JM, Law A, et al
Adaptive radiotherapy for muscle-invasive bladder cancer: Optimisation of plan sizes.
J Med Imaging Radiat Oncol. 2012;56:661-7.
Abstract Related articles

ABED EL RAHMAN D , Matei VD, Musi G, Bottero D, et al
Neoadjuvant chemotherapy for invasive bladder cancer: an interesting case report.
Arch Ital Urol Androl. 2012;84:167-70.
Abstract Related articles

FABIANI A , Filosa A, Piergallina M, Servi L, et al
The potential role of transrectal ultrasound as a tool for diagnosis or recurrence detection in bladder cancer. Two cases report.
Arch Ital Urol Androl. 2012;84:161-4.
Abstract Related articles

MASSON-LECOMTE A , Vordos D, Hoznek A, Yiou R, et al
External Validation of Extranodal Extension and Lymph Node Density as Predictors of Survival in Node-positive Bladder Cancer after Radical Cystectomy.
Ann Surg Oncol. 2012.
Abstract Related articles

FUJIKAWA A , Yumura Y, Yao M, Tsuchiya F, et al
An evaluation to define the role of repeat transurethral resection in a treatment algorithm for non-muscle-invasive bladder cancer.
Indian J Urol. 2012;28:267-70.
Abstract Related articles

KNOWLES LM , Zewe J, Malik G, Parwani AV, et al
CLT1 Targets Bladder Cancer through Integrin alpha5beta1 and CLIC3.
Mol Cancer Res. 2012.
Abstract Related articles

FRISTRUP N , Birkenkamp-Demtroder K, Reinert T, Sanchez-Carbayo M, et al
Multicenter Validation of Cyclin D1, MCM7, TRIM29, and UBE2C as Prognostic Protein Markers in Non-Muscle Invasive Bladder Cancer.
Am J Pathol. 2012 Nov 27. pii: S0002-9440(12)00811.
Abstract Related articles

LIN TY , Li YP, Zhang H, Luo J, et al
Tumor-targeting multifunctional micelles for imaging and chemotherapy of advanced bladder cancer.
Nanomedicine (Lond). 2012.
Abstract Related articles

CHAI X , van Herk M, Betgen A, Hulshof M, et al
Semiautomatic bladder segmentation on CBCT using a population-based model for multiple-plan ART of bladder cancer.
Phys Med Biol. 2012;57:N525-N541.
Abstract Related articles

MOYNIHAN C , Lewis R, Hall E, Jones E, et al
The Patient Deficit Model Overturned: a qualitative study of patients' perceptions of invitation to participate in a randomized controlled trial comparing selective bladder preservation against surgery in muscle invasive bladder cancer (SPARE, CRUK/07
Trials. 2012;13:228.
Abstract Related articles

AL HUSSAIN TO , Akhtar M
Molecular basis of urinary bladder cancer.
Adv Anat Pathol. 2013;20:53-60.
Abstract Related articles

Bladder cancer: Should all radical cystectomy patients receive alvimopan?
Nat Rev Urol. 2012 Dec 11. doi: 10.1038/nrurol.2012.
Abstract Related articles

FENNER A
Bladder cancer: EGF-diphtheria chimeric protein as a novel intravesical treatment.
Nat Rev Urol. 2012 Dec 11. doi: 10.1038/nrurol.2012.
Abstract Related articles

GALSKY MD , Hahn NM, Powles T, Hellerstedt BA, et al
Gemcitabine, Cisplatin, and Sunitinib for Metastatic Urothelial Carcinoma and as Preoperative Therapy for Muscle-Invasive Bladder Cancer.
Clin Genitourin Cancer. 2012 Dec 7. pii: S1558-7673(12)00231.
Abstract Related articles

FUJIMOTO K , Hamamoto Y, Honjo S, Kawasaki Y, et al
Possible link of pioglitazone with bladder cancer in Japanese patients with type 2 diabetes.
Diabetes Res Clin Pract. 2012 Dec 7. pii: S0168-8227(12)00475.
Abstract Related articles

FANG D , Tan F, Wang C, Zhu X, et al
Egg intake and bladder cancer risk: A meta-analysis.
Exp Ther Med. 2012;4:906-912.
Abstract Related articles

PEEK EM , Li DR, Zhang H, Kim HP, et al
Stromal modulation of bladder cancer-initiating cells in a subcutaneous tumor model.
Am J Cancer Res. 2012;2:745-51.
Abstract Related articles

SGNAOLIN V , Pereira TC, Bogo MR, Zanin R, et al
Functional and molecular characterization of kinin B(1) and B (2) receptors in human bladder cancer: implication of the PI3Kgamma pathway.
Invest New Drugs. 2012.
Abstract Related articles

YILDIRIM-POYRAZ N , Ozdemir E, Uzun B, Turkolmez S, et al
Dual phase (18)F-fluorodeoxyglucose positron emission tomography/computed tomography with forced diuresis in diagnostic imaging evaluation of bladder cancer.
Rev Esp Med Nucl Imagen Mol. 2012 Dec 4. pii: S2253-654X(12)00232.
Abstract Related articles

CHANG SS , Dinney CP, Donat SM, Dahm P, et al
12th Annual Meeting of the Society of Urologic Oncology (SUO) Bladder Cancer Sessions I and II summary report.
Urol Oncol. 2012;30:944-7.
Abstract Related articles

APOLO AB , Grossman HB, Bajorin D, Steinberg G, et al
Practical use of perioperative chemotherapy for muscle-invasive bladder cancer: Summary of session at the Society of Urologic Oncology annual meeting.
Urol Oncol. 2012;30:772-80.
Abstract Related articles

LIU SY , Liang Y, Lin TX, Su F, et al
MEK1 and MEK2 differentially regulate human insulin- and insulin glargine-induced human bladder cancer T24 cell proliferation.
Chin Med J (Engl). 2012;125:4197-201.
Abstract Related articles

LIBRENJAK D , Novakovic ZS, Milostic K
Carcinoma in situ of urinary bladder: incidence, treatment and clinical outcomes during ten-year follow-up.
Acta Clin Croat. 2012;51:201-7.
Abstract Related articles

SIEFKER-RADTKE A
Urachal adenocarcinoma: a clinician's guide for treatment.
Semin Oncol. 2012;39:619-24.
Abstract Related articles

SADEGHI S , Garcia JA
Current status of targeted therapy in metastatic transitional cell carcinoma of the bladder.
Semin Oncol. 2012;39:608-14.
Abstract Related articles

STAMATAKIS L , Godoy G, Lerner SP
Innovations in radical cystectomy and pelvic lymph node dissection.
Semin Oncol. 2012;39:573-82.
Abstract Related articles

PETROVIC J , Barisic G, Krivokapic Z, Krivokapic B, et al
Mucinous adenocarcinoma of the urinary bladder after long-term duodeno-renal and colovesical fistula--case report.
Chirurgia (Bucur). 2012;107:534-6.
Abstract Related articles

SALAMA RH , Selem TH, Elhagagy AE, El-Gammal M, et al
Urinary tumor marker in bladder carcinoma in Upper Egypt, correlations with different clinicopathological features.
Saudi J Kidney Dis Transpl. 2012;23:1068-73.
Abstract Related articles

SHRINGARPURE SS , Thachil JV, Maya M
PEComa of the urinary bladder.
Saudi J Kidney Dis Transpl. 2012;23:1032-4.
Abstract Related articles

ANDREU-BARASOAIN M , Gomez de la Fuente E, Pinedo F, Nuno A, et al
Intravesical mitomycin C-induced generalized pustular folliculitis.
J Am Acad Dermatol. 2012;67:e142-3.
Abstract Related articles

SAIED A , Salzman S, Hochwald SN, Trevino JG, et al
Traumatic intraperitoneal rupture of an urachal leiomyosarcoma: unique presentation as hemorrhagic shock.
Am Surg. 2012;78:E409-11.
Abstract Related articles

ROS MM , Bueno-de-Mesquita HB, Kampman E, Aben KK, et al
Plasma carotenoids and vitamin C concentrations and risk of urothelial cell carcinoma in the European Prospective Investigation into Cancer and Nutrition.
Am J Clin Nutr. 2012.
Abstract Related articles

BRENNEN WN , Rosen DM, Wang H, Isaacs JT, et al
Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug.
J Natl Cancer Inst. 2012;104:1320-34.
Abstract Related articles

SANO T , Tomita K, Takimoto K, Kim CJ, et al
[Psoas abscess after ureteral stent exchange for cutaneous ureterostomy: report of a case].
Hinyokika Kiyo. 2012;58:341-4.
Abstract Related articles

KARNES RJ , Fernandez CA, Shuber AP
A noninvasive multianalyte urine-based diagnostic assay for urothelial cancer of the bladder in the evaluation of hematuria.
Mayo Clin Proc. 2012;87:835-42.
Abstract Related articles

TYLER A
Urothelial cancers: ureter, renal pelvis, and bladder.
Semin Oncol Nurs. 2012;28:154-62.
Abstract Related articles

GUPTA P , Hanamshetti S, Kulkarni JN
Primary amyloidosis with high grade transitional cell carcinoma of bladder: a rare case report.
J Cancer Res Ther. 2012;8:297-9.
Abstract Related articles

CASTILLO OA , Foneron A, Sepulveda F, Sanchez-Salas R, et al
Bladder hemangioma: case report.
Arch Esp Urol. 2012;65:623-5.
Abstract Related articles

HUGUET J
[Editorial comment: robotic assisted radical cystectomy: oncological safety].
Arch Esp Urol. 2012;65:599-600.
Abstract Related articles

MONZO GARDINER JI
Robotic assisted radical cystectomy: oncological safety.
Arch Esp Urol. 2012;65:593-8.
Abstract Related articles

MALMSTROM PU
Prognostic markers for urothelial cancer: obstacles and opportunities.
Urol Oncol. 2012;30:516-7.
Abstract Related articles

SVAJDLER M JR , Andrasina I, Ilencikova D, Rychly B, et al
Recurring multifocal leiomyosarcoma of the urinary bladder 22 years after therapy for bilateral (hereditary) retinoblastoma: a case report and review of the literature.
Cesk Patol. 2012;48:44-8.
Abstract Related articles

PONNUSAMY S , Selvam SP, Mehrotra S, Kawamori T, et al
Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signalling to regulate tumour metastasis.
EMBO Mol Med. 2012;4:761-75.
Abstract Related articles

FAHED AC , Nonaka D, Kanofsky JA, Huang WC, et al
Cystic mucinous tumors of the urachus: carcinoma in situ or adenoma of unknown malignant potential?
Can J Urol. 2012;19:6310-3.
Abstract Related articles

LIANG PI , Wu LC, Sheu JJ, Wu TF, et al
Rsf-1/HBXAP overexpression is independent of gene amplification and is associated with poor outcome in patients with urinary bladder urothelial carcinoma.
J Clin Pathol. 2012;65:802-7.
Abstract Related articles

URQUIDI V , Rosser CJ, Goodison S
Molecular diagnostic trends in urological cancer: biomarkers for non-invasive diagnosis.
Curr Med Chem. 2012;19:3653-63.
Abstract Related articles

IGAWA Y , Schneider T, Yamazaki Y, Tatemichi S, et al
Functional investigation of beta-adrenoceptors in human isolated detrusor focusing on the novel selective beta3-adrenoceptor agonist KUC-7322.
Naunyn Schmiedebergs Arch Pharmacol. 2012;385:759-67.
Abstract Related articles

COSKUNER ER , Ozkan B, Yalcin V
Urachal adenocarcinoma: big dimensions without involvement of the bladder wall.
Urol J. 2012;9:533-5.
Abstract Related articles

SHIRAKAWA H , Kozakai N, Sawafuji M, Sugiura H, et al
Urinary bladder metastasis originating from lung adenocarcinoma: a case definitively diagnosed by immunohistochemistry.
Urol J. 2012;9:530-2.
Abstract Related articles

KOZYRAKIS D , Prombonas I, Kyrikos V, Grigorakis A, et al
Left retrocaval ureter associated with urothelial malignancy: presentation of a rare case.
Urol J. 2012;9:527-9.
Abstract Related articles

ZHU X , Zhong ZH, Zhang XZ, Zhang L, et al
Comorbidity relationship to outcome of radical cystectomy in Chinese: a single institution study with the ACE-27 comorbidity index.
Asian Pac J Cancer Prev. 2012;13:827-31.
Abstract Related articles

BHAGIRATH D , Abrol N, Khan R, Sharma M, et al
Expression of CD147, BIGH3 and Stathmin and their potential role as diagnostic marker in patients with urothelial carcinoma of the bladder.
Clin Chim Acta. 2012;413.
Abstract Related articles

BOFFETTA P , Winn DM, Ioannidis JP, Thomas DC, et al
Recommendations and proposed guidelines for assessing the cumulative evidence on joint effects of genes and environments on cancer occurrence in humans.
Int J Epidemiol. 2012;41:686-704.
Abstract Related articles

VAN BEMMEL D , Lenz P, Liao LM, Baris D, et al
Correlation of LINE-1 methylation levels in patient-matched buffy coat, serum, buccal cell, and bladder tumor tissue DNA samples.
Cancer Epidemiol Biomarkers Prev. 2012;21:1143-8.
Abstract Related articles

FISCH M
[Sigmoid-rectum pouch: a modification of the ureterosigmoidostomy].
Aktuelle Urol. 2012;43:123-33.
Abstract Related articles

MAFFEZZINI M , Campodonico F, Capponi G, Manuputty E, et al
Fast-track surgery and technical nuances to reduce complications after radical cystectomy and intestinal urinary diversion with the modified Indiana pouch.
Surg Oncol. 2012;21:191-5.
Abstract Related articles

DAVIES B , Ranu H, Jackson M
Pulmonary complications of intravesicular BCG immunotherapy.
Thorax. 2012;67:933-4.
Abstract Related articles

CHAUX A , Cohen JS, Schultz L, Albadine R, et al
High epidermal growth factor receptor immunohistochemical expression in urothelial carcinoma of the bladder is not associated with EGFR mutations in exons 19 and 21: a study using formalin-fixed, paraffin-embedded archival tissues.
Hum Pathol. 2012;43:1590-5.
Abstract Related articles

SELLA A , Kovel S
Combination of gemcitabine and carboplatin in urothelial cancer patients unfit for cisplatin due to impaired renal or cardiac function.
Int Braz J Urol. 2012;38:49-56.
Abstract Related articles

LANG EK , Nguyen Q, Zhang K
Enhanced computed tomograms provide accurate assessment of local extension and stage of bladder carcinoma.
Int Braz J Urol. 2012;38:129-31.
Abstract Related articles

BABJUK M , Oosterlinck W, Sylvester R, Kaasinen E, et al
[EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update].
Actas Urol Esp. 2012;36:389-402.
Abstract Related articles

DI PIERRO-GIOVANNI B , Danuser H, Mattei A
[Intravesical protrusion of retropubic osteophyte mimicking an urinary bladder tumour].
Actas Urol Esp. 2012;36:446-7.
Abstract Related articles

KORRECT GS , Minevich EA, Sivan B
High-grade transitional cell carcinoma of the pediatric bladder.
J Pediatr Urol. 2012;8:e36-8.
Abstract Related articles

JINDAL T , Mandal SN, Kamal MR, Das AK, et al
Occult mucin secreting adenocarcinoma of gall bladder with metastasis to urinary bladder.
Updates Surg. 2012;64:239-40.
Abstract Related articles

WANG H , Albadine R, Magheli A, Guzzo TJ, et al
Increased EZH2 protein expression is associated with invasive urothelial carcinoma of the bladder.
Urol Oncol. 2012;30:428-33.
Abstract Related articles

NOVARETTI JP , Silva RD, Cotrim CA, Souto LR, et al
Migration mesh mimicking bladder malignancy after open inguinal hernia repair.
Hernia. 2012;16:467-70.
Abstract Related articles

ELLINGER J , Muller DC, Muller SC, Hauser S, et al
Circulating mitochondrial DNA in serum: a universal diagnostic biomarker for patients with urological malignancies.
Urol Oncol. 2012;30:509-15.
Abstract Related articles

CHEN CH , Yang HJ, Shun CT, Huang CY, et al
A cocktail regimen of intravesical mitomycin-C, doxorubicin, and cisplatin (MDP) for non-muscle-invasive bladder cancer.
Urol Oncol. 2012;30:421-7.
Abstract Related articles

YOU J , Madigan MC, Rowe A, Sajinovic M, et al
An inverse relationship between KAI1 expression, invasive ability, and MMP-2 expression and activity in bladder cancer cell lines.
Urol Oncol. 2012;30:502-8.
Abstract Related articles

CHIYOMARU T , Enokida H, Kawakami K, Tatarano S, et al
Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
Urol Oncol. 2012;30:434-43.
Abstract Related articles

SUN CC , Zhang Z, Zhang SY, Li J, et al
Up-regulation of glucosylceramide synthase in urinary bladder neoplasms.
Urol Oncol. 2012;30:444-9.
Abstract Related articles

LEE JT , Lee SD, Lee JZ, Chung MK, et al
Expression analysis and clinical significance of CXCL16/CXCR6 in patients with bladder cancer.
Oncol Lett. 2013;5:229-235.
Abstract Related articles

WEBSTER GJ , Stratford J, Rodgers J, Livsey JE, et al
Comparison of adaptive radiotherapy techniques for the treatment of bladder cancer.
Br J Radiol. 2013;86:20120433.
Abstract Related articles

NASELLI A , Hurle R, Puppo P
The role of narrow-band imaging in the management of non-muscle-invasive bladder cancer.
Expert Rev Anticancer Ther. 2012;12:1523-8.
Abstract Related articles

BACHIR BG , Kassouf W
Cause-effect? Understanding the risk factors associated with bladder cancer.
Expert Rev Anticancer Ther. 2012;12:1499-502.
Abstract Related articles

RIVAS A , Burzio V, Landerer E, Borgna V, et al
Determination of the differential expression of mitochondrial long non-coding RNAs as a noninvasive diagnosis of bladder cancer.
BMC Urol. 2012;12:37.
Abstract Related articles

OLIVEIRA AI , Jeronimo C, Henrique R
Moving forward in bladder cancer detection and diagnosis: the role of epigenetic biomarkers.
Expert Rev Mol Diagn. 2012;12:871-8.
Abstract Related articles

WEN H , Feng CC, Fang ZJ, Xia GW, et al
Study on Bladder Cancer Susceptibility and Genetic Polymorphisms of XPC, XPG, and CYP in Smokers and Non-Smokers.
Actas Urol Esp. 2012 Dec 12. pii: S0210-4806(12)00333.
Abstract Related articles

EL-MESALLAMY H , Salman TM, Ashmawey AM, Osama N, et al
Evaluating the Role of Curcum Powder as a Protective Factor against Bladder Cancer - An Experimental Study.
Asian Pac J Cancer Prev. 2012;13:5287-90.
Abstract Related articles

AHMADI M , Ranjbaran H, Amiri MM, Nozari J, et al
Epidemiologic and Socioeconomic Status of Bladder Cancer in Mazandaran province, Northern Iran.
Asian Pac J Cancer Prev. 2012;13:5053-6.
Abstract Related articles

CHAUDHARY UB , Verma N, Keane T, Gudena V, et al
A Phase II Study of Gemcitabine and Irinotecan in Patients With Locally Advanced or Metastatic Bladder Cancer.
Am J Clin Oncol. 2012.
Abstract Related articles

TRAN MN , Choi W, Wszolek MF, Navai N, et al
The p63 isoform DeltaNp63alpha inhibits epithelial-mesenchymal transition in human bladder cancer cells: Role of miR205.
J Biol Chem. 2012.
Abstract Related articles

SINGER S , Ziegler C, Schwalenberg T, Hinz A, et al
Quality of life in patients with muscle invasive and non-muscle invasive bladder cancer.
Support Care Cancer. 2012.
Abstract Related articles

HONDA M , Suzuki K, Sugaya S, Kuruma H, et al
[Solitary adrenal metastasis of bladder carcinoma : a case report].
Hinyokika Kiyo. 2012;58:495-7.
Abstract Related articles

HIRASAWA T , Umemoto S, Fujinami K, Senga Y, et al
[Clinical studies of inverted papilloma of the bladder].
Hinyokika Kiyo. 2012;58:471-4.
Abstract Related articles

SANJO H , Ito Y, Osaka K, Komiya A, et al
[Metastatic micropapillary variant of the urinary bladder: progression from low grade non-muscle invasive bladder carcinoma].
Hinyokika Kiyo. 2012;58:447-51.
Abstract Related articles

MATSUMURA E , Oshiro Y, Miyagi R, Kimura R, et al
[A case of renal salt wasting syndrome progressing to severe hyponatremia after gemcitabine-cisplatin chemotherapy].
Hinyokika Kiyo. 2012;58:425-9.
Abstract Related articles

SCHMEISER HH , Kucab JE, Arlt VM, Phillips DH, et al
Evidence of exposure to aristolochic acid in patients with urothelial cancer from a Balkan endemic nephropathy region of Romania.
Environ Mol Mutagen. 2012;53:636-41.
Abstract Related articles

KIM B , Choi HJ, Kim MH, Cho KS, et al
Recurrence patterns of bladder transitional cell carcinoma after radical cystectomy.
Acta Radiol. 2012;53:943-9.
Abstract Related articles

ZHANG HH , Qi F, Zu XB, Xu L, et al
Recurrence of inflammatory myofibroblastic tumor in bladder secondary to prostate treated with laparoscopic radical cystectomy.
Med Sci Monit. 2012;18:CS63-66.
Abstract Related articles

GRUBER JF , Karagas MR, Gilbert-Diamond D, Bagley PJ, et al
Associations between toenail arsenic concentration and dietary factors in a New Hampshire population.
Nutr J. 2012;11:45.
Abstract Related articles

BONNETERRE V , Mathern G, Pelen O, Balthazard AL, et al
Cancer incidence in a chlorochemical plant in Isere, France: an occupational cohort study, 1979-2002.
Am J Ind Med. 2012;55:756-67.
Abstract Related articles

TYRITZIS SI , Anastasiou I, Stravodimos KG, Alevizopoulos A, et al
Radical cystectomy over the age of 75 is safe and increases survival.
BMC Geriatr. 2012;12:18.
Abstract Related articles

FROEHLICH JM , Triantafyllou M, Fleischmann A, Vermathen P, et al
Does quantification of USPIO uptake-related signal loss allow differentiation of benign and malignant normal-sized pelvic lymph nodes?
Contrast Media Mol Imaging. 2012;7:346-55.
Abstract Related articles

KIM W , Song C, Park S, Kim J, et al
Value of immediate second resection of the tumor bed to improve the effectiveness of transurethral resection of bladder tumor.
J Endourol. 2012;26:1059-64.
Abstract Related articles

ZHOU J , Smith S, Giovannucci E, Michaud DS, et al
Reexamination of Total Fluid Intake and Bladder Cancer in the Health Professionals Follow-Up Study Cohort.
Am J Epidemiol. 2012.
Abstract Related articles

WANG YH , Yeh SD, Shen KH, Shen CH, et al
Association of hOGG1 and XPD polymorphisms with urothelial carcinoma in Taiwan.
Anticancer Res. 2011;31:3939-44.
Abstract Related articles

MIYATA Y , Watanabe S, Takahashi H, Sagara Y, et al
Effect of maintenance chemotherapy with gemcitabine and paclitaxel on recurrent squamous cell carcinoma of the bladder: a case report.
Anticancer Res. 2011;31:4465-8.
Abstract Related articles

FALSO MJ , Buchholz BA, White RW
Stem-like Cells in Bladder Cancer Cell Lines with Differential Sensitivity to Cisplatin.
Anticancer Res. 2012;32:733-8.
Abstract Related articles

CHO IC , Kim EK, Joung JY, Seo HK, et al
Adjuvant Intravesical Instillation for Primary T1G3 Bladder Cancer: BCG versus MMC in Korea.
Anticancer Res. 2012;32:1493-8.
Abstract Related articles

HIWASA K , Nagaya H, Terao S, Acharya B, et al
Improved Gene Transfer into Bladder Cancer Cells Using Adenovirus Vector Containing RGD Motif.
Anticancer Res. 2012;32:3137-40.
Abstract Related articles

HAUSER S , Kogej M, Fechner G, VON Ruecker A, et al
Cell-free Serum DNA in Patients with Bladder Cancer: Results of a Prospective Multicenter Study.
Anticancer Res. 2012;32:3119-24.
Abstract Related articles

LUDECKE G , Pilatz A, Hauptmann A, Bschleipfer T, et al
Comparative analysis of sensitivity to blood in the urine for urine-based point-of-care assays (UBC rapid, NMP22 BladderChek and BTA-stat) in primary diagnosis of bladder carcinoma. Interference of blood on the results of urine-based POC tests.
Anticancer Res. 2012;32:2015-8.
Abstract Related articles

KUNZE D , Erdmann K, Froehner M, Wirth MP, et al
siRNA-mediated Inhibition of Antiapoptotic Genes Enhances Chemotherapy Efficacy in Bladder Cancer Cells.
Anticancer Res. 2012;32:4313-8.
Abstract Related articles

HATZICHRISTODOULOU G , Kubler H, Schwaibold H, Wagenpfeil S, et al
Nuclear Matrix Protein 22 for Bladder Cancer Detection: Comparative Analysis of the BladderChek(R) and ELISA.
Anticancer Res. 2012;32:5093-7.
Abstract Related articles

OOI WL , Lee F, Wallace DM, Hayne D, et al
'One stop' haematuria clinic in Fremantle Hospital, Western Australia: a report of the first 500 patients.
BJU Int. 2011;108 Suppl 2:62-6.
Abstract Related articles

LOSCO G , Antoniou S, Mark S
Male flexible cystoscopy: does waiting after insertion of topical anaesthetic lubricant improve patient comfort?
BJU Int. 2011;108 Suppl 2:42-4.
Abstract Related articles

CHOUDHURY SM , Mahesan NM, Elhage O, Khan MS, et al
Oncological outcomes of robot-assisted radical cystectomy.
BJU Int. 2011;108:1679-80.
Abstract Related articles

YATES DR , Vaessen C, Roupret M
From Leonardo to da Vinci: the history of robot-assisted surgery in urology.
BJU Int. 2011;108:1708-13.
Abstract Related articles

ISFOSS BL
The sensitivity of fluorescent-light cystoscopy for the detection of carcinoma in situ (CIS) of the bladder: a meta-analysis with comments on gold standard.
BJU Int. 2011;108:1703-7.
Abstract Related articles

GAKIS G , Todenhofer T, Renninger M, Schilling D, et al
Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C-reactive protein and standard pathological risk factors: the TNR-C score.
BJU Int. 2011;108:1800-5.
Abstract Related articles

LEE R , Ng CK, Shariat SF, Borkina A, et al
The economics of robotic cystectomy: cost comparison of open versus robotic cystectomy.
BJU Int. 2011;108:1886-92.
Abstract Related articles

ZOU X , Zhang G, Wang X, Yuan Y, et al
A one-port pneumovesicum method in en bloc laparoscopic nephroureterectomy with bladder cuff resection is feasible and safe for upper tract transitional cell carcinoma.
BJU Int. 2011;108:1497-500.
Abstract Related articles

HSIEH JT , Zhou J, Gore C, Zimmern P, et al
R11, a novel cell-permeable peptide, as an intravesical delivery vehicle.
BJU Int. 2011;108:1666-71.
Abstract Related articles

MIYAZAKI J , Kawai K, Kojima T, Oikawa T, et al
The liposome-incorporating cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guein can directly enhance the susceptibility of cancer cells to lymphokine-activated killer cells through up-regulation of natural-killer group 2, member D ligands
BJU Int. 2011;108:1520-6.
Abstract Related articles

GAKIS G , Schwentner C, Todenhoefer T, Stenzl A, et al
Current status of molecular markers for prognostication and outcome in invasive bladder cancer.
BJU Int. 2012 Jan 11. doi: 10.1111/j.1464-410X.2011.10839.
Abstract Related articles

KOGA F , Fujii Y, Masuda H, Numao N, et al
Pathology-based risk stratification of muscle-invasive bladder cancer patients undergoing cystectomy for persistent disease after induction chemoradiotherapy in bladder-sparing approaches.
BJU Int. 2012 Jan 30. doi: 10.1111/j.1464-410X.2011.10874.
Abstract Related articles

SHEN P , Yang J, Wei W, Li Y, et al
Effects of fluorescent light-guided transurethral resection on non-muscle-invasive bladder cancer: a systematic review and meta-analysis.
BJU Int. 2012 Jan 31. doi: 10.1111/j.1464-410X.2011.10892.
Abstract Related articles

DANESHMAND S
THE VALUE OF EXTENDED TRANSURETHRAL RESECTION OF BLADDER TUMOUR (TURBT) IN THE TREATMENT OF BLADDER CANCER.
BJU Int. 2012 Feb 7. doi: 10.1111/j.1464-410X.2011.10919.
Abstract Related articles

RICHTERSTETTER M , Wullich B, Amann K, Haeberle L, et al
The value of extended transurethral resection of bladder tumour (TURBT) in the treatment of bladder cancer.
BJU Int. 2012 Feb 7. doi: 10.1111/j.1464-410X.2011.10904.
Abstract Related articles

SHIRAKAWA H , Kikuchi E, Tanaka N, Matsumoto K, et al
Prognostic significance of Bacillus Calmette-Guerin failure classification in non-muscle-invasive bladder cancer.
BJU Int. 2012 Feb 7. doi: 10.1111/j.1464-410X.2011.10894.
Abstract Related articles

HUBER S , Schwentner C, Taeger D, Pesch B, et al
Nuclear matrix protein-22: a prospective evaluation in a population at risk for bladder cancer. Results from the UroScreen study.
BJU Int. 2012 Feb 7. doi: 10.1111/j.1464-410X.2011.10883.
Abstract Related articles

SHELLEY MD , Jones G, Cleves A, Wilt TJ, et al
Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic review.
BJU Int. 2012;109:496-505.
Abstract Related articles

THULIN H , Steineck G, Kreicbergs U, Onelov E, et al
Hygiene and urinary tract infections after cystectomy in 452 Swedish survivors of bladder cancer.
BJU Int. 2009.
Abstract Related articles

KU JH , Godoy G, Amiel GE, Lerner SP, et al
Urine survivin as a diagnostic biomarker for bladder cancer: a systematic review.
BJU Int. 2012 Feb 21. doi: 10.1111/j.1464-410X.2011.10884.
Abstract Related articles

JENSEN JB , Ulhoi BP, Jensen KM
Evaluation of different lymph node (LN) variables as prognostic markers in patients undergoing radical cystectomy and extended LN dissection to the level of the inferior mesenteric artery.
BJU Int. 2012;109:388-93.
Abstract Related articles

GAZQUEZ C , Ribal MJ, Marin-Aguilera M, Kayed H, et al
Biomarkers vs conventional histological analysis to detect lymph node micrometastases in bladder cancer: a real improvement?
BJU Int. 2012 Mar 15. doi: 10.1111/j.1464-410X.2012.11025.
Abstract Related articles

YEO L , Jain S
Good quality white-light transurethral resection of bladder tumours (gq-wlturbt) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation acro
BJU Int. 2012;109:E27.
Abstract Related articles

VAN RHIJN BW , Liu L, Vis AN, Bostrom PJ, et al
Prognostic value of molecular markers, sub-stage and European Organisation for the Research and Treatment of Cancer risk scores in primary T1 bladder cancer.
BJU Int. 2012 Mar 27. doi: 10.1111/j.1464-410X.2012.10996.
Abstract Related articles

ABDOLLAH F , Sun M, Jeldres C, Schmitges J, et al
Survival after radical cystectomy of non-bilharzial squamous cell carcinoma vs urothelial carcinoma: a competing-risks analysis.
BJU Int. 2012;109:564-9.
Abstract Related articles

BADALATO GM , Gaya JM, Hruby G, Patel T, et al
Immediate radical cystectomy vs conservative management for high grade cT1 bladder cancer: is there a survival difference?
BJU Int. 2012 Apr 4. doi: 10.1111/j.1464-410X.2012.11116.
Abstract Related articles

NIELSEN ME , Smith AB, Pruthi RS, Guzzo TJ, et al
Reported use of intravesical therapy for non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Advocacy Network (BCAN) survey.
BJU Int. 2012 Apr 4. doi: 10.1111/j.1464-410X.2012.11060.
Abstract Related articles

DANESHMAND S
SURVEILLANCE GUIDELINES BASED ON RECURRENCE PATTERNS AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER: THE CANADIAN BLADDER CANCER NETWORK EXPERIENCE.
BJU Int. 2012 Apr 13. doi: 10.1111/j.1464-410X.2012.11158.
Abstract Related articles

SZARVAS T , Dorp FV, Niedworok C, Melchior-Becker A, et al
High insulin-like growth factor mRNA-binding protein 3 (IMP3) protein expression is associated with poor survival in muscle-invasive bladder cancer.
BJU Int. 2012 Apr 13. doi: 10.1111/j.1464-410X.2012.11149.
Abstract Related articles

YAFI FA , Aprikian AG, Fradet Y, Chin JL, et al
Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience.
BJU Int. 2012 Apr 13. doi: 10.1111/j.1464-410X.2012.11133.
Abstract Related articles

GREEN DA , Durand M, Gumpeni N, Rink M, et al
Role of magnetic resonance imaging in bladder cancer: current status and emerging techniques.
BJU Int. 2012 Apr 13. doi: 10.1111/j.1464-410X.2012.11129.
Abstract Related articles

PAPALIA R , Simone G, Grasso R, Augelli R, et al
Diffusion-weighted magnetic resonance imaging in patients selected for radical cystectomy: detection rate of pelvic lymph node metastases.
BJU Int. 2012;109:1031-6.
Abstract Related articles

NASELLI A , Introini C, Germinale F, Spina B, et al
En bloc transurethral resection of bladder lesions: a trick to retrieve specimens up to 4.5 cm.
BJU Int. 2012;109:960-3.
Abstract Related articles

MATSUMOTO K , Kikuchi E, Shirakawa H, Hayakawa N, et al
Risk of subsequent tumour recurrence and stage progression in bacille Calmette-Guerin relapsing non-muscle-invasive bladder cancer.
BJU Int. 2012 May 10. doi: 10.1111/j.1464-410X.2012.11194.
Abstract Related articles

KATES M , Badalato GM, Gupta M, McKiernan JM, et al
Secondary bladder cancer after upper tract urothelial carcinoma in the US population.
BJU Int. 2012 May 7. doi: 10.1111/j.1464-410X.2012.11108.
Abstract Related articles

ZHAO LC , Meeks JJ, Helfand BT, Ross FR, et al
Screening urine analysis before bacille Calmette-Guerin instillation does not reduce the rate of infectious complications.
BJU Int. 2012;109:1819-21.
Abstract Related articles

MIYAMOTO H , Yao JL, Chaux A, Zheng Y, et al
Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder.
BJU Int. 2012;109:1716-26.
Abstract Related articles

MOSTAFID H , Brausi M
Measuring and improving the quality of transurethral resection for bladder tumour (TURBT).
BJU Int. 2012;109:1579-82.
Abstract Related articles

FRANCOIS A , Battah S, Macrobert AJ, Bezdetnaya L, et al
Fluorescence diagnosis of bladder cancer: a novel in vivo approach using 5-aminolevulinic acid (ALA) dendrimers.
BJU Int. 2012 Aug 10. doi: 10.1111/j.1464-410X.2012.11407.
Abstract Related articles

HERR HW
Outpatient urological procedures in antibiotic-naive patients with bladder cancer with asymptomatic bacteriuria.
BJU Int. 2012 Aug 9. doi: 10.1111/j.1464-410X.2012.11405.
Abstract Related articles

PAYNE R , Hsieh M
REINFORCEMENTS ARRIVE FOR THE WAR AGAINST CHRONIC CYSTITIS AND BLADDER CANCER.
BJU Int. 2012 Aug 9. doi: 10.1111/j.1464-410X.2012.11417.
Abstract Related articles

GAKIS G
A PRECYSTECTOMY DECISION MODEL TO PREDICT PATHOLOGICAL UPSTAGING AND ONCOLOGICAL OUTCOMES IN CLINICAL STAGE T2 BLADDER CANCER.
BJU Int. 2012 Aug 29. doi: 10.1111/j.1464-410X.2012.11426.
Abstract Related articles

MITRA AP , Skinner EC, Miranda G, Daneshmand S, et al
A precystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancer.
BJU Int. 2012 Aug 29. doi: 10.1111/j.1464-410X.2012.11424.
Abstract Related articles

BACHIR BG , Shariat SF, Zlotta A, Svatek R, et al
Demographic analysis of randomized controlled trials in bladder cancer.
BJU Int. 2012 Aug 29. doi: 10.1111/j.1464-410X.2012.11401.
Abstract Related articles

SINGH BP , Dhakad U
Prognostic significance of bacillus calmette-guerin failure classification in non-muscle-invasive bladder cancer.
BJU Int. 2012;110:E163-4.
Abstract Related articles

ROGERS A , Ng JK, Glendinning J, Rix D, et al
The management of transitional cell carcinoma (TCC) in a European regional renal transplant population.
BJU Int. 2012;110.
Abstract Related articles

GUDJONSSON S , Blackberg M, Chebil G, Jahnson S, et al
The value of bladder mapping and prostatic urethra biopsies for detection of carcinoma in situ (CIS).
BJU Int. 2012;110.
Abstract Related articles

ZHENG C , Lv Y, Zhong Q, Wang R, et al
Narrow band imaging diagnosis of bladder cancer: systematic review and meta-analysis.
BJU Int. 2012 Sep 18. doi: 10.1111/j.1464-410X.2012.11500.
Abstract Related articles

NEUZILLET Y , Lebret T, Molinie V, Yonneau L, et al
Perivesical fat invasion in bladder cancer: implications for prognosis comparing pT2b, pT3a and pT3b stages and consequences for adjuvant chemotherapy indications.
BJU Int. 2012 Mar 30. doi: 10.1111/j.1464-410X.2012.11104.
Abstract Related articles

LAURBERG JR , Brems-Eskildsen AS, Nordentoft I, Fristrup N, et al
Expression of TIP60 (tat-interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment-specific outcome of localised invasive bladder cancer.
BJU Int. 2012 Oct 9. doi: 10.1111/j.1464-410X.2012.11564.
Abstract Related articles

HERREL LA , Canter DJ
PRINCIPAL COMPONENT ANALYSIS BASED PRE-CYSTECTOMY MODEL TO PREDICT PATHOLOGICAL STAGE IN PATIENTS WITH CLINICAL ORGAN-CONFINED BLADDER CANCER.
BJU Int. 2012 Oct 4. doi: 10.1111/j.1464-410X.2012.11511.
Abstract Related articles

AHMADI H , Mitra AP, Abdelsayed GA, Cai J, et al
Principal component analysis based pre-cystectomy model to predict pathological stage in patients with clinical organ-confined bladder cancer.
BJU Int. 2012 Oct 4. doi: 10.1111/j.1464-410X.2012.11502.
Abstract Related articles

GANPULE A
En bloc transurethral resection of bladder lesions: a trick to retrieve specimens up to 4.5 cm.
BJU Int. 2012;110:E158-9.
Abstract Related articles

NEVOUX P , Ouzzane A, Ahmed HU, Emberton M, et al
Quantitative tissue analyses of prostate cancer foci in an unselected cystoprostatectomy series.
BJU Int. 2011 Dec 22. doi: 10.1111/j.1464-410X.2011.10776.
Abstract Related articles

SHIRAKAWA H , Kikuchi E
RE: Prognostic significance of Bacillus Calmette-Guerin failure classification in non-muscle-invasive bladder cancer.
BJU Int. 2012;110:E164.
Abstract Related articles

ROY A , Pal P, Arya M, Persad R, et al
Photodynamic diagnostic cystoscopy.
BJU Int. 2012;110:914-7.
Abstract Related articles

TURKER P , Bostrom PJ, Wroclawski ML, van Rhijn B, et al
Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome.
BJU Int. 2012;110:804-11.
Abstract Related articles

MAYR R , May M, Martini T, Lodde M, et al
Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder.
BJU Int. 2012;110.
Abstract Related articles

GOOSSENS-LAAN CA , Visser O, Hulshof MC, Wouters MW, et al
Survival after treatment for carcinoma invading bladder muscle: a Dutch population-based study on the impact of hospital volume.
BJU Int. 2012;110:226-32.
Abstract Related articles

STERNBERG IA , Keren Paz GE, Chen LY, Herr HW, et al
Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.
BJU Int. 2012 Nov 13. doi: 10.1111/j.1464-410X.2012.11391.
Abstract Related articles

TILKI D , Shariat SF, Lotan Y, Rink M, et al
Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy.
BJU Int. 2012 Nov 26. doi: 10.1111/j.1464-410X.2012.11455.
Abstract Related articles

LOGAN C , Brown M, Hayne D
Intravesical therapies for bladder cancer - indications and limitations.
BJU Int. 2012;110 Suppl 4:12-21.
Abstract Related articles

KIM SP , Boorjian SA, Shah ND, Karnes RJ, et al
Contemporary trends of in-hospital complications and mortality for radical cystectomy.
BJU Int. 2012;110:1163-8.
Abstract Related articles

YOUSSEF R , Kapur P, Shariat SF, Arendt T, et al
Prognostic value of apoptotic markers in squamous cell carcinoma of the urinary bladder.
BJU Int. 2012;110:961-6.
Abstract Related articles

HOUGHTON BB , Chalasani V, Hayne D, Grimison P, et al
Intravesical chemotherapy plus bacille Calmette-Guerin in non-muscle invasive bladder cancer: a systematic review with meta-analysis.
BJU Int. 2012 Dec 17. doi: 10.1111/j.1464-410X.2012.11390.
Abstract Related articles

SIMPSON GR , Horvath A, Annels NE, Pencavel T, et al
Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer.
Br J Cancer. 2012 Jan 12. doi: 10.1038/bjc.2011.
Abstract Related articles

WU JW , Cross AJ, Baris D, Ward MH, et al
Dietary intake of meat, fruits, vegetables, and selective micronutrients and risk of bladder cancer in the New England region of the United States.
Br J Cancer. 2012 May 8. doi: 10.1038/bjc.2012.
Abstract Related articles

PIGNOT G , Vieillefond A, Vacher S, Zerbib M, et al
Hedgehog pathway activation in human transitional cell carcinoma of the bladder.
Br J Cancer. 2012;106:1177-86.
Abstract Related articles

QAYYUM T , Fyffe G, Duncan M, McArdle PA, et al
The interrelationships between Src, Cav-1 and RhoGD12 in transitional cell carcinoma of the bladder.
Br J Cancer. 2012;106:1187-95.
Abstract Related articles

MIAH S , Dudziec E, Drayton RM, Zlotta AR, et al
An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer.
Br J Cancer. 2012 May 29. doi: 10.1038/bjc.2012.
Abstract Related articles

WOLK M , Martin JE
Fetal haemopoiesis marking low-grade urinary bladder cancer.
Br J Cancer. 2012 Jun 26. doi: 10.1038/bjc.2012.
Abstract Related articles

TRAN WT , Iradji S, Sofroni E, Giles A, et al
Microbubble and ultrasound radioenhancement of bladder cancer.
Br J Cancer. 2012 Jul 12. doi: 10.1038/bjc.2012.
Abstract Related articles

SAEB-PARSY K , Wilson A, Scarpini C, Corcoran M, et al
Diagnosis of bladder cancer by immunocytochemical detection of minichromosome maintenance protein-2 in cells retrieved from urine.
Br J Cancer. 2012 Sep 11. doi: 10.1038/bjc.2012.
Abstract Related articles

DYRSKJOT L , Zieger K, Kissow Lildal T, Reinert T, et al
Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma.
Br J Cancer. 2012;107:116-22.
Abstract Related articles

MONDUL AM , Weinstein SJ, Virtamo J, Albanes D, et al
Influence of vitamin D binding protein on the association between circulating vitamin D and risk of bladder cancer.
Br J Cancer. 2012 Sep 18. doi: 10.1038/bjc.2012.
Abstract Related articles

DYRSKJOT L , Reinert T, Novoradovsky A, Zuiverloon TC, et al
Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCR.
Br J Cancer. 2012 Sep 13. doi: 10.1038/bjc.2012.
Abstract Related articles

HALL JS , Taylor J, Valentine HR, Irlam JJ, et al
Enhanced stability of microRNA expression facilitates classification of FFPE tumour samples exhibiting near total mRNA degradation.
Br J Cancer. 2012;107:684-94.
Abstract Related articles

BROWN T , Slack R, Rushton L
Occupational cancer in Britain. Urinary tract cancers: bladder and kidney.
Br J Cancer. 2012;107 Suppl 1:S76-84.
Abstract Related articles

KOAY EJ , Teh BS, Paulino AC, Butler EB, et al
A Surveillance, Epidemiology, and End Results analysis of small cell carcinoma of the bladder: epidemiology, prognostic variables, and treatment trends.
Cancer. 2011;117:5325-33.
Abstract Related articles

SCOSYREV E , Messing EM, van Wijngaarden E, Peterson DR, et al
Neoadjuvant gemcitabine and cisplatin chemotherapy for locally advanced urothelial cancer of the bladder.
Cancer. 2012;118:72-81.
Abstract Related articles

GORE JL , Wright JL, Daratha KB, Roberts KP, et al
Hospital-level variation in the quality of urologic cancer surgery.
Cancer. 2012;118:987-96.
Abstract Related articles

THOMAS F , Rosario DJ, Rubin N, Goepel JR, et al
The long-term outcome of treated high-risk nonmuscle-invasive bladder cancer: Time to change treatment paradigm?
Cancer. 2012 Apr 27. doi: 10.1002/cncr.27587.
Abstract Related articles

DUGGAN B , Ruddock M, Williamson K
Reply to the impact of biomarkers in multivariate algorithms for bladder cancer diagnosis in patients with hematuria.
Cancer. 2012 May 4. doi: 10.1002/cncr.27549.
Abstract Related articles

CAI T , Malossini G, Bartoletti R
The impact of biomarkers in multivariate algorithms for bladder cancer diagnosis in patients with hematuria.
Cancer. 2012 May 4. doi: 10.1002/cncr.27548.
Abstract Related articles

YATES TJ , Knapp J, Gosalbez M, Lokeshwar SD, et al
C-X-C chemokine receptor 7: A functionally associated molecular marker for bladder cancer.
Cancer. 2012 Jun 26. doi: 10.1002/cncr.27661.
Abstract Related articles

VICKERS AJ , Bennette C, Kibel AS, Black A, et al
Who should be included in a clinical trial of screening for bladder cancer?: A decision analysis of data from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
Cancer. 2012 Jun 26. doi: 10.1002/cncr.27692.
Abstract Related articles

BLICK C , Hall P, Pwint T, Al-Terkait F, et al
Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder.
Cancer. 2012;118:3920-7.
Abstract Related articles

DANCIK GM , Ru Y, Owens CR, Theodorescu D, et al
A framework to select clinically relevant cancer cell lines for investigation by establishing their molecular similarity with primary human cancers.
Cancer Res. 2011;71:7398-409.
Abstract Related articles

HO PL , Lay EJ, Jian W, Parra D, et al
Stat3 activation in urothelial stem cells leads to direct progression to invasive bladder cancer.
Cancer Res. 2012.
Abstract Related articles

FEI DL , Sanchez-Mejias A, Wang Z, Flaveny C, et al
Hedgehog Signaling Regulates Bladder Cancer Growth And Tumorigenicity.
Cancer Res. 2012.
Abstract Related articles

WANG M , Chu H, Li P, Yuan L, et al
Genetic variants in microRNAs predict bladder cancer risk and recurrence.
Cancer Res. 2012.
Abstract Related articles

DIACONU I , Cerullo V, Hirvinen ML, Escutenaire S, et al
Immune response is an important aspect of the antitumor effect produced by a CD40L-encoding oncolytic adenovirus.
Cancer Res. 2012;72:2327-38.
Abstract Related articles

BUCHSER WJ , Laskow TC, Pavlik PJ, Lin HM, et al
Cell-mediated autophagy promotes cancer cell survival.
Cancer Res. 2012;72:2970-9.
Abstract Related articles

SMITH SC , Baras AS, Owens CR, Dancik G, et al
Transcriptional signatures of Ral GTPase are associated with aggressive clinicopathologic characteristics in human cancer.
Cancer Res. 2012;72:3480-91.
Abstract Related articles

DHAWAN D , Ramos-Vara JA, Naughton JF, Cheng L, et al
Targeting Folate Receptors to Treat Invasive Urinary Bladder Cancer.
Cancer Res. 2012.
Abstract Related articles

ROUDNICKY F , Poyet C, Wild P, Krampitz S, et al
Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesis.
Cancer Res. 2012.
Abstract Related articles

YU C , Zhang Z, Liao W, Zhao X, et al
The tumor-suppressor gene Nkx2.8 suppresses bladder cancer proliferation through upregulation of FOXO3a and inhibition of the MEK/ERK signaling pathway.
Carcinogenesis. 2012.
Abstract Related articles

CHADALAPAKA G , Jutooru I, Safe S
Celastrol decreases specificity proteins (Sp) and fibroblast growth factor receptor-3 (FGFR3) in bladder cancer cells.
Carcinogenesis. 2012.
Abstract Related articles

ZHOU H , Huang HY, Shapiro E, Lepor H, et al
Urothelial tumor initiation requires deregulation of multiple signaling pathways: implications in target-based therapies.
Carcinogenesis. 2012;33:770-80.
Abstract Related articles

RIESTER M , Taylor J, Feifer A, Koppie TM, et al
Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer.
Clin Cancer Res. 2012.
Abstract Related articles

YANG X , Kessler E, Su LJ, Thorburn A, et al
Diphtheria Toxin-Epidermal Growth Factor Fusion Protein DAB389EGF for the Treatment of Bladder Cancer.
Clin Cancer Res. 2012.
Abstract Related articles

SJODAHL G , Lauss M, Lovgren K, Chebil G, et al
A molecular taxonomy for urothelial carcinoma.
Clin Cancer Res. 2012;18:3377-86.
Abstract Related articles

Current world literature.
Curr Opin Urol. 2011;21:440-5.
Abstract Related articles

BOYLE H , Flechon A, Droz JP
Treatment of uncommon malignant tumours of the bladder.
Curr Opin Urol. 2011;21:309-14.
Abstract Related articles

JICHLINSKI P , Lovisa B
High magnification cystoscopy in the primary diagnosis of bladder tumors.
Curr Opin Urol. 2011;21:398-402.
Abstract Related articles

MITRA AP , Jorda M, Cote RJ
Pathological possibilities and pitfalls in detecting aggressive bladder cancer.
Curr Opin Urol. 2012.
Abstract Related articles

RODRIGUEZ FABA O , Palou J
Predictive factors for recurrence progression and cancer specific survival in high-risk bladder cancer.
Curr Opin Urol. 2012.
Abstract Related articles

FRANTZI M , Makridakis M, Vlahou A
Biomarkers for bladder cancer aggressiveness.
Curr Opin Urol. 2012.
Abstract Related articles

LEBRET T , Neuzillet Y
Indication and timing of cystectomy in high-risk bladder cancer.
Curr Opin Urol. 2012.
Abstract Related articles

SCHWENTNER C , Stenzl A, Gakis G
Monitoring high-risk bladder cancer.
Curr Opin Urol. 2012.
Abstract Related articles

PORTEN SP , Cooperberg MR
High-risk nonmuscle invasive bladder cancer: definition and epidemiology.
Curr Opin Urol. 2012;22:385-9.
Abstract Related articles

KU JH , Lerner SP
Strategies to prevent progression of high-risk bladder cancer at initial diagnosis.
Curr Opin Urol. 2012;22:405-14.
Abstract Related articles

Current world literature.
Curr Opin Urol. 2012;22:432-43.
Abstract Related articles

EDELINE J , Loriot Y, Culine S, Massard C, et al
Accelerated MVAC chemotherapy in patients with advanced bladder cancer previously treated with a platinum-gemcitabine regimen.
Eur J Cancer. 2012.
Abstract Related articles

SUN M , Abdollah F, Bianchi M, Trinh QD, et al
Conditional survival of patients with urothelial carcinoma of the urinary bladder treated with radical cystectomy.
Eur J Cancer. 2012;48:1503-11.
Abstract Related articles

KRAJEWSKI KM , Fougeray R, Bellmunt J, Pons F, et al
Optimisation of the size variation threshold for imaging evaluation of response in patients with platinum-refractory advanced transitional cell carcinoma of the urothelium treated with vinflunine.
Eur J Cancer. 2012;48:1495-502.
Abstract Related articles

MORALES-BARRERA R , Bellmunt J, Suarez C, Valverde C, et al
Cisplatin and gemcitabine administered every two weeks in patients with locally advanced or metastatic urothelial carcinoma and impaired renal function.
Eur J Cancer. 2012;48:1816-21.
Abstract Related articles

SIMONATO A , Ennas M
Re: Ben J. Challacombe, Bernard H. Bochner, Prokar Dasgupta, et al. The Role of Laparoscopic and Robotic Cystectomy in the Management of Muscle-Invasive Bladder Cancer with Special Emphasis on Cancer Control and Complications. Eur Urol 2011;60:767-75.
Eur Urol. 2011.
Abstract Related articles

BANERJEE S , Kumar V
Re: Sven van den Bosch, J. Alfred Witjes. Long-term Cancer-specific Survival in Patients with High-risk, Non-muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review. Eur Urol 2011;60:493-500.
Eur Urol. 2011.
Abstract Related articles

CHALLACOMBE B , Dasgupta P
Reply to Alchiede Simonato and Marco Ennas' Letter to the Editor re: Ben J. Challacombe, Bernard H. Bochner, Prokar Dasgupta, et al. The Role of Laparoscopic and Robotic Cystectomy in the Management of Muscle-Invasive Bladder Cancer with Special Empha
Eur Urol. 2011.
Abstract Related articles

PALOU J , Rodriguez Faba O, Pena JA
Reply from Authors re: J. Alfred Witjes. Prognosis of T1G3 Bladder Cancer: How Well Can We Predict Progression? Eur Urol. In press. DOI:10.1016/j.eururo.2011.11.001.
Eur Urol. 2011.
Abstract Related articles

MAURER T , Souvatzoglou M, Kubler H, Opercan K, et al
Diagnostic Efficacy of [11C]Choline Positron Emission Tomography/Computed Tomography Compared With Conventional Computed Tomography in Lymph Node Staging of Patients With Bladder Cancer Prior to Radical Cystectomy.
Eur Urol. 2011.
Abstract Related articles

ROSCIGNO M , Brausi M, Heidenreich A, Lotan Y, et al
Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer.
Eur Urol. 2011;60:776-83.
Abstract Related articles

BOORJIAN SA
Postoperative intravesical therapy to prevent bladder tumor recurrence: are we ready to listen yet?
Eur Urol. 2011;60:711-2.
Abstract Related articles

O'BRIEN T , Ray E, Singh R, Coker B, et al
Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial).
Eur Urol. 2011;60:703-10.
Abstract Related articles

BURGER M , Otto W, Hartmann A
Re: Bas W.G. van Rhijn, Theo H. van der Kwast, Sultan S. Alkhateeb, et al. A New and Highly Prognostic System to Discern T1 Bladder Cancer Substage. Eur Urol 2012;61:378-84.
Eur Urol. 2012.
Abstract Related articles

VAN RHIJN BW , van der Kwast TH, Jewett MA, Zlotta AR, et al
Reply to Maximilian Burger, Wolfgang Otto, and Arndt Hartmann's Letter to the Editor re: Bas W.G. van Rhijn, Theo H. van der Kwast, Sultan S. Alkhateeb, et al. A New and Highly Prognostic System to Discern T1 Bladder Cancer Substage. Eur Urol 2012;61:
Eur Urol. 2012.
Abstract Related articles

KANDIMALLA R , van Tilborg AA, Kompier LC, Stumpel DJ, et al
Genome-wide Analysis of CpG Island Methylation in Bladder Cancer Identified TBX2, TBX3, GATA2, and ZIC4 as pTa-Specific Prognostic Markers.
Eur Urol. 2012.
Abstract Related articles

NASELLI A , Introini C, Timossi L, Spina B, et al
A Randomized Prospective Trial to Assess the Impact of Transurethral Resection in Narrow Band Imaging Modality on Non-Muscle-Invasive Bladder Cancer Recurrence.
Eur Urol. 2012.
Abstract Related articles

KIM SP , Karnes RJ
Standard or extended lymphadenectomy in radical cystectomy: what metric of surgical quality for lymph node dissections matters in improving patient outcomes?
Eur Urol. 2011;60:953-4.
Abstract Related articles

JONSSON MN , Adding LC, Hosseini A, Schumacher MC, et al
Robot-assisted radical cystectomy with intracorporeal urinary diversion in patients with transitional cell carcinoma of the bladder.
Eur Urol. 2011;60:1066-73.
Abstract Related articles

DORIN RP , Daneshmand S, Eisenberg MS, Chandrasoma S, et al
Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study.
Eur Urol. 2011;60:946-52.
Abstract Related articles

TARIN TV , Power NE, Ehdaie B, Sfakianos JP, et al
Lymph Node-Positive Bladder Cancer Treated With Radical Cystectomy and Lymphadenectomy: Effect of the Level of Node Positivity.
Eur Urol. 2012.
Abstract Related articles

BURGER M , Mulders P, Witjes W
Use of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer Is Low Among Major European Centres: Results of a Feasibility Questionnaire.
Eur Urol. 2012.
Abstract Related articles

BID HK
Re: markers predicting response to bacillus calmette-guerin immunotherapy in high-risk bladder cancer patients: a systematic review.
Eur Urol. 2012;61:846-7.
Abstract Related articles

BRAUSI MA
Re: Long-Term Follow-up of T1 High-Grade Bladder Cancer After Intravesical Bacille Calmette-Guerin (BCG) Treatment.
Eur Urol. 2012;61:845-6.
Abstract Related articles

CULINE S , Flechon A, Guillot A, Le Moulec S, et al
Gemcitabine or gemcitabine plus oxaliplatin in the first-line treatment of patients with advanced transitional cell carcinoma of the urothelium unfit for cisplatin-based chemotherapy: a randomized phase 2 study of the French Genitourinary Tumor Group
Eur Urol. 2011;60:1251-7.
Abstract Related articles

BOORJIAN SA , Kim SP, Weight CJ, Cheville JC, et al
Risk factors and outcomes of urethral recurrence following radical cystectomy.
Eur Urol. 2011;60:1266-72.
Abstract Related articles

BRAUSI M
Are New Technologies for Detection and Treatment of Non-Muscle-Invasive Bladder Cancer (NMIBC) So Important? A Plea For Adoption by Teaching Programs to Improve Results After Standard White Light Transurethral Resection of NMIBC.
Eur Urol. 2012.
Abstract Related articles

NASELLI A , Puppo P
Reply from Authors re: Maurizio Brausi. Are New Technologies for Detection and Treatment of Non-Muscle-Invasive Bladder Cancer (NMIBC) So Important? A Plea For Adoption by Teaching Programs to Improve Results After Standard White Light Transurethral R
Eur Urol. 2012.
Abstract Related articles

XYLINAS E , Rink M, Margulis V, Karakiewicz P, et al
Multifocal Carcinoma In Situ of the Upper Tract Is Associated With High Risk of Bladder Cancer Recurrence.
Eur Urol. 2012.
Abstract Related articles

ORSOLA A , de Torres I, Morote J
Re: Bas W.G. van Rhijn, Theo H. van der Kwast, Sultan S. Alkhateeb, et al. A New and Highly Prognostic System to Discern T1 Bladder Cancer Substage. Eur Urol 2012;61:378-84.
Eur Urol. 2012.
Abstract Related articles

SOLSONA E
Re: International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastin Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial.
Eur Urol. 2012;61:1063-4.
Abstract Related articles

VAN RHIJN BW , van der Kwast TH, Jewett MA, Zlotta AR, et al
Reply to Anna Orsola, Ines de Torres and Juan Morote's Letter to the Editor re: Bas W.G. van Rhijn, Theo H. van der Kwast, Sultan S. Alkhateeb, et al. A New and Highly Prognostic System to Discern T1 Bladder Cancer Substage. Eur Urol 2012:61:378-84.
Eur Urol. 2012.
Abstract Related articles

RINK M , Shariat SF
Can we apply nomograms derived in the United States to European patients? Yes, we can!
Eur Urol. 2012;61:65-6.
Abstract Related articles

NUHN P , May M, Sun M, Fritsche HM, et al
External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder.
Eur Urol. 2012;61:58-64.
Abstract Related articles

ODISHO AY , Berry AB, Ahmad AE, Cooperberg MR, et al
Reflex ImmunoCyt Testing for the Diagnosis of Bladder Cancer in Patients with Atypical Urine Cytology.
Eur Urol. 2012.
Abstract Related articles

VAN DER POEL HG
Re: super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study.
Eur Urol. 2012;61:1266-7.
Abstract Related articles

ZLOTTA AR
Limited, extended, superextended, megaextended pelvic lymph node dissection at the time of radical cystectomy: what should we perform?
Eur Urol. 2012;61:243-4.
Abstract Related articles

DESAI MM , Berger AK, Brandina RR, Zehnder P, et al
Robotic and laparoscopic high extended pelvic lymph node dissection during radical cystectomy: technique and outcomes.
Eur Urol. 2012;61:350-5.
Abstract Related articles

EFSTATHIOU JA , Shipley WU, Zietman AL
Reply to Neeraj Kumar Goyal, Manish Garg, and Apul Goel's Letter to the Editor re: Re: Jason A. Efstathiou, Daphna Y. Spiegel, William U. Shipley, et al. Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bl
Eur Urol. 2012.
Abstract Related articles

STUDER UE , Sylvester R
Re: Shahrokh F. Shariat, Behfar Ehdaie, Michael Rink, et al. Clinical Nodal Staging Scores for Bladder Cancer: A Proposal for Preoperative Risk Assessment. Eur Urol 2012;61:237-42.
Eur Urol. 2012.
Abstract Related articles

STENZL A , Cowan NC, De Santis M, Kuczyk MA, et al
Reply to Santhanam Sundar's Letter to the Editor re: Arnulf Stenzl, Nigel C. Cowan, Maria De Santis, et al. Treatment of Muscle-Invasive and Metastatic Bladder Cancer: Update of the EAU Guidelines. Eur Urol 2011;59:1009-18.
Eur Urol. 2012.
Abstract Related articles

GOYAL NK , Garg M, Goel A
Re: Jason A. Efstathiou, Daphna Y. Spiegel, William U. Shipley, et al. Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience. Eur Urol 2012;61:705-11.
Eur Urol. 2012.
Abstract Related articles

SOUKUP V , Babjuk M, Bellmunt J, Dalbagni G, et al
Follow-up After Surgical Treatment of Bladder Cancer: A Critical Analysis of the Literature.
Eur Urol. 2012.
Abstract Related articles

BERTZ S , Otto W, Denzinger S, Wieland WF, et al
Combination of CK20 and Ki-67 Immunostaining Analysis Predicts Recurrence, Progression, and Cancer-Specific Survival in pT1 Urothelial Bladder Cancer.
Eur Urol. 2012.
Abstract Related articles

COLOMBO R , Rocchini L, Suardi N, Benigni F, et al
Neoadjuvant Short-term Intensive Intravesical Mitomycin C Regimen Compared with Weekly Schedule for Low-grade Recurrent Non-muscle-invasive Bladder Cancer: Preliminary Results of a Randomised Phase 2 Study.
Eur Urol. 2012.
Abstract Related articles

RUBENWOLF PC , Denzinger S, Otto W
Aquaporin 3 protein expression in transitional cell carcinoma: a potential marker with regard to tumour progression and prognosis?
Eur Urol. 2012;61:627-8.
Abstract Related articles

BIRTLE AJ , Lewis R, Hall E
Re: Marco Roscigno, Maurizio Brausi, Axel Heidenreich, et al. Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer. Eur Urol 2011;60:776-83.
Eur Urol. 2012;61:e16.
Abstract Related articles

GOEL A , Paul S
Re: Tim O'Brien, Eleanor Ray, Rajinder Singh, Bola Coker, Ralph Beard, British Association of Urological Surgeons Section of Oncology. Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prosp
Eur Urol. 2012;61:e14.
Abstract Related articles

HOLMANG S , Strock V
Should follow-up cystoscopy in bacillus Calmette-Guerin-treated patients continue after five tumour-free years?
Eur Urol. 2012;61:503-7.
Abstract Related articles

MEEKS JJ , Bellmunt J, Bochner BH, Clarke NW, et al
A Systematic Review of Neoadjuvant and Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer.
Eur Urol. 2012.
Abstract Related articles

RINK M , Chun FK, Dahlem R, Soave A, et al
Prognostic role and HER2 expression of circulating tumor cells in peripheral blood of patients prior to radical cystectomy: a prospective study.
Eur Urol. 2012;61:810-7.
Abstract Related articles

SIMONE G , Gallucci M
Multimodality treatment versus radical cystectomy: bladder sparing at cost of life?
Eur Urol. 2012;61:712-3.
Abstract Related articles

BRYAN RT
Optimising Existing Therapeutic Strategies for the Treatment of Non-Muscle-Invasive Bladder Cancer: The Role of Intensive Neoadjuvant Intravesical Mitomycin C.
Eur Urol. 2012.
Abstract Related articles

SHARIAT SF , Rink M, Ehdaie B, Xylinas E, et al
Pathologic Nodal Staging Score for Bladder Cancer: A Decision Tool for Adjuvant Therapy After Radical Cystectomy.
Eur Urol. 2012.
Abstract Related articles

HAUTMANN RE , de Petriconi RC, Pfeiffer C, Volkmer BG, et al
Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients.
Eur Urol. 2012;61:1039-47.
Abstract Related articles

SOLOWAY MS
ICUD-EAU International Consultation on Bladder Cancer 2012: Recommendations on Bladder Cancer-Progress in a Cancer that Lacks the Limelight.
Eur Urol. 2012.
Abstract Related articles

BOCHNER BH , Laudone V
Technical Advances in Bladder Cancer Patient Care: Progress or Promise?
Eur Urol. 2012.
Abstract Related articles

SKELDON SC , Semotiuk K, Aronson M, Holter S, et al
Patients with Lynch Syndrome Mismatch Repair Gene Mutations Are at Higher Risk for Not Only Upper Tract Urothelial Cancer but Also Bladder Cancer.
Eur Urol. 2012.
Abstract Related articles

FAJKOVIC H , Cha EK, Jeldres C, Robinson BD, et al
Extranodal Extension Is a Powerful Prognostic Factor in Bladder Cancer Patients with Lymph Node Metastasis.
Eur Urol. 2012.
Abstract Related articles

BURGER M , Catto JW, Dalbagni G, Grossman HB, et al
Epidemiology and Risk Factors of Urothelial Bladder Cancer.
Eur Urol. 2012.
Abstract Related articles

PRAKASH J , Goel A, Garg M
Re: Anobel Y. Odisho, Anna B. Berry, Ardalan E. Ahmad, Matthew R. Cooperberg, Peter R. Carroll, Badrinath R. Konety. Reflex ImmunoCyt Testing for the Diagnosis of Bladder Cancer in Patients with Atypical Urine Cytology. Eur Urol. In press. http://dx.d
Eur Urol. 2012.
Abstract Related articles

RINK M , Furberg H, Zabor EC, Xylinas E, et al
Impact of Smoking and Smoking Cessation on Oncologic Outcomes in Primary Non-muscle-invasive Bladder Cancer.
Eur Urol. 2012.
Abstract Related articles

HERR HW
Intravesical Bacille Calmette-Guerin Eradicates Bacteriuria in Antibiotic-naive Bladder Cancer Patients.
Eur Urol. 2012.
Abstract Related articles

ODISHO AY , Berry AB, Ahmad AE, Cooperberg MR, et al
Reply to Jai Prakash, Apul Goel and Manish Garg's Letter to the Editor re: Anobel Y. Odisho, Anna B. Berry, Ardalan E. Ahmad, Matthew R. Cooperberg, Peter R. Carroll, Badrinath R. Konety. Reflex ImmunoCyt Testing for the Diagnosis of Bladder Cancer in
Eur Urol. 2012.
Abstract Related articles

GAKIS G , Efstathiou J, Lerner SP, Cookson MS, et al
ICUD-EAU International Consultation on Bladder Cancer 2012: Radical Cystectomy and Bladder Preservation for Muscle-Invasive Urothelial Carcinoma of the Bladder.
Eur Urol. 2012.
Abstract Related articles

STERNBERG CN , Bellmunt J, Sonpavde G, Siefker-Radtke AO, et al
ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for Urothelial Carcinoma-Neoadjuvant and Adjuvant Settings.
Eur Urol. 2012.
Abstract Related articles

PALOU J , Wood D, Bochner BH, van der Poel H, et al
ICUD-EAU International Consultation on Bladder Cancer 2012: Urothelial Carcinoma of the Prostate.
Eur Urol. 2012.
Abstract Related articles

YATES DR , Brausi MA, Catto JW, Dalbagni G, et al
Treatment Options Available for Bacillus Calmette-Guerin Failure in Non-muscle-invasive Bladder Cancer.
Eur Urol. 2012.
Abstract Related articles

THOMAS F , Noon AP, Rubin N, Goepel JR, et al
Comparative Outcomes of Primary, Recurrent, and Progressive High-risk Non-muscle-invasive Bladder Cancer.
Eur Urol. 2012 Sep 5. pii: S0302-2838(12)01017.
Abstract Related articles

BURGER M , Oosterlinck W, Konety B, Chang S, et al
ICUD-EAU International Consultation on Bladder Cancer 2012: Non-Muscle-Invasive Urothelial Carcinoma of the Bladder.
Eur Urol. 2012 Sep 5. pii: S0302-2838(12)01014.
Abstract Related articles

RINK M , Xylinas E, Babjuk M, Pycha A, et al
Smoking Reduces the Efficacy of Intravesical Bacillus Calmette-Guerin Immunotherapy in Non-muscle-invasive Bladder Cancer.
Eur Urol. 2012 Sep 5. pii: S0302-2838(12)01010.
Abstract Related articles

HAUTMANN RE , Abol-Enein H, Davidsson T, Gudjonsson S, et al
ICUD-EAU International Consultation on Bladder Cancer 2012: Urinary Diversion.
Eur Urol. 2012 Aug 31. pii: S0302-2838(12)01003.
Abstract Related articles

WITJES JA
The Impact of Recurrent Non-Muscle-Invasive Bladder Cancer on Progression.
Eur Urol. 2012 Sep 25. pii: S0302-2838(12)01110.
Abstract Related articles

GARG M , Goel A, Prakash J
Re: Renzo Colombo, Lorenzo Rocchini, Nazareno Suardi, et al. Neoadjuvant Short-term Intensive Intravesical Mitomycin C Regimen Compared with Weekly Schedule for Low-grade Recurrent Non-muscle-invasive Bladder Cancer: Preliminary Results of a Randomise
Eur Urol. 2012 Sep 23. pii: S0302-2838(12)01098.
Abstract Related articles

MESSING EM
Re: Preexisting BCG-specific T Cells Improve Intravesical Immunotherapy for Bladder Cancer.
Eur Urol. 2012;62:935-6.
Abstract Related articles

COLOMBO R , Rocchini L, Suardi N, Benigni F, et al
Reply to Manish Garg, Apul Goel, and Jai Prakash's Letter to the Editor re: Renzo Colombo, Lorenzo Rocchini, Nazareno Suardi, et al. Neoadjuvant Short-term Intensive Intravesical Mitomycin C Regimen Compared with Weekly Schedule for Low-grade Recurren
Eur Urol. 2012 Sep 23. pii: S0302-2838(12)01097.
Abstract Related articles

HANSEL DE , Amin MB, Comperat E, Cote RJ, et al
A Contemporary Update on Pathology Standards for Bladder Cancer: Transurethral Resection and Radical Cystectomy Specimens.
Eur Urol. 2012 Oct 12. pii: S0302-2838(12)01227.
Abstract Related articles

KAMAT AM , Hegarty PK, Gee JR, Clark PE, et al
ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, Diagnosis, and Molecular Markers.
Eur Urol. 2012 Oct 4. pii: S0302-2838(12)01144.
Abstract Related articles

AMIN MB , McKenney JK, Paner GP, Hansel DE, et al
ICUD-EAU International Consultation on Bladder Cancer 2012: Pathology.
Eur Urol. 2012 Oct 5. pii: S0302-2838(12)01150.
Abstract Related articles

BRAUSI MA
Primary Prevention and Early Detection of Bladder Cancer: Two Main Goals for Urologists.
Eur Urol. 2012 Oct 26. pii: S0302-2838(12)01269.
Abstract Related articles

WITJES JA
Maintenance Bacillus Calmette-Guerin for Non-Muscle-Invasive Bladder Cancer: Do We Finally Know the Best Schedule?
Eur Urol. 2012 Nov 16. pii: S0302-2838(12)01354.
Abstract Related articles

RINK M , Zabor EC, Furberg H, Xylinas E, et al
Impact of Smoking and Smoking Cessation on Outcomes in Bladder Cancer Patients Treated with Radical Cystectomy.
Eur Urol. 2012 Nov 27. pii: S0302-2838(12)01414.
Abstract Related articles

SHIMIZU T , Suzuki H, Nojima M, Kitamura H, et al
Methylation of a Panel of MicroRNA Genes Is a Novel Biomarker for Detection of Bladder Cancer.
Eur Urol. 2012 Nov 23. pii: S0302-2838(12)01405.
Abstract Related articles

GRAY PJ , Fedewa SA, Shipley WU, Efstathiou JA, et al
Use of Potentially Curative Therapies for Muscle-invasive Bladder Cancer in the United States: Results from the National Cancer Data Base.
Eur Urol. 2012 Nov 19. pii: S0302-2838(12)01346.
Abstract Related articles

EFSTATHIOU JA , Shipley WU
Re: Radiotherapy with or without Chemotherapy in Muscle-invasive Bladder Cancer.
Eur Urol. 2013;63:181-2.
Abstract Related articles

YU HY , Hevelone ND, Lipsitz SR, Kowalczyk KJ, et al
Comparative analysis of outcomes and costs following open radical cystectomy versus robot-assisted laparoscopic radical cystectomy: results from the US Nationwide Inpatient Sample.
Eur Urol. 2012;61:1239-44.
Abstract Related articles

PAN D , Soloway MS
The importance of transurethral resection in managing patients with urothelial cancer in the bladder: proposal for a transurethral resection of bladder tumor checklist.
Eur Urol. 2012;61:1199-203.
Abstract Related articles

DIVRIK RT , Sahin AF
Re: Maurizio A. Brausi. Challenging the EAU guidelines regarding early repeat transurethral resection. Eur Urol Suppl 2011;10:e5-7.
Eur Urol. 2012;62:e21-2.
Abstract Related articles

LIN J , Forman MR, Wang J, Grossman HB, et al
Intake of red meat and heterocyclic amines, metabolic pathway genes, and bladder cancer risk.
Int J Cancer. 2012 Jan 19. doi: 10.1002/ijc.27437.
Abstract Related articles

BLAKELY T , Soeberg M, Carter K, Costilla R, et al
Bias in relative survival methods when using incorrect life-tables: Lung and bladder cancer by smoking status and ethnicity in New Zealand.
Int J Cancer. 2012 Mar 15. doi: 10.1002/ijc.27531.
Abstract Related articles

TAKEUCHI A , Eto M, Yamada H, Tatsugami K, et al
A reduction of recipient regulatory T cells by cyclophosphamide contributes to an anti-tumor effect of nonmyeloablative allogeneic stem cell transplantation in mice.
Int J Cancer. 2012;130:365-76.
Abstract Related articles

BARIS D , Karagas MR, Koutros S, Colt JS, et al
Non-steroidal anti-inflammatory drugs (NSAIDs) and other analgesic use and bladder cancer in northern New England.
Int J Cancer. 2012 Apr 14. doi: 10.1002/ijc.27590.
Abstract Related articles

CHO HS , Toyokawa G, Daigo Y, Hayami S, et al
The JmjC domain-containing histone demethylase KDM3A is a positive regulator of the G1/S transition in cancer cells via transcriptional regulation of the HOXA1 gene.
Int J Cancer. 2012;131:E179-89.
Abstract Related articles

COON BG , Crist S, Gonzalez-Bonet AM, Kim HK, et al
Fibronectin attachment protein from bacillus Calmette-Guerin as targeting agent for bladder tumor cells.
Int J Cancer. 2012;131:591-600.
Abstract Related articles

NEWTON CC , Gapstur SM, Campbell PT, Jacobs EJ, et al
Type 2 diabetes mellitus, insulin use, and risk of bladder cancer in a large cohort study.
Int J Cancer. 2012 Oct 1. doi: 10.1002/ijc.27878.
Abstract Related articles

PIGNOT G , Cizeron-Clairac G, Vacher S, Susini A, et al
Microrna expression profile in a large series of bladder tumors: Identification of a 3-mirna signature associated with aggressiveness of muscle-invasive bladder cancer.
Int J Cancer. 2012 Nov 20. doi: 10.1002/ijc.27949.
Abstract Related articles

MANIECKI MB , Etzerodt A, Ulhoi BP, Steiniche T, et al
Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells.
Int J Cancer. 2012;131:2320-31.
Abstract Related articles

MIZUTANI Y , Katsuoka Y, Bonavida B
Low circulating serum levels of second mitochondria-derived activator of caspase (Smac/DIABLO) in patients with bladder cancer.
Int J Oncol. 2012 Jan 3. doi: 10.3892/ijo.2012.1324.
Abstract Related articles

TAKEUCHI A , Eto M, Shiota M, Tatsugami K, et al
Sunitinib enhances antitumor effects against chemotherapy-resistant bladder cancer through suppression of ERK1/2 phosphorylation.
Int J Oncol. 2012 Feb 13. doi: 10.3892/ijo.2012.1368.
Abstract Related articles

YAMASAKI T , Yoshino H, Enokida H, Hidaka H, et al
Novel molecular targets regulated by tumor suppressors microRNA-1 and microRNA-133a in bladder cancer.
Int J Oncol. 2012 Feb 29. doi: 10.3892/ijo.2012.1391.
Abstract Related articles

UEKI H , Watanabe M, Kaku H, Huang P, et al
A novel gene expression system for detecting viable bladder cancer cells.
Int J Oncol. 2012 Mar 28. doi: 10.3892/ijo.2012.1417.
Abstract Related articles

WANG Y , Chen W, Yang C, Wu W, et al
Long non-coding RNA UCA1a(CUDR) promotes proliferation and tumorigenesis of bladder cancer.
Int J Oncol. 2012;41:276-284.
Abstract Related articles

HIRATA T , Watanabe M, Kaku H, Kobayashi Y, et al
REIC/Dkk-3-encoding adenoviral vector as a potentially effective therapeutic agent for bladder cancer.
Int J Oncol. 2012 May 31. doi: 10.3892/ijo.2012.1503.
Abstract Related articles

KUNZE D , Kraemer K, Erdmann K, Froehner M, et al
Simultaneous siRNA-mediated knockdown of antiapoptotic BCL2, Bcl-xL, XIAP and survivin in bladder cancer cells.
Int J Oncol. 2012 Jul 6. doi: 10.3892/ijo.2012.1549.
Abstract Related articles

SUZUKI Y , Sutoh M, Hatakeyama S, Mori K, et al
MUC1 carrying core 2 O-glycans functions as a molecular shield against NK cell attack, promoting bladder tumor metastasis.
Int J Oncol. 2012;40:1831-8.
Abstract Related articles

IZUMI K , Zheng Y, Li Y, Zaengle J, et al
Epidermal growth factor induces bladder cancer cell proliferation through activation of the androgen receptor.
Int J Oncol. 2012 Aug 21. doi: 10.3892/ijo.2012.1593.
Abstract Related articles

YUN SJ , Jeong P, Kim WT, Kim TH, et al
Cell-free microRNAs in urine as diagnostic and prognostic biomarkers of bladder cancer.
Int J Oncol. 2012 Sep 6. doi: 10.3892/ijo.2012.1622.
Abstract Related articles

HU X , Ruan Y, Cheng F, Yu W, et al
p130Cas, E-cadherin and beta-catenin in human transitional cell carcinoma of the bladder: expression and clinicopathological significance.
Int J Urol. 2011;18:630-7.
Abstract Related articles

KOGA F , Kihara K
Selective bladder preservation with curative intent for muscle-invasive bladder cancer: A contemporary review.
Int J Urol. 2012 Mar 12. doi: 10.1111/j.1442-2042.2012.02974.
Abstract Related articles

YANG Z , Pan L, Cheng J, Hu S, et al
Clinical value of whole body fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of metastatic bladder cancer.
Int J Urol. 2012 Mar 27. doi: 10.1111/j.1442-2042.2012.02989.
Abstract Related articles

MARCH VILLALBA JA
Editorial comment to a case of large bladder hemangioma successfully treated with endoscopic yttrium aluminium garnet laser irradiation.
Int J Urol. 2012;19:85.
Abstract Related articles

AZUMA H , Inamoto T, Takahara K, Ibuki N, et al
Neoadjuvant and adjuvant chemotherapy for locally advanced bladder carcinoma: development of novel bladder preservation approach, Osaka Medical College regimen.
Int J Urol. 2012;19:26-38.
Abstract Related articles

HELLENTHAL NJ
Editorial comment to extended versus limited lymph node dissection in radical cystectomy: impact on recurrence pattern and survival.
Int J Urol. 2012;19:47-8.
Abstract Related articles

JENSEN JB , Ulhoi BP, Jensen KM
Extended versus limited lymph node dissection in radical cystectomy: impact on recurrence pattern and survival.
Int J Urol. 2012;19:39-47.
Abstract Related articles

SHIGEMURA K , Yamanaka N, Imanishi O, Yamashita M, et al
Wallace direct versus anti-reflux Le Duc ureteroileal anastomosis: comparative analysis in modified Studer orthotopic neobladder reconstruction.
Int J Urol. 2012;19:49-53.
Abstract Related articles

CANTER D
Editorial Comment to Influence of baseline renal function and dose reduction of nephrotoxic chemotherapeutic agents on the outcome of metastatic urothelial carcinoma: a retrospective study.
Int J Urol. 2012;19:116-7.
Abstract Related articles

MARU S , Abe T, Shinohara N, Sazawa A, et al
Influence of baseline renal function and dose reduction of nephrotoxic chemotherapeutic agents on the outcome of metastatic urothelial carcinoma: a retrospective study.
Int J Urol. 2012;19:110-6.
Abstract Related articles

MATSUYAMA H
Editorial Comment to Role of routine transurethral biopsy and isolated upper tract cytology after intravesical treatment of high-grade non-muscle invasive bladder cancer.
Int J Urol. 2012 Jul 4. doi: 10.1111/j.1442-2042.2012.03096.
Abstract Related articles

LIGHTFOOT AJ , Rosevear HM, Nepple KG, O'Donnell MA, et al
Role of routine transurethral biopsy and isolated upper tract cytology after intravesical treatment of high-grade non-muscle invasive bladder cancer.
Int J Urol. 2012 Jul 4. doi: 10.1111/j.1442-2042.2012.03089.
Abstract Related articles

SANDERS I , Holdenrieder S, Walgenbach-Brunagel G, von Ruecker A, et al
Evaluation of reference genes for the analysis of serum miRNA in patients with prostate cancer, bladder cancer and renal cell carcinoma.
Int J Urol. 2012 Jul 12. doi: 10.1111/j.1442-2042.2012.03082.
Abstract Related articles

DEL ROSSO A , Pace G, Masciovecchio S, Saldutto P, et al
Plasmakinetic bipolar versus monopolar transurethral resection of non-muscle invasive bladder cancer: A single center randomized controlled trial.
Int J Urol. 2012 Sep 25. doi: 10.1111/j.1442-2042.2012.03174.
Abstract Related articles

LI K , Lin T, Fan X, Duan Y, et al
Diagnosis of narrow-band imaging in non-muscle-invasive bladder cancer: A systematic review and meta-analysis.
Int J Urol. 2012 Nov 1. doi: 10.1111/j.1442-2042.2012.03211.
Abstract Related articles

NASELLI A
Editorial Comment to Plasmakinetic bipolar versus monopolar transurethral resection of non-muscle invasive bladder cancer: A single center randomized controlled trial.
Int J Urol. 2012 Nov 1. doi: 10.1111/j.1442-2042.2012.03180.
Abstract Related articles

GONDO T , Nakashima J, Ohno Y, Hashimoto T, et al
Preoperative prediction of malignant involvement of resected ureters in patients undergoing radical cystectomy for bladder cancer.
Int J Urol. 2012 Oct 29. doi: 10.1111/j.1442-2042.2012.03203.
Abstract Related articles

LIN X , Wu G, Huo WQ, Zhang Y, et al
Resveratrol induces apoptosis associated with mitochondrial dysfunction in bladder carcinoma cells.
Int J Urol. 2012;19:757-64.
Abstract Related articles

MATSUYAMA H
Could basic research shed light on false positivity in photodynamic diagnosis?
Int J Urol. 2012;19:695-6.
Abstract Related articles

KONDO T , Tanabe K
Role of lymphadenectomy in the management of urothelial carcinoma of the bladder and the upper urinary tract.
Int J Urol. 2012;19:710-21.
Abstract Related articles

CHEN D , Yang Z, Wang Y, Zhu G, et al
Capsaicin induces cycle arrest by inhibiting cyclin-dependent-kinase in bladder carcinoma cells.
Int J Urol. 2012;19:662-8.
Abstract Related articles

GOU X , Wang M, He WY, Liu CD, et al
Laparoscopic radical cystectomy for bladder cancer with prostatic and neurovascular sparing: initial experience.
Int Urol Nephrol. 2012.
Abstract Related articles

COX J , Colli JL
Urothelial cancers after renal transplantation.
Int Urol Nephrol. 2011;43:681-6.
Abstract Related articles

DE NUNZIO C , Cicione A, Leonardo F, Rondoni M, et al
Extraperitoneal radical cystectomy and ureterocutaneostomy in octogenarians.
Int Urol Nephrol. 2011;43:663-7.
Abstract Related articles

TAKENAKA A , Hara I, Soga H, Sakai I, et al
Assessment of long-term quality of life in patients with orthotopic neobladder followed for more than 5 years.
Int Urol Nephrol. 2011;43:749-54.
Abstract Related articles

LIN YL , Liu XQ, Li WP, Sun G, et al
Promoter methylation of H-cadherin is a potential biomarker in patients with bladder transitional cell carcinoma.
Int Urol Nephrol. 2012;44:111-7.
Abstract Related articles

ARAI S , Hasumi M, Shimizu N
Long-term survival and onset of granulomatous pneumonia after lung metastasectomy in a patient with non-muscle-invasive bladder cancer.
Int Urol Nephrol. 2012.
Abstract Related articles

COSKUNER E , Cevik I, Ozkan A, Dillioglugil O, et al
In the cystoscopic follow-up of non-muscle-invasive transitional cell carcinoma, NMP-22 works for high grades, but unreliable in low grades and upper urinary tract tumors.
Int Urol Nephrol. 2012;44:793-8.
Abstract Related articles

BADAWY AA , Saleem MD, El-Baset EA, Morsi ES, et al
Decreasing operative time and incontinence rates in patients treated with radical cystectomy and urethral diversion: a prospective randomized trial using a new suturing device (CAPIO).
Int Urol Nephrol. 2012;44:769-74.
Abstract Related articles

ANTONIEWICZ AA , Paziewska A, Mikula M, Goryca K, et al
Lack of evidence for increased level of circulating urothelial cells in the peripheral blood after transurethral resection of bladder tumors.
Int Urol Nephrol. 2012;44:761-7.
Abstract Related articles

ENGLES CD , Slobodov G, Buethe DD, Lightfoot S, et al
Primary mixed neuroendocrine carcinoma of the bladder with large cell component: a case report and review of the literature.
Int Urol Nephrol. 2012;44:1021-5.
Abstract Related articles

SZUCS M , Keszthelyi A, Szendroi A, Dombovari P, et al
Investigation of anal sphincter function following Mainz pouch type II urinary diversion after radical cystectomy.
Int Urol Nephrol. 2012;44:1013-20.
Abstract Related articles

CHING CB , Chen L, Fergany A
Prostatic urethral recurrence of urachal adenocarcinoma.
J Clin Oncol. 2011;29:e736-8.
Abstract Related articles

DREICER R
The future of drug development in urothelial cancer.
J Clin Oncol. 2012;30:473-5.
Abstract Related articles

BASSETT JC , Gore JL, Chi AC, Kwan L, et al
Impact of a Bladder Cancer Diagnosis on Smoking Behavior.
J Clin Oncol. 2012.
Abstract Related articles

LAMMERS RJ , Witjes WP, Janzing-Pastors MH, Caris CT, et al
Intracutaneous and Intravesical Immunotherapy With Keyhole Limpet Hemocyanin Compared With Intravesical Mitomycin in Patients With Non-Muscle-Invasive Bladder Cancer: Results From a Prospective Randomized Phase III Trial.
J Clin Oncol. 2012.
Abstract Related articles

WONG YN , Litwin S, Vaughn D, Cohen S, et al
Phase II trial of cetuximab with or without paclitaxel in patients with advanced urothelial tract carcinoma.
J Clin Oncol. 2012;30:3545-51.
Abstract Related articles

DEB AA , Wilson SS, Rove KO, Kumar B, et al
Potentiation of mitomycin C tumoricidal activity for transitional cell carcinoma by histone deacetylase inhibitors in vitro.
J Urol. 2011;186:2426-33.
Abstract Related articles

PELLUCCHI F , Freschi M, Ibrahim B, Rocchini L, et al
Clinical reliability of the 2004 WHO histological classification system compared with the 1973 WHO system for Ta primary bladder tumors.
J Urol. 2011;186:2194-9.
Abstract Related articles

MONTIRONI R
Editorial comment.
J Urol. 2011;186:2199-200.
Abstract Related articles

WOOD DP
Re: International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial.
J Urol. 2012;187:473.
Abstract Related articles

WOOD DP
Re: bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer.
J Urol. 2012;187:473-4.
Abstract Related articles

FERNANDEZ MI , Lopez JF, Vivaldi B, Coz F, et al
Long-Term Impact of Arsenic in Drinking Water on Bladder Cancer Health Care and Mortality Rates 20 Years After End of Exposure.
J Urol. 2012.
Abstract Related articles

KAMAT AM , Dickstein RJ, Messetti F, Anderson R, et al
Use of Fluorescence In Situ Hybridization to Predict Response to Bacillus Calmette-Guerin Therapy for Bladder Cancer: Results of a Prospective Trial.
J Urol. 2012.
Abstract Related articles

WOOD DP
Re: Effect of mitomycin C on concentrations of vascular endothelial growth factor and its receptors in bladder cancer cells and in bladders of rats intravesically instilled with mitomycin C.
J Urol. 2012;187:352-3.
Abstract Related articles

ZHANG X , Shi X, Li J, Hu Z, et al
A Novel Therapeutic Vaccine of Mouse GM-CSF Surface Modified MB49 Cells Against Metastatic Bladder Cancer.
J Urol. 2012.
Abstract Related articles

GRIEBLING TL
Re: diminished efficacy of bacille calmette-guerin among elderly patients with nonmuscle invasive bladder cancer.
J Urol. 2012;187:879-80.
Abstract Related articles

HENDRICKSEN K , Cornel EB, Reijke TM, Arentsen HC, et al
Phase 2 Study of Adjuvant Intravesical Instillations of Apaziquone for High Risk Nonmuscle Invasive Bladder Cancer.
J Urol. 2012.
Abstract Related articles

CAMERON AP , Rodriguez GM, Schomer KG
Systematic review of urological followup after spinal cord injury.
J Urol. 2012;187:391-7.
Abstract Related articles

VAN RHIJN BW
Editorial comment.
J Urol. 2012;187:462.
Abstract Related articles

COOKSON MS , Chang SS, Oefelein MG, Gallagher JR, et al
National Practice Patterns for Immediate Postoperative Instillation of Chemotherapy in Nonmuscle Invasive Bladder Cancer.
J Urol. 2012.
Abstract Related articles

ROTH B , Zehnder P, Birkhauser FD, Burkhard FC, et al
Is Bilateral Extended Pelvic Lymphadenectomy Necessary for Strictly Unilateral Invasive Bladder Cancer?
J Urol. 2012.
Abstract Related articles

WOOD DP
Re: instillation of mitomycin C after transurethral resection of bladder cancer impairs wound healing: an animal model.
J Urol. 2012;187:1508.
Abstract Related articles

KISPAL ZF , Vajda P, Kereskai L, Jakab CS, et al
Composite urinary reservoir in dogs: histological findings.
J Urol. 2012;187:1110-5.
Abstract Related articles

HUMPHREY PA
Urothelial carcinoma in situ of the bladder.
J Urol. 2012;187:1057-8.
Abstract Related articles

FAJKOVIC H , Cha EK, Jeldres C, Donner G, et al
Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinoma.
J Urol. 2012;187:845-51.
Abstract Related articles

REN H , Park KC, Pan R, Waltzer WC, et al
Early detection of carcinoma in situ of the bladder: a comparative study of white light cystoscopy, narrow band imaging, 5-ALA fluorescence cystoscopy and 3-dimensional optical coherence tomography.
J Urol. 2012;187:1063-70.
Abstract Related articles

MARGEL D , Bostrom P, Baniel J, Yossepowitch O, et al
External validation of a biomarker based pre-cystectomy algorithm to predict nonorgan confined urothelial cancers.
J Urol. 2012;187:840-4.
Abstract Related articles

RICARDO-GONZALEZ RR , Nguyen M, Gokden N, Sangoi AR, et al
Plasmacytoid carcinoma of the bladder: a urothelial carcinoma variant with a predilection for intraperitoneal spread.
J Urol. 2012;187:852-5.
Abstract Related articles

KIM SP , Shah ND, Karnes RJ, Weight CJ, et al
The Implications of Hospital Acquired Adverse Events on Mortality, Length of Stay and Costs for Patients Undergoing Radical Cystectomy for Bladder Cancer.
J Urol. 2012.
Abstract Related articles

LOTAN Y , Goodman PJ, Youssef RF, Svatek RS, et al
Evaluation of Vitamin E and Selenium Supplementation for the Prevention of Bladder Cancer in SWOG Coordinated SELECT.
J Urol. 2012.
Abstract Related articles

BABAYAN RK
Re: defecation disturbances after cystectomy for urinary bladder cancer.
J Urol. 2012;187:1588.
Abstract Related articles

WOOD DP
Re: the role of haematuria in bladder cancer screening among men with former occupational exposure to aromatic amines.
J Urol. 2012;187:1586-7.
Abstract Related articles

BOCKHOLT NA , Knudson MJ, Henning JR, Maymi JL, et al
Anti-Interleukin-10R1 Monoclonal Antibody Enhances Bacillus Calmette-Guerin Induced T-Helper Type 1 Immune Responses and Antitumor Immunity in a Mouse Orthotopic Model of Bladder Cancer.
J Urol. 2012.
Abstract Related articles

BONGIOVANNI L , Pirozzi F, Guidi F, Orsini M, et al
Bradeion (SEPT4) as a Urinary Marker of Transitional Cell Bladder Cancer: A Real-Time Polymerase Chain Reaction Study of Gene Expression.
J Urol. 2012.
Abstract Related articles

DEGRAFF DJ , Matusik RJ
Gender Specific Differences in Bladder Cancer.
J Urol. 2012.
Abstract Related articles

GROSSMAN HB , Stenzl A, Fradet Y, Mynderse LA, et al
Long-Term Decrease in Bladder Cancer Recurrence with Hexaminolevulinate Enabled Fluorescence Cystoscopy.
J Urol. 2012.
Abstract Related articles

WOOD DP
Re: electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial.
J Urol. 2012;187:2023-4.
Abstract Related articles

THONG AE , Gonzalgo ML
Learning from our patients: complications and the future of radical cystectomy for bladder cancer.
J Urol. 2012;187:2018.
Abstract Related articles

SHIOTA M , Takeuchi A, Yokomizo A, Kashiwagi E, et al
Androgen Receptor Signaling Regulates Cell Growth and Vulnerability to Doxorubicin in Bladder Cancer.
J Urol. 2012.
Abstract Related articles

WOOD DP
Re: do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of southwest oncology group-directed intergroup study (s8710).
J Urol. 2012;188:72.
Abstract Related articles

ZARAVINOS A , Radojicic J, Lambrou GI, Volanis D, et al
Expression of miRNAs Involved in Angiogenesis, Tumor Cell Proliferation, Tumor Suppressor Inhibition, Epithelial-Mesenchymal Transition and Activation of Metastasis in Bladder Cancer.
J Urol. 2012.
Abstract Related articles

LIU JJ , Droller MJ, Liao JC
New Optical Imaging Technologies for Bladder Cancer: Considerations and Perspectives.
J Urol. 2012.
Abstract Related articles

ATALA A
Re: Acquired Platinum Resistance Enhances Tumour Angiogenesis Through Angiotensin II Type 1 Receptor in Bladder Cancer.
J Urol. 2012;188:675.
Abstract Related articles

GRIEBLING TL
Re: use of restaging bladder tumor resection for bladder cancer among medicare beneficiaries.
J Urol. 2012;188:415-6.
Abstract Related articles

WOOD DP
Re: bladder cancer: evaluation of staging accuracy using dynamic MRI.
J Urol. 2012;188:414.
Abstract Related articles

SWIETEK N , Waldert M, Rom M, Schatzl G, et al
The Value of Transurethral Bladder Biopsy after Intravesical Bacillus Calmette-Guerin Instillation Therapy for Nonmuscle Invasive Bladder Cancer: A Retrospective, Single Center Study and Cumulative Analysis of the Literature.
J Urol. 2012.
Abstract Related articles

SANDES EO , Lodillinsky C, Langle Y, Belgorosky D, et al
Inducible Nitric Oxide Synthase and PPARgamma are Involved in Bladder Cancer Progression.
J Urol. 2012.
Abstract Related articles

O'SULLIVAN P , Sharples K, Dalphin M, Davidson P, et al
A Multigene Urine Test for the Detection and Stratification of Bladder Cancer in Patients Presenting with Hematuria.
J Urol. 2012.
Abstract Related articles

WOOD DP
Re: metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression.
J Urol. 2012;188:1045-6.
Abstract Related articles

KNOEDLER JJ , Boorjian SA, Kim SP, Weight CJ, et al
Does Partial Cystectomy Compromise Oncologic Outcomes for Patients with Bladder Cancer Compared to Radical Cystectomy? A Matched Case-Control Analysis.
J Urol. 2012.
Abstract Related articles

MERTENS LS , Meijer RP, Kerst JM, Bergman AM, et al
Carboplatin Based Induction Chemotherapy for Nonorgan Confined Bladder Cancer-A Reasonable Alternative for Cisplatin Unfit Patients?
J Urol. 2012.
Abstract Related articles

MORGAN TM , Kaffenberger SD, Cookson MS
Surgical and Chemotherapeutic Management of Regional Lymph Nodes in Bladder Cancer.
J Urol. 2012.
Abstract Related articles

JOHNSON MH , Nepple KG, Humphrey PA
Bladder lymphoma.
J Urol. 2012;188:269-70.
Abstract Related articles

ANDERSON CB , Cookson MS, Chang SS, Clark PE, et al
Voiding function in women with orthotopic neobladder urinary diversion.
J Urol. 2012;188:200-4.
Abstract Related articles

SAGALOWSKY AI
Editorial comment.
J Urol. 2012;188:62.
Abstract Related articles

EHDAIE B , Maschino A, Shariat SF, Rioja J, et al
Comparative outcomes of pure squamous cell carcinoma and urothelial carcinoma with squamous differentiation in patients treated with radical cystectomy.
J Urol. 2012;187:74-9.
Abstract Related articles

PENSON DF
Re: smoking knowledge assessment and cessation trends in patients with bladder cancer presenting to a tertiary referral center.
J Urol. 2012;188:1122-3.
Abstract Related articles

LINTON KD , Rosario DJ, Thomas F, Rubin N, et al
Disease specific mortality in patients with low risk bladder cancer and the impact of cystoscopic surveillance.
J Urol. 2012 Sep 24. pii: S0022-5347(12)04977-4. doi: 10.1016/j.juro.2012.
Abstract Related articles

BOLENZ C , Gorzelanny C, Knauf D, Keil T, et al
Assessing The Invasive Potential Of Bladder Cancer: Development And Validation Of A New Preclinical Assay.
J Urol. 2012 Oct 10. pii: S0022-5347(12)05186-5. doi: 10.1016/j.juro.2012.
Abstract Related articles

URQUIDI V , Goodison S, Ross S, Chang M, et al
Diagnostic Potential of Urinary alpha1-Antitrypsin and Apolipoprotein E in the Detection of Bladder Cancer.
J Urol. 2012 Oct 19. pii: S0022-5347(12)04372-8. doi: 10.1016/j.juro.2012.
Abstract Related articles

BURKE JM , Lamm DL, Meng MV, Nemunaitis JJ, et al
A First in Human Phase 1 Study of CG0070, a GM-CSF Expressing Oncolytic Adenovirus, for the Treatment of Nonmuscle Invasive Bladder Cancer.
J Urol. 2012 Oct 19. pii: S0022-5347(12)04375-3. doi: 10.1016/j.juro.2012.
Abstract Related articles

LANGLE Y , Lodillinsky C, Belgorosky D, Sandes EO, et al
Role of Peroxisome Proliferator Activated Receptor-Gamma in Bacillus Calmette-Guerin Bladder Cancer Therapy.
J Urol. 2012 Oct 19. pii: S0022-5347(12)04415-1. doi: 10.1016/j.juro.2012.
Abstract Related articles

AMASYALI AS , Kucukgergin C, Erdem S, Sanli O, et al
Nitric Oxide Synthase (eNOS4a/b) Gene Polymorphism is Associated with Tumor Recurrence and Progression in Superficial Bladder Cancer Cases.
J Urol. 2012 Oct 19. pii: S0022-5347(12)04374-1. doi: 10.1016/j.juro.2012.
Abstract Related articles

ABD EL-LATIF A , Watts KE, Elson P, Fergany A, et al
The Sensitivity of Initial Transurethral Resection or Biopsy of Bladder Tumor(s) in Detecting Bladder Cancer Variants on Radical Cystectomy.
J Urol. 2012 Oct 17. pii: S0022-5347(12)05283-4. doi: 10.1016/j.juro.2012.
Abstract Related articles

DJALADAT H , Bruins HM, Miranda G, Cai J, et al
Reproductive Organ Involvement in Female Patients Undergoing Radical Cystectomy for Urothelial Bladder Cancer.
J Urol. 2012 Oct 17. pii: S0022-5347(12)04481-3. doi: 10.1016/j.juro.2012.
Abstract Related articles

SO A , Rennie PS, Jia W
Intravesical Oncoviral Therapy for Bladder Cancer.
J Urol. 2012 Oct 17. pii: S0022-5347(12)04869-0. doi: 10.1016/j.juro.2012.
Abstract Related articles

RINK M , Xylinas E, Babjuk M, Hansen J, et al
Impact of Smoking on Outcomes of Patients with a History of Recurrent Nonmuscle Invasive Bladder Cancer.
J Urol. 2012 Oct 17. pii: S0022-5347(12)04486-2. doi: 10.1016/j.juro.2012.
Abstract Related articles

PICOZZI S , Ricci C, Gaeta M, Ratti D, et al
Upper Urinary Tract Recurrence Following Radical Cystectomy for Bladder Cancer: A Meta-Analysis on 13,185 Patients.
J Urol. 2012 Oct 17. pii: S0022-5347(12)04471-0. doi: 10.1016/j.juro.2012.
Abstract Related articles

BURKS FN , Liu AB, Suh RS, Schuster TG, et al
Understanding the Use of Immediate Intravesical Chemotherapy for Patients with Bladder Cancer.
J Urol. 2012 Oct 17. pii: S0022-5347(12)04501-6. doi: 10.1016/j.juro.2012.
Abstract Related articles

LEE CT , Barocas D, Globe DR, Oefelein MG, et al
Economic and Humanistic Consequences of Preventable Bladder Tumor Recurrences in Nonmuscle Invasive Bladder Cancer Cases.
J Urol. 2012 Oct 17. pii: S0022-5347(12)04442-4. doi: 10.1016/j.juro.2012.
Abstract Related articles

SCHER MB , Elbaum MB, Mogilevkin Y, Hilbert DW, et al
Detecting DNA Methylation of the BCL2, CDKN2A and NID2 Genes in Urine Using a Nested Methylation Specific Polymerase Chain Reaction Assay to Predict Bladder Cancer.
J Urol. 2012 Oct 17. pii: S0022-5347(12)04452-7. doi: 10.1016/j.juro.2012.
Abstract Related articles

NIELSEN ME
Editorial comment.
J Urol. 2012;188:753.
Abstract Related articles

BJURLIN MA , Cohn MR, Freeman VL, Lombardo LM, et al
Ethnicity and smoking status are associated with awareness of smoking related genitourinary diseases.
J Urol. 2012;188:724-8.
Abstract Related articles

YUH BE , Ruel N, Wilson TG, Vogelzang N, et al
Pooled Analysis of Clinical Outcomes with Neoadjuvant Cisplatin and Gemcitabine Chemotherapy for Muscle-Invasive Bladder Cancer.
J Urol. 2012 Oct 31. pii: S0022-5347(12)05429-8. doi: 10.1016/j.juro.2012.
Abstract Related articles

BARLOW LJ , McKiernan JM, Benson MC
Long-term survival outcomes with intravesical docetaxel in the management of recurrent non-muscle-invasive bladder cancer (NMIBC) after previous BCG therapy.
J Urol. 2012 Oct 30. pii: S0022-5347(12)05356-6. doi: 10.1016/j.juro.2012.
Abstract Related articles

VAN KESSEL KE , Kompier LC, de Bekker-Grob EW, Zuiverloon TC, et al
FGFR3 mutation analysis on voided urine samples to reduce cystoscopies and cost in non-muscle invasive bladder cancer surveillance: a comparison of three different strategies.
J Urol. 2012 Nov 6. pii: S0022-5347(12)05470-5. doi: 10.1016/j.juro.2012.
Abstract Related articles

MERTENS LS , Fioole-Bruining A, van Rhijn BW, Kerst JM, et al
FDG-PET/CT in Monitoring Response of Pelvic Lymph Node Metastases to Neoadjuvant Chemotherapy in Bladder Cancer.
J Urol. 2012 Nov 6. pii: S0022-5347(12)05474-2. doi: 10.1016/j.juro.2012.
Abstract Related articles

PIETERS BR , Horenblas S, Koning CC
Does Partial Cystectomy Compromise Oncologic Outcomes for Patients with Bladder Cancer Compared to Radical Cystectomy? A Matched Case-Control Analysis.
J Urol. 2012 Nov 6. pii: S0022-5347(12)05466-3. doi: 10.1016/j.juro.2012.
Abstract Related articles

WOOD DP
Re: radiotherapy with or without chemotherapy in muscle-invasive bladder cancer.
J Urol. 2012;188:2151.
Abstract Related articles

FALKE J , Lammers RJ, Arentsen HC, Ravic M, et al
Results of a phase 1 dose escalation study of intravesical TMX-101 in patients with non-muscle invasive bladder cancer.
J Urol. 2012 Nov 30. pii: S0022-5347(12)05771-0. doi: 10.1016/j.juro.2012.
Abstract Related articles

ZUIVERLOON TC , Beukers W, van der Keur KA, Nieuweboer AJ, et al
Combinations of urinary biomarkers for surveillance of patients with incident non-muscle invasive bladder cancer: The European FP7 UROMOL Project.
J Urol. 2012 Nov 27. pii: S0022-5347(12)05624-8. doi: 10.1016/j.juro.2012.
Abstract Related articles

ATALA A
Re: an epirubicin-conjugated nanocarrier with MRI function to overcome lethal multidrug-resistant bladder cancer.
J Urol. 2013;189:385-6.
Abstract Related articles

ATALA A
Re: MicroRNA-449a Acts as a Tumor Suppressor in Human Bladder Cancer Through the Regulation of Pocket Proteins.
J Urol. 2013;189:385.
Abstract Related articles

WOOD DP
Re: quality of care in patients with bladder cancer: a case report?
J Urol. 2013;189:73-4.
Abstract Related articles

XU B , He Y, Wu X, Luo C, et al
Exploration of the correlations between interferon-gamma in patient serum and HEPACAM in bladder transitional cell carcinoma, and the interferon-gamma mechanism inhibiting BIU-87 proliferation.
J Urol. 2012;188:1346-53.
Abstract Related articles

GALSKY MD
Editorial comment.
J Urol. 2012;188:1114.
Abstract Related articles

BRUINS HM , Visser O, Ploeg M, Hulsbergen-van de Kaa CA, et al
The clinical epidemiology of urachal carcinoma: results of a large, population based study.
J Urol. 2012;188:1102-7.
Abstract Related articles

SAITO R , Shirakawa R, Nishiyama H, Kobayashi T, et al
Downregulation of Ral GTPase-activating protein promotes tumor invasion and metastasis of bladder cancer.
Oncogene. 2012 Mar 26. doi: 10.1038/onc.2012.
Abstract Related articles

MURA M , Swain RK, Zhuang X, Vorschmitt H, et al
Identification and angiogenic role of the novel tumor endothelial marker CLEC14A.
Oncogene. 2012;31:293-305.
Abstract Related articles

SCHEPELER T , Lamy P, Laurberg JR, Fristrup N, et al
A high resolution genomic portrait of bladder cancer: correlation between genomic aberrations and the DNA damage response.
Oncogene. 2012 Aug 27. doi: 10.1038/onc.2012.
Abstract Related articles

LIN HY , Huang CH, Yu TJ, Wu WJ, et al
p53 codon 72 polymorphism as a progression index for bladder cancer.
Oncol Rep. 2011 Dec 22. doi: 10.3892/or.2011.1610.
Abstract Related articles

CHEN NG , Lu CC, Lin YH, Shen WC, et al
Proteomic approaches to study epigallocatechin gallate-provoked apoptosis of TSGH-8301 human urinary bladder carcinoma cells: roles of AKT and heat shock protein 27-modulated intrinsic apoptotic pathways.
Oncol Rep. 2011;26:939-47.
Abstract Related articles

LI B , Wu Z, Li W, Jia G, et al
Chlorophyllin e4 is a novel photosensitizer against human bladder cancer cells.
Oncol Rep. 2012 Jan 26. doi: 10.3892/or.2012.1656.
Abstract Related articles

MOYER GC , Grubb RL 3rd, Johnson FE
Intestinal adenocarcinoma arising in urinary conduits.
Oncol Rep. 2012;27:371-5.
Abstract Related articles

JAYASOORIYA RG , Choi YH, Moon SK, Kim WJ, et al
Methanol extract of Hydroclathrus clathratus suppresses matrix metalloproteinase-9 in T24 bladder carcinoma cells by suppressing the NF-kappaB and MAPK pathways.
Oncol Rep. 2012;27:541-6.
Abstract Related articles

LIU Y , Wang H, Lin T, Wei Q, et al
Interactions between cigarette smoking and XPC-PAT genetic polymorphism enhance bladder cancer risk.
Oncol Rep. 2012 Apr 9. doi: 10.3892/or.2012.1759.
Abstract Related articles

LUBET RA , Clapper ML, McCormick DL, Pereira MA, et al
Chemopreventive efficacy of Targretin in rodent models of urinary bladder, colon/intestine, head and neck and mammary cancers.
Oncol Rep. 2012;27:1400-6.
Abstract Related articles

XIONG D , Ye YL, Chen MK, Qin ZK, et al
Non-muscle myosin II is an independent predictor of overall survival for cystectomy candidates with early-stage bladder cancer.
Oncol Rep. 2012 Aug 10. doi: 10.3892/or.2012.1965.
Abstract Related articles

SPINOIT AF , Petit T, Elalouf V, Saint F, et al
[Signet-ring cell primitive bladder carcinoma: a rare and aggressive tumor].
Prog Urol. 2011;21:651-3.
Abstract Related articles

HOUEDE N , Beuzeboc P, Culine S, Soulie M, et al
[Chemotherapy in perioperative setting for infiltrative bladder cancer].
Prog Urol. 2012;22:139-45.
Abstract Related articles

DEVILLE JL
[Chemotherapy in urologic oncology].
Prog Urol. 2011;21:816-21.
Abstract Related articles

QUINTENS H , Roupret M, Larre S, Neuzillet Y, et al
[Chemoradiotherapy for muscle-invasive cancer: methods, surveillance and results. An update from the cancer committee of the French National Association of Urology].
Prog Urol. 2012;22:13-6.
Abstract Related articles

LARRE S , Quintens H, Houede N, Comperat E, et al
[Benefit of bladder and upper urinary tract urothelial tumors lymph node dissection: Review from the Bladder Cancer Committee of the French National Association of Urology ("CC-AFU Vessie")].
Prog Urol. 2012;22:380-7.
Abstract Related articles

BERTRAND J , Soustelle L, Gres P, Wagner L, et al
[Interest of flexible videocystoscopy in blue light (+Hexvix((R))) in consultation for the diagnosis of vesical tumor].
Prog Urol. 2012;22:172-7.
Abstract Related articles

TOLEDANO H , Bastide C, Thoulouzan M, Arroua F, et al
[Radical cystectomy for urothelial bladder cancer: Prognostic impact of lymph node metastasis and soft tissue surgical margins].
Prog Urol. 2012;22:705-10.
Abstract Related articles

NGUYEN-HUU Y , Delorme G, Lillaz J, Bedgedjian I, et al
[Muscularis mucosae invasion: prognostic factor for intravesical BCG immunotherapy failure for T1 bladder carcinoma].
Prog Urol. 2012;22:284-90.
Abstract Related articles

BALLOUHEY Q , Thoulouzan M, Lunardi P, Bellec L, et al
[Prospective study of the results of ureterointestinal anastomosis in 100 patients after the Hautmann ileal neobladder with double chimney].
Prog Urol. 2012;22:255-60.
Abstract Related articles

AUDENET F , Lejay V, Mejean A, De La Taille A, et al
[Are therapeutics decisions homogeneous in multidisciplinary onco-urology staff meeting? Comparison of therapeutic options taken in four departments from Paris].
Prog Urol. 2012;22:433-7.
Abstract Related articles

ROUPRET M , Neuzillet Y, Larre S, Pignot G, et al
[Guidelines for good practice of intravesical instillations of BCG and mitomycin C from the French national cancer committee (CC-AFU) for non-muscle invasive bladder cancer].
Prog Urol. 2012;22:920-31.
Abstract Related articles

NEUZILLET Y , Roupret M, Wallerand H, Pignot G, et al
[Diagnosis and management of adverse events occuring during BCG therapy for non-muscle invasive bladder cancer (NMIBC): Review of the Cancer Committee of the French Association of Urology].
Prog Urol. 2012;22:989-98.
Abstract Related articles

NEUZILLET Y , Comperat E, Roupret M, Larre S, et al
[Intradiverticular bladder tumours: review of the Cancer Committee of the French Association of Urology].
Prog Urol. 2012;22:495-502.
Abstract Related articles

MAY M , Bastian PJ, Brookman-May S, Burger M, et al
Pathological upstaging detected in radical cystectomy procedures is associated with a significantly worse tumour-specific survival rate for patients with clinical T1 urothelial carcinoma of the urinary bladder.
Scand J Urol Nephrol. 2011;45:251-7.
Abstract Related articles

KIELY B , McLaughlin AM, Lynch TH, Keane J, et al
Intravesical bacille Calmette-Guerin-induced multiorgan failure after treatment for transitional cell carcinoma.
Scand J Urol Nephrol. 2011;45:278-80.
Abstract Related articles

EL-BAHNASAWY MS , Osman Y, El-Hefnawy A, Hafez A, et al
Radical cystectomy and urinary diversion in women: impact on sexual function.
Scand J Urol Nephrol. 2011;45:332-8.
Abstract Related articles

JANCKE G , Rosell J, Jahnson S
Residual tumour in the marginal resection after a complete transurethral resection is associated with local recurrence in Ta/T1 urinary bladder cancer.
Scand J Urol Nephrol. 2012.
Abstract Related articles

HERMANN GG , Mogensen K, Toft BG, Glenthoj A, et al
Outpatient diagnostic of bladder tumours in flexible cystoscopes: evaluation of fluorescence-guided flexible cystoscopy and bladder biopsies.
Scand J Urol Nephrol. 2012;46:31-6.
Abstract Related articles

LIEDBERG F , Holmberg E, Holmang S, Ljungberg B, et al
Long-term follow-up after radical cystectomy with emphasis on complications and reoperations: a Swedish population-based survey.
Scand J Urol Nephrol. 2012;46:14-8.
Abstract Related articles

OLSSON H , Fyhr IM, Hultman P, Jahnson S, et al
HER2 status in primary stage T1 urothelial cell carcinoma of the urinary bladder.
Scand J Urol Nephrol. 2012;46:102-7.
Abstract Related articles

LIEDBERG F , Bendahl PO, Davidsson T, Gudjonsson S, et al
Preoperative staging of locally advanced bladder cancer before radical cystectomy using 3 tesla magnetic resonance imaging with a standardized protocol.
Scand J Urol Nephrol. 2012.
Abstract Related articles

ZHOU Y , Wu D, Tao J, Qu P, et al
MicroRNA-133 inhibits cell proliferation, migration and invasion by targeting epidermal growth factor receptor and its downstream effector proteins in bladder cancer.
Scand J Urol Nephrol. 2012.
Abstract Related articles

CERULLI C , Busetto GM, Antonini G, Giovannone R, et al
Primary Metastatic Neuroendocrine Small Cell Bladder Cancer: A Case Report and Literature Review.
Urol Int. 2012.
Abstract Related articles

JOVANOVIC M , Soldatovic I, Janjic A, Vuksanovic A, et al
Diagnostic value of the nuclear matrix protein 22 test and urine cytology in upper tract urothelial tumors.
Urol Int. 2011;87:134-7.
Abstract Related articles

KRUCK S , Bedke J, Hennenlotter J, Amend B, et al
Virtual bladder tumor transurethral resection: an objective evaluation tool to overcome learning curves with and without photodynamic diagnostics.
Urol Int. 2011;87:138-42.
Abstract Related articles

KRAMER MW , Waalkes S, Serth J, Hennenlotter J, et al
Decreased galectin-8 is a strong marker for recurrence in urothelial carcinoma of the bladder.
Urol Int. 2011;87:143-50.
Abstract Related articles

IDE H , Satou A, Hoshino K, Yasumizu Y, et al
Successful management of metastatic urothelial carcinoma with gemcitabine and Paclitaxel chemotherapy in a hemodialysis patient.
Urol Int. 2011;87:245-7.
Abstract Related articles

KANG SG , Kang SH, Choi H, Ko YH, et al
Robot-assisted partial cystectomy of a bladder pheochromocytoma.
Urol Int. 2011;87:241-4.
Abstract Related articles

RACIOPPI M , D'Agostino D, Totaro A, Pinto F, et al
Value of Current Chemotherapy and Surgery in Advanced and Metastatic Bladder Cancer.
Urol Int. 2012.
Abstract Related articles

RELJIC A , Trnski D
We Abandoned 'Superficial Bladder Cancer': We Accepted 'Non-Muscle-Invasive Bladder Cancer', but ... - On Occasion of the 10th Anniversary of the first EAU Guidelines on Bladder Cancer.
Urol Int. 2012.
Abstract Related articles

WANG AX , Chang JW, Li CY, Liu K, et al
H-ras Mutation Detection in Bladder Cancer by COLD-PCR Analysis and Direct Sequencing.
Urol Int. 2012.
Abstract Related articles

ZHU YP , Shen YJ, Ye DW, Wang CF, et al
Narrow-band imaging flexible cystoscopy in the detection of clinically unconfirmed positive urine cytology.
Urol Int. 2012;88:84-7.
Abstract Related articles

LI Y , Zhao X, Tang H, Zhong Z, et al
Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
Urol Int. 2012;88:95-101.
Abstract Related articles

ALTIERI VM , Castellucci R, Palumbo P, Verratti V, et al
Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer Using EORTC Risk Tables.
Urol Int. 2012.
Abstract Related articles

ORTEGREN J , Sundqvist P, Strandberg C, Weber P, et al
Arterial Bleeding during Transurethral Resection of Bladder Cancer Managed by Endovascular Intervention.
Urol Int. 2012.
Abstract Related articles

YAZAWA S , Kikuchi E, Takeda T, Matsumoto K, et al
Surgical and chemotherapeutic options for urachal carcinoma: report of ten cases and literature review.
Urol Int. 2012;88:209-14.
Abstract Related articles

VOLPE A , Racioppi M, Bongiovanni L, D'Agostino D, et al
Thermochemotherapy for Non-Muscle-Invasive Bladder Cancer: Is There a Chance to Avoid Early Cystectomy?.
Urol Int. 2012.
Abstract Related articles

MERTENS LS , Meinhardt W, Rier WB, Nooter RI, et al
Extravasation of Intravesical Chemotherapy for Non-Muscle-Invasive Bladder Cancer.
Urol Int. 2012.
Abstract Related articles

YANG Z , Lv Y, Lv Y, Wang Y, et al
Meta-Analysis Shows Strong Positive Association of the TNF-alpha Gene with Tumor Stage in Bladder Cancer.
Urol Int. 2012.
Abstract Related articles

WANG X , Lin YW, Wang S, Wu J, et al
A Meta-Analysis of Tea Consumption and the Risk of Bladder Cancer.
Urol Int. 2012.
Abstract Related articles

DE VRIES RR , Kauer P, van Tinteren H, van der Poel HG, et al
Short-term outcome after cystectomy: comparison of two different perioperative protocols.
Urol Int. 2012;88:383-9.
Abstract Related articles

KYROU D , Staios D, Papatsoris AG
Bladder perivascular epithelioid cell tumor: a novel rare neoplasm.
Urol Int. 2012;88:480-2.
Abstract Related articles

RACIOPPI M , Cappa E, D'Agostino D, Filianoti A, et al
Size of Bladder Cancers: Correlation among Different Types of Measurement.
Urol Int. 2012.
Abstract Related articles

BERGLUND RK
Editorial comment.
Urology. 2011;78:984.
Abstract Related articles

ORVIETO MA , DeCastro GJ, Trinh QD, Jeldres C, et al
Oncological and functional outcomes after robot-assisted radical cystectomy: critical review of current status.
Urology. 2011;78:977-84.
Abstract Related articles

LI Y , Jin X, Li J, Jin X, et al
Expression of TRAIL, DR4, and DR5 in Bladder Cancer: Correlation With Response to Adjuvant Therapy and Implications of Prognosis.
Urology. 2012.
Abstract Related articles

PARK SY , Rha KH
Re: Hemal et al.: Robotic-assisted nephroureterectomy and bladder cuff excision without intraoperative repositioning (Urology 2011;78:357-364).
Urology. 2011;78:1444.
Abstract Related articles

CARINI M , Minervini A
Editorial comment.
Urology. 2011;78:1354-5.
Abstract Related articles

KONETY BR
Editorial comment.
Urology. 2011;78:1349-50.
Abstract Related articles

ABDELSALAM YM , Mokhtar AA, Kurkar AA, Saleh MA, et al
Defining patient selection for prostate-sparing cystectomy in squamous cell carcinoma of the urinary bladder associated with bilharziasis: an overview of 236 patients.
Urology. 2011;78:1351-4.
Abstract Related articles

MURAMAKI M , Miyake H, Terakawa T, Kusuda Y, et al
Expression profile of E-cadherin and N-cadherin in urothelial carcinoma of the upper urinary tract is associated with disease recurrence in patients undergoing nephroureterectomy.
Urology. 2011;78:1443.
Abstract Related articles

GUPTA AD , Bandari J, Ross AE, McCall CM, et al
Management of primary squamous cell carcinoma at the mucocutaneous junction of an ileal conduit.
Urology. 2011;78:1229-31.
Abstract Related articles

KNOPF J , Messing E
Editorial comment.
Urology. 2012;79:171.
Abstract Related articles

HORI S , Thiruchelvam N
Life-threatening hematuria due to recurrent arterial-conduit fistula.
Urology. 2012;79:23-7.
Abstract Related articles

LECUONA AT , Van Wyk AC, Smit SG, Zarrabi AD, et al
Inflammatory myofibroblastic tumor of the bladder in a 3-year-old boy.
Urology. 2012;79:215-8.
Abstract Related articles

URQUIDI V , Goodison S, Kim J, Chang M, et al
Vascular Endothelial Growth Factor, Carbonic Anhydrase 9, and Angiogenin as Urinary Biomarkers for Bladder Cancer Detection.
Urology. 2012.
Abstract Related articles

TORREY RR , Chan KG, Yip W, Josephson DY, et al
Functional Outcomes and Complications in Patients With Bladder Cancer Undergoing Robotic-assisted Radical Cystectomy With Extracorporeal Indiana Pouch Continent Cutaneous Urinary Diversion.
Urology. 2012.
Abstract Related articles

ZHANG CJ , Shen ZJ, Pan CW, Zhong S, et al
Engagement of integrinbeta1 induces resistance of bladder cancer cells to mitomycin-C.
Urology. 2012;79:638-43.
Abstract Related articles

TODENHOFER T , Hennenlotter J, Kuhs U, Tews V, et al
Influence of urinary tract instrumentation and inflammation on the performance of urine markers for the detection of bladder cancer.
Urology. 2012;79:620-5.
Abstract Related articles

CHUN SY , Kim HT, Lee JS, Kim MJ, et al
Characterization of Urine-Derived Cells From Upper Urinary Tract in Patients With Bladder Cancer.
Urology. 2012.
Abstract Related articles

TRITSCHLER S , Mosler C, Tilki D, Buchner A, et al
Interobserver Variability Limits Exact Preoperative Staging by Computed Tomography in Bladder Cancer.
Urology. 2012.
Abstract Related articles

GONDO T , Nakashima J, Ohno Y, Choichiro O, et al
Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Establishment of Novel Preoperative Risk Stratification Model in Bladder Cancer Patients Treated with Radical Cystectomy.
Urology. 2012.
Abstract Related articles

HA YS , Jeong P, Kim JS, Kwon WA, et al
Tumorigenic and Prognostic Significance of RASSF1A Expression in Low-grade (WHO Grade 1 and Grade 2) Nonmuscle-invasive Bladder Cancer.
Urology. 2012.
Abstract Related articles

JIANG B , Li EH, Lu YY, Jiang Q, et al
Inhibition of Fatty-acid Synthase Suppresses P-AKT and Induces Apoptosis in Bladder Cancer.
Urology. 2012.
Abstract Related articles

KUEHHAS FE , Weibl P, Tosev G, Schatzl G, et al
Multidetector computed tomography virtual cystoscopy: an effective diagnostic tool in patients with hematuria.
Urology. 2012;79:270-6.
Abstract Related articles

YESHCHINA O , Badalato GM, Wosnitzer MS, Hruby G, et al
Relative efficacy of perioperative gemcitabine and cisplatin versus methotrexate, vinblastine, adriamycin, and cisplatin in the management of locally advanced urothelial carcinoma of the bladder.
Urology. 2012;79:384-90.
Abstract Related articles

RUBINO B , Dorin R, Naemi K, Skinner EC, et al
A 37-year-old man with a history of bladder augmentation presented with gross hematuria, weight loss and flank pain.
Urology. 2012;79:256-9.
Abstract Related articles

CHEN H , Niu ZB, Yang Y
Bladder leiomyoma in a 6-year-old boy.
Urology. 2012;79:434-6.
Abstract Related articles

CANTER D , Simhan J, Smaldone MC, Lebed B, et al
Clinical Stage T1 micropapillary urothelial carcinoma presenting with metastasis to the pancreas.
Urology. 2012;79:e9-10.
Abstract Related articles

BARBALAT Y , Dombrovskiy VY, Weiss RE
Association Between Pioglitazone and Urothelial Bladder Cancer.
Urology. 2012.
Abstract Related articles

SZARVAS T , Jager T, Laszlo V, Kramer G, et al
Circulating Angiostatin, bFGF, and Tie2/TEK Levels and Their Prognostic Impact in Bladder Cancer.
Urology. 2012.
Abstract Related articles

NIEDER AM
Editorial comment.
Urology. 2012;79:625.
Abstract Related articles

WANG JK , Tollefson MK, Krambeck AE, Trost LW, et al
High rate of pathologic upgrading at nephroureterectomy for upper tract urothelial carcinoma.
Urology. 2012;79:615-9.
Abstract Related articles

GUILLOTREAU J , Miocinovic R, Game X, Forest S, et al
Outcomes of laparoscopic and robotic radical cystectomy in the elderly patients.
Urology. 2012;79:585-90.
Abstract Related articles

ZHANG ZH , Yang LS, Sun YH
Re: li et Al.: milk and dairy consumption and risk of bladder cancer: a meta-analysis (urology 2011;78:1298-1305).
Urology. 2012;80:231-2.
Abstract Related articles

AGARWAL MM , Mavuduru R, Singh SK, Mandal AK, et al
Preliminary short-term outcomes of a modified double-T ileal continent cutaneous urinary diversion using Yang-Monti tube implantation through serosa-lined extramural tunnel: the PGIMER pouch.
Urology. 2012;79:943-9.
Abstract Related articles

RISTAU BT , Tomaszewski JJ, Ost MC
Upper tract urothelial carcinoma: current treatment and outcomes.
Urology. 2012;79:749-56.
Abstract Related articles

NOUHAUD FX , Le Gal S
Bladder metastasis from maxillary sinus undifferentiated carcinoma: a rare case.
Urology. 2012;79:e67-8.
Abstract Related articles

SLEEPER J , Margulis V
Editorial comment.
Urology. 2012;79:1091.
Abstract Related articles

HERR HW
Editorial comment.
Urology. 2012;79:851-2.
Abstract Related articles

GEAVLETE B , Multescu R, Georgescu D, Stanescu F, et al
Narrow band imaging cystoscopy and bipolar plasma vaporization for large nonmuscle-invasive bladder tumors--results of a prospective, randomized comparison to the standard approach.
Urology. 2012;79:846-51.
Abstract Related articles

BALA I , Bharti N, Chaubey VK, Mandal AK, et al
Efficacy of gabapentin for prevention of postoperative catheter-related bladder discomfort in patients undergoing transurethral resection of bladder tumor.
Urology. 2012;79:853-7.
Abstract Related articles

DUDLEY AG , Tomaszewski JJ, Hughes AH, Davies BJ, et al
Incidentally discovered osseous metaplasia within high-grade urothelial carcinoma of the bladder.
Urology. 2012;79:e59-60.
Abstract Related articles

JANCKE G , Rosell J, Chebil G, Jahnson S, et al
Bladder wash cytology at diagnosis of ta-t1 bladder cancer is predictive for recurrence and progression.
Urology. 2012;80:625-31.
Abstract Related articles

NOUHAUD FX , Di Fiore F, Noel N, Gobet F, et al
Scrotal Metastasis From a Nonmuscle-infiltrative Bladder Cancer: A Surprising Clinical Evolution.
Urology. 2012.
Abstract Related articles

SAWAZAKI H , Goto H, Takao N, Taki Y, et al
Clear cell adenocarcinoma arising from abdominal wall endometriosis mimicking urachal tumor.
Urology. 2012;79:e84-5.
Abstract Related articles

STYN NR , Montgomery JS, Wood DP, Hafez KS, et al
Matched comparison of robotic-assisted and open radical cystectomy.
Urology. 2012;79:1303-8.
Abstract Related articles

HERR HW
Editorial comment.
Urology. 2012;79:1308.
Abstract Related articles

RAHMAT JN , Esuvaranathan K, Mahendran R
Bacillus Calmette-Guerin induces cellular reactive oxygen species and lipid peroxidation in cancer cells.
Urology. 2012;79:1411.
Abstract Related articles

ANDERSON CB , Feurer ID, Large MC, Steinberg GD, et al
Psychometric characteristics of a condition-specific, health-related quality-of-life survey: the FACT-Vanderbilt Cystectomy Index.
Urology. 2012;80:77-83.
Abstract Related articles

GILBERT S
Editorial comment.
Urology. 2012;80:83.
Abstract Related articles

ZAPATERO A , Martin De Vidales C, Arellano R, Ibanez Y, et al
Long-term Results of Two Prospective Bladder-sparing Trimodality Approaches for Invasive Bladder Cancer: Neoadjuvant Chemotherapy and Concurrent Radio-chemotherapy.
Urology. 2012 Sep 18. pii: S0090-4295(12)00867.
Abstract Related articles

LEE C , Kim KH, You D, Jeong IG, et al
Smoking and Survival After Radical Cystectomy for Bladder Cancer.
Urology. 2012 Oct 5. pii: S0090-4295(12)00941.
Abstract Related articles

DANESHMAND S , Ahmadi H, Huynh LN, Dobos N, et al
Preoperative Staging of Invasive Bladder Cancer With Dynamic Gadolinium-enhanced Magnetic Resonance Imaging: Results From a Prospective Study.
Urology. 2012 Oct 4. pii: S0090-4295(12)00924.
Abstract Related articles

MENG MV
Editorial comment.
Urology. 2012;80:359.
Abstract Related articles

KARAOLIDES T , Skolarikos A, Bourdoumis A, Konandreas A, et al
Hexaminolevulinate-induced fluorescence versus white light during transurethral resection of noninvasive bladder tumor: does it reduce recurrences?
Urology. 2012;80:354-9.
Abstract Related articles

WANG H , Isaji T, Satoh M, Li D, et al
Antitumor Effects of Exogenous Ganglioside GM3 on Bladder Cancer in an Orthotopic Cancer Model.
Urology. 2012 Oct 24. pii: S0090-4295(12)00927.
Abstract Related articles

MORGAN TM , Barocas DA, Penson DF, Chang SS, et al
Lymph node yield at radical cystectomy predicts mortality in node-negative and not node-positive patients.
Urology. 2012;80:632-40.
Abstract Related articles

DANESHMAND S
Editorial comment.
Urology. 2012;80:639.
Abstract Related articles

SZYMANSKI LJ , Szymanski JM, Muhletaler F, Alassi O, et al
A 50-year-old with gross hematuria.
Urology. 2012;80:509-11.
Abstract Related articles

CHAN ES , Patel AR, Hansel DE, Larchian WA, et al
Sunitinib malate provides activity against murine bladder tumor growth and invasion in a preclinical orthotopic model.
Urology. 2012;80:736.
Abstract Related articles

MSAOUEL P , Koutsilieris M
Diagnostic value of circulating tumor cell detection in bladder and urothelial cancer: systematic review and meta-analysis.
BMC Cancer. 2011;11:336.
Abstract Related articles

TOLLE A , Suhail S, Jung M, Jung K, et al
Fatty acid binding proteins (FABPs) in prostate, bladder and kidney cancer cell lines and the use of IL-FABP as survival predictor in patients with renal cell carcinoma.
BMC Cancer. 2011;11:302.
Abstract Related articles

CHEN B , Zeng ZC, Wang GM, Zhang L, et al
Radiotherapy may improve overall survival of patients with T3/T4 transitional cell carcinoma of the renal pelvis or ureter and delay bladder tumour relapse.
BMC Cancer. 2011;11:297.
Abstract Related articles

SUN JM , Sung JY, Park SH, Kwon GY, et al
ERCC1 as a biomarker for bladder cancer patients likely to benefit from adjuvant chemotherapy.
BMC Cancer. 2012;12:187.
Abstract Related articles

JI C , Liu Z, Chen H, Guo H, et al
An association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer in non-smokers: a meta-analysis.
BMC Cancer. 2012;12:335.
Abstract Related articles

OTTO W , Rubenwolf PC, Burger M, Fritsche HM, et al
Loss of aquaporin 3 protein expression constitutes an independent prognostic factor for progression-free survival: an immunohistochemical study on stage pT1 urothelial bladder cancer.
BMC Cancer. 2012;12:459.
Abstract Related articles

CHANG J , Dinney CP, Huang M, Wu X, et al
Genetic variants in telomere-maintenance genes and bladder cancer risk.
PLoS One. 2012;7:e30665.
Abstract Related articles

JOHNEN G , Gawrych K, Bontrup H, Pesch B, et al
Performance of Survivin mRNA as a Biomarker for Bladder Cancer in the Prospective Study UroScreen.
PLoS One. 2012;7:e35363.
Abstract Related articles

ZHAO Y , Guo S, Sun J, Huang Z, et al
Methylcap-seq reveals novel DNA methylation markers for the diagnosis and recurrence prediction of bladder cancer in a chinese population.
PLoS One. 2012;7:e35175.
Abstract Related articles

DEGRAFF DJ , Clark PE, Cates JM, Yamashita H, et al
Loss of the Urothelial Differentiation Marker FOXA1 Is Associated with High Grade, Late Stage Bladder Cancer and Increased Tumor Proliferation.
PLoS One. 2012;7:e36669.
Abstract Related articles

URQUIDI V , Kim J, Chang M, Dai Y, et al
CCL18 in a Multiplex Urine-Based Assay for the Detection of Bladder Cancer.
PLoS One. 2012;7:e37797.
Abstract Related articles

PATCHSUNG M , Boonla C, Amnattrakul P, Dissayabutra T, et al
Long interspersed nuclear element-1 hypomethylation and oxidative stress: correlation and bladder cancer diagnostic potential.
PLoS One. 2012;7:e37009.
Abstract Related articles

WEI H , Kamat A, Chen M, Ke HL, et al
Association of polymorphisms in oxidative stress genes with clinical outcomes for bladder cancer treated with bacillus calmette-guerin.
PLoS One. 2012;7:e38533.
Abstract Related articles

HO JR , Chapeaublanc E, Kirkwood L, Nicolle R, et al
Deregulation of rab and rab effector genes in bladder cancer.
PLoS One. 2012;7:e39469.
Abstract Related articles

LUO J , Cai Q, Wang W, Huang H, et al
A MicroRNA-7 Binding Site Polymorphism in HOXB5 Leads to Differential Gene Expression in Bladder Cancer.
PLoS One. 2012;7:e40127.
Abstract Related articles

KELLY JD , Dudderidge TJ, Wollenschlaeger A, Okoturo O, et al
Bladder cancer diagnosis and identification of clinically significant disease by combined urinary detection of mcm5 and nuclear matrix protein 22.
PLoS One. 2012;7:e40305.
Abstract Related articles

MAJEWSKI T , Spiess PE, Bondaruk J, Black P, et al
Detection of bladder cancer using proteomic profiling of urine sediments.
PLoS One. 2012;7:e42452.
Abstract Related articles

HUANG KH , Kuo KL, Chen SC, Weng TI, et al
Down-regulation of glucose-regulated protein (GRP) 78 potentiates cytotoxic effect of celecoxib in human urothelial carcinoma cells.
PLoS One. 2012;7:e33615.
Abstract Related articles

VAN TILBORG AA , Kompier LC, Lurkin I, Poort R, et al
Selection of Microsatellite Markers for Bladder Cancer Diagnosis without the Need for Corresponding Blood.
PLoS One. 2012;7:e43345.
Abstract Related articles

LEE SJ , Lee EJ, Kim SK, Jeong P, et al
Identification of Pro-Inflammatory Cytokines Associated with Muscle Invasive Bladder Cancer; The Roles of IL-5, IL-20, and IL-28A.
PLoS One. 2012;7:e40267.
Abstract Related articles

CZACHOROWSKI MJ , Amaral AF, Montes-Moreno S, Lloreta J, et al
Cyclooxygenase-2 Expression in Bladder Cancer and Patient Prognosis: Results from a Large Clinical Cohort and Meta-Analysis.
PLoS One. 2012;7:e45025.
Abstract Related articles

MAJID S , Dar AA, Saini S, Shahryari V, et al
MicroRNA-1280 Inhibits Invasion and Metastasis by Targeting ROCK1 in Bladder Cancer.
PLoS One. 2012;7:e46743.
Abstract Related articles

REINERT T , Borre M, Christiansen A, Hermann GG, et al
Diagnosis of Bladder Cancer Recurrence Based on Urinary Levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 Hypermethylation.
PLoS One. 2012;7:e46297.
Abstract Related articles

GOODISON S , Chang M, Dai Y, Urquidi V, et al
A multi-analyte assay for the non-invasive detection of bladder cancer.
PLoS One. 2012;7:e47469.
Abstract Related articles

CHEN Z , Ding W, Xu K, Tan J, et al
The 1973 WHO Classification Is More Suitable than the 2004 WHO Classification for Predicting Prognosis in Non-Muscle-Invasive Bladder Cancer.
PLoS One. 2012;7:e47199.
Abstract Related articles

GAO T , Wang S, He B, Pan Y, et al
The Association of RAS Association Domain Family Protein1A (RASSF1A) Methylation States and Bladder Cancer Risk: A Systematic Review and Meta-Analysis.
PLoS One. 2012;7:e48300.
Abstract Related articles

PICHU S , Krishnamoorthy S, Shishkov A, Zhang B, et al
Knockdown of Ki-67 by Dicer-Substrate Small Interfering RNA Sensitizes Bladder Cancer Cells to Curcumin-Induced Tumor Inhibition.
PLoS One. 2012;7:e48567.
Abstract Related articles

HIRATA H , Ueno K, Shahryari V, Tanaka Y, et al
Oncogenic miRNA-182-5p Targets Smad4 and RECK in Human Bladder Cancer.
PLoS One. 2012;7:e51056.
Abstract Related articles

HEPBURN AC , Veeratterapillay R, Williamson SC, El-Sherif A, et al
Side population in human non-muscle invasive bladder cancer enriches for cancer stem cells that are maintained by MAPK signalling.
PLoS One. 2012;7:e50690.
Abstract Related articles

RATERT N , Meyer HA, Jung M, Mollenkopf HJ, et al
Reference miRNAs for miRNAome analysis of urothelial carcinomas.
PLoS One. 2012;7:e39309.
Abstract Related articles

LINDGREN D , Sjodahl G, Lauss M, Staaf J, et al
Integrated genomic and gene expression profiling identifies two major genomic circuits in urothelial carcinoma.
PLoS One. 2012;7:e38863.
Abstract Related articles

ROPERTO S , Borzacchiello G, Esposito I, Riccardi M, et al
Productive infection of bovine papillomavirus type 2 in the placenta of pregnant cows affected with urinary bladder tumors.
PLoS One. 2012;7:e33569.
Abstract Related articles

WEI H , Kamat AM, Aldousari S, Ye Y, et al
Genetic variations in the transforming growth factor Beta pathway as predictors of bladder cancer risk.
PLoS One. 2012;7:e51758.
Abstract Related articles

Correction for Volkmer et al., Three differentiation states risk-stratify bladder cancer into distinct subtypes.
Proc Natl Acad Sci U S A. 2012.
Abstract Related articles

FU YP , Kohaar I, Rothman N, Earl J, et al
Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk.
Proc Natl Acad Sci U S A. 2012.
Abstract Related articles

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Pierre Fabre.

Design:

;